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A B S T R A C T
Background
In people who have had a stroke, upper limb paresis affects many activities of daily life. Reducing disability is therefore a major aim of
rehabilitative interventions. Despite preserving or recovering movement ability after stroke, sometimes people do not fully realise this
ability in their everyday activities. Constraint-induced movement therapy (CIMT) is an approach to stroke rehabilitation that involves
the forced use and massed practice of the affected arm by restraining the unaffected arm. This has been proposed as a useful tool for
recovering abilities in everyday activities.
Objectives
To assess the efficacy of CIMT, modified CIMT (mCIMT), or forced use (FU) for arm management in people with hemiparesis after
stroke.
Search methods
We searched the Cochrane Stroke Group trials register (last searched June 2015), the Cochrane Central Register of Controlled Trials
(CENTRAL; The Cochrane Library Issue 1, 2015), MEDLINE (1966 to January 2015), EMBASE (1980 to January 2015), CINAHL
(1982 to January 2015), and the Physiotherapy Evidence Database (PEDro; January 2015).
Selection criteria
Randomised control trials (RCTs) and quasi-RCTs comparing CIMT, mCIMT or FU with other rehabilitative techniques, or none.
Data collection and analysis
One author identified trials from the results of the electronic searches according to the inclusion and exclusion criteria, three review
authors independently assessed methodological quality and risk of bias, and extracted data. The primary outcome was disability.
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Main results
We included 42 studies involving 1453 participants. The trials included participants who had some residual motor power of the paretic
arm, the potential for further motor recovery and with limited pain or spasticity, but tended to use the limb little, if at all. The majority
of studies were underpowered (median number of included participants was 29) and we cannot rule out small-trial bias. Eleven trials
(344 participants) assessed disability immediately after the intervention, indicating a non-significant standard mean difference (SMD)
0.24 (95% confidence interval (CI) -0.05 to 0.52) favouring CIMT compared with conventional treatment. For the most frequently
reported outcome, arm motor function (28 studies involving 858 participants), the SMD was 0.34 (95% CI 0.12 to 0.55) showing a
significant effect (P value 0.004) in favour of CIMT. Three studies involving 125 participants explored disability after a few months of
follow-up and found no significant difference, SMD -0.20 (95% CI -0.57 to 0.16) in favour of conventional treatment.
Authors’ conclusions
CIMT is a multi-faceted intervention where restriction of the less affected limb is accompanied by increased exercise tailored to the
person’s capacity. We found that CIMT was associated with limited improvements in motor impairment and motor function, but
that these benefits did not convincingly reduce disability. This differs from the result of our previous meta-analysis where there was
a suggestion that CIMT might be superior to traditional rehabilitation. Information about the long-term effects of CIMT is scarce.
Further trials studying the relationship between participant characteristics and improved outcomes are required.
P L A I N L A N G U A G E S U M M A R Y
Constraint-induced movement therapy for upper limb (arm) recovery after stroke
Review question
We wanted to assess the effects of constraint-induced movement therapy (CIMT) on ability to manage daily activities and on the
recovery of movement in paralysed arms after a stroke.
Background
After a stroke, people can suffer from paralysis of an arm, and, even if some movement control remains, use it less than the unaffected
arm. The paralysis makes arm movements, such as reaching, grasping, and manipulating objects difficult. In turn, this causes many
difficulties in activities of daily life, such as bathing, dressing, eating and using the toilet. During CIMT the unaffected arm is restrained
so it cannot be used, which means the affected arm has to be used instead. The unaffected arm and hand are prevented from moving
with a glove or a special arm rest. CIMT is supposed to be a useful tool for recovering the ability to perform everyday activities.
Study characteristics
We, a team of Cochrane researchers, searched widely through the medical literature and identified 42 relevant studies involving 1453
participants. The evidence is current to January 2015. The participants in these studies had some control of their affected arm and were
generally able to open their affected hand by extending the wrist and fingers. CIMT treatments varied between studies in terms of the
time for which the participants’ unaffected arm was constrained each day, and the amount of active exercise that the affected arm was
required to do. CIMT was compared mainly to active physiotherapy treatments, and sometimes to no treatment.
Key results
The 42 studies assessed different aspects of recovery from stroke, and not all measured the same things. Eleven studies (with 344
participants) assessed the effect of CIMT on disability (the effective use of the arm in daily living) and found that the use of CIMT
did not lead to improvement in ability to manage everyday activities such as bathing, dressing, eating, and toileting. Twenty-eight trials
(with 858 participants) tested whether CIMT improved the ability to use the affected arm. CIMT appeared to be more effective at
improving arm movement than active physiotherapy treatments or no treatment.
Quality of the evidence
The quality of the evidence for each outcome is limited due to small numbers of study participants and poor reporting of study details.
We considered the quality of the evidence to be low for disability and very low for the ability to use the affected arm.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Constraint-induced movement therapy (CIMT) or modified CIMT (mCIMT) or Forced Use (FU) compared with usual care or no treatment for the recovery of affected upper limb in
people with stroke
Patient or population: people with stroke receiving upper limb rehabilitation
Settings: inpatient and outpatients
Intervention: CIMT or mCIMT or FU
Comparison: usual care or no treatment
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Comments
Assumed risk Corresponding risk
Usual care or no treatment CIMT or mCIMT or FU
Disability
different scales assessing dis-
ability or dependence in activ-
ities of daily living
Follow-up: at the end of treat-
ment
The mean disability in the in-
tervention groups was
0.24 standard deviations
higher
(-0.05 lower to 0.52 higher)
344
(11 studies)
A standard deviation of 0.24 rep-
resents a small difference between
the groups
The estimated effect is non signifi-
cant because its 95% interval con-
fidence includes the null effect
Arm Motor Function
different scales assessing
motor ability and functioning
of upper extremity in functional
tasks
Follow-up: at the end of treat-
ment
The mean arm motor function
in the intervention groups was
0.34 standard deviations
higher
(0.12 to 0.55 higher)
858
(28 studies)
A standard deviation of 0.34 rep-
resents a small difference between
the groups
Perceived Arm Motor Func-
tion (Quality of Use)
Motor Activity Log scale.
Follow-up: at the end of treat-
ment
The mean perceived arm mo-
tor function (quality of use)
ranged across control groups
from 0.14 to 1.4 points
The mean perceived arm mo-
tor function (quality of use) in
the intervention groups was
0.68 higher
(0.47 to 0.88 higher)
891
(24 studies)
The minimal clinically important dif-
ference for this scale assessing the
quality of use is 1 or 1.1 points
depending on the dominance of the
affected arm (Lang 2008).
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Perceived Arm Motor Func-
tion (Amount of Use)
Motor Activity Log scale Fol-
low-up: at the end of treatment
The mean perceived arm mo-
tor function (amount of use)
ranged across control groups
from -0.07 to 1.6 points
The mean perceived arm mo-
tor function (amount of use) in
the intervention groups was
0.79 higher
(0.50 to 1.08 higher)
851
(23 studies)
Arm Motor Impairment
different scales assessing the
impairment
Follow-up: at the end of treat-
ment
The mean arm motor im-
pairment in the intervention
groups was
0.82 standard deviations
higher
(0.31 to 1.34 higher)
372
(16 studies)
A standard deviation of 0.82 rep-
resents a large difference between
the groups
Quality of life
Stroke Impact Scale
Follow-up: at the end of treat-
ment
The mean quality of life score
ranged across control groups
from -3.46 to 7.5 points
The mean quality of life in the
intervention groups was
6.54 higher
(-1.2 lower to 14.28 higher)
96
(3 studies)
Dexterity
Different tests assessing dex-
terity
Follow-up: at the end of treat-
ment
The mean dexterity in the in-
tervention groups was
0.42 standard deviations
higher
(0.04 lower to 0.79 higher)
113
(4 studies)
A standard deviation of 0.42 rep-
resents a small difference between
the groups
*The assumed risk is based on the highest and the lowest estimate of the scores in the control groups. The corresponding risk (and its 95% confidence interval) is based on the assumed
risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval
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B A C K G R O U N D
Description of the condition
Stroke is a health concern worldwide and one of the main causes
of disability (Albert 2012; WHO 2011). In Europe, stroke costs
around EUR 64.1 billion, and in the United Kingdom around
GBP 8.9 billion per annum is spent on community care and reha-
bilitation of people after stroke (Gustavsson 2010; Saka 2009). In
fact, only 12% of people that experience a stroke are independent
in basic activities of daily living (ADL) one week after stroke onset
(Wade 1987); in the long-term, up to 74% of them have to rely
on assistance for basic ADLs like feeding, self-care, and mobility
(Miller 2010).
Description of the intervention
To restore independence to stroke survivors and reduce the cost
of therapy and care, a number of approaches are now being in-
vestigated in an attempt to increase the effectiveness of stroke re-
habilitation techniques for the recovery of the upper extremity
(Pollock 2014). The management of upper extremity in people
with stroke can involve a number of different treatments, which
include: bilateral arm training (McCombe Waller 2008), biofeed-
back (Crow1989;Moreland 1994;Rathkolb 1990; Sathian2000),
brain stimulation (Dayan 2013; Kagan 2012), electrical stimu-
lation/functional electrical stimulation (Pomeroy 2006), mental
practice (Page 2005a; Page 2007a), mirror therapy (Michielsen
2010), robot assistance (Hesse 2003; Lum 2002; Masiero 2007;
Mehrholz 2012), repetitive task training (French 2007), virtual
reality (Laver 2011), and constraint-induced movement therapy
(CIMT; Miltner 1999; Page 2001; Page 2002a; Taub 1993; Taub
1994; Taub 1999).
CIMT, as described by the first authors (Miltner 1999; Taub 1994;
Taub 1999), is based on two fundamental principles.
• Forced use of the affected arm by restraining the unaffected
arm, with a sling or a hand splint, during dedicated exercise
sections or usual ADLs (90% of waking hours).
• Massed practice (several hours of exercise) of the affected
arm through a shaping method, where shaping involves a
commonly operant conditioning method in which a behavioural
objective (in this case ’movement’) is approached in small steps
of progressively increasing difficulty. The participant is rewarded
with enthusiastic approval for improvement, but never blamed
or punished for failure.
The initial report of the use of CIMT proposed extensive and
intensive training (six to eight hours per day; Miltner 1999; Taub
1994; Taub 1999); over the years, though, others have developed
different forms of constraint therapy, reducing the training during
the period of restraint (Page 2001; Page 2002a; Page 2002b), or
concentrating only on the use of restraint (forced use), with no
additional treatment of the affected arm (Burns 2007; Ploughman
2004).
How the intervention might work
The rationale for CIMT is based on the theory of ’learning non-
use’ from experiments onmonkeys. Researchers observed that after
upper limb de-afferentation (interruption of nerves), monkeys did
not use their affected limb even though their motor ability was
nearly normal (Knapp 1963; Taub 1977; Taub 1980). This ’non-
use’ was an acquired behaviour learned during the spinal shock
period and, as a consequence of its origin, could be reversed by
behavioural measures such as, for example, constraint of the sound
limb. Thus the learned ’non-use’ theory predicts that people after
stroke have, in fact, greater movement ability than they show in
their everyday tasks. If this is correct, constraint of the unaffected
arm would be a useful tool for realising this ability in everyday
activities (Sterr 2006).
Why it is important to do this review
Over recent years, the neuroplasticity and cortical reorganisation
of the central nervous system (CNS) has been observed and de-
scribed in trials with people after stroke undergoing CIMT (Kim
2004; Levy 2001; Liepert 2000; Liepert 2001; Lin 2010; Ro 2006;
Schaechter 2002; Szaflarski 2006). The preliminary findings sug-
gest that the functional improvements produced by CIMT are ac-
companied by plastic brain reorganisation associating noticeable
brain changes with functional improvements related to CIMT.
Our initial review published in 2008 identified 19 studies, now
several new studies have been published and an update of our re-
view was necessary in order to define better the effect of constrain-
ing therapies on stroke recovery.
O B J E C T I V E S
To assess the efficacy of CIMT, modified CIMT (mCIMT), or
forced use (FU) for arm management in people with hemiparesis
after stroke.
M E T H O D S
Criteria for considering studies for this review
Types of studies
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Randomised controlled trials (RCTs) and quasi-RCTs comparing
CIMT or mCIMT or FU with other rehabilitative techniques
(occupational therapy or physiotherapy), or none.
Types of participants
We examined trials of adults (aged over 18 years) with a clinical di-
agnosis of stroke, either ischaemic or haemorrhagic (WorldHealth
Organization (WHO) definition; Hatano 1976), with paresis of
an arm.
Types of interventions
The studies included all used CIMT or mCIMT or FU for the
treatment of the affected upper limb compared with other reha-
bilitative techniques (occupational therapy or physiotherapy) or
none.
For the purpose of this review we used the following definitions
(as described in Hoare 2007):
• CIMT: restraint of the unaffected upper limb, with more
than three hours per day of therapy;
• mCIMT: restraint of the unaffected upper limb, with three
hours or less per day of therapy;
• FU: restraint of the unaffected upper limb but no specific
treatment of the affected upper limb.
We considered all interventions, irrespective of:
• number of hours of training per day;
• number of hours of restraint per day;
• duration of treatment;
• type of exercise used in training sessions.
Types of outcome measures
If a study presented more than one measure for the same outcome
category, we included the measure most frequently used across
studies in the analysis.
Primary outcomes
Disability
Functional Independence Measure (FIM), Barthel Index (BI).
Secondary outcomes
Arm motor function
Wolf Motor Function Test (only score; WFMT), Arm Research
ArmTest (ARAT), ArmMotorAbilityTest (AMAT), Emory Func-
tion Test (EMF), Assessment of motor and process skills (AMPS).
Perceived arm motor function
Motor Activity Log (MAL): Amount of Use (AoU) and Quality
of Use (QoU).
Arm motor impairment
Fugl Meyer Assessment (FMA), Chedoke McMaster Impairment
Inventory (CMII), hand strength.
Quality of life
Stoke Impact Scale (SIS).
Dexterity*
Nine-Hole Peg Test (9HPT), Sixteen-Hole Peg Test (16HPT),
Grooved Pegboard Test (GPT).
* a low score in scales assessing this item indicates a positive out-
come and indicates a better performance.
Search methods for identification of studies
See the ’Specialized register’ section in the Cochrane Stroke Group
module.We searched for trials in all languages and arranged trans-
lation of relevant papers where necessary.
Electronic searches
We searched the Cochrane Stroke Group Trials Register (last
searched June 2015), the Cochrane Central Register of Controlled
Trials (CENTRAL; The Cochrane Library 2015, Issue 1; Appendix
1), MEDLINE Ovid (1966 to January 2015; Appendix 2), EM-
BASE Ovid (1980 to January 2015; Appendix 3), CINAHL Eb-
sco (1982 to January 2015; Appendix 4), AMED Ovid (1985 to
January 2015; Appendix 5), and in January 2015 the Physiother-
apy Evidence Database (PEDro; http://ptwww.cchs.usyd.edu.au/
pedro/; Appendix 6).
In addition, we searched the following trials registries:
• National Institute of Health Clinical Trials Database (http:/
/www.clinicaltrials.gov; 1 June 2015);
• Stroke Trials Registry (www.strokecenter.org/trials/; 1 June
2015).
Searching other resources
We also searched the reference lists of relevant papers.
Data collection and analysis
Selection of studies
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One review author (DC) read the titles of identified references and
eliminated obviously irrelevant studies. We obtained abstracts for
the remaining studies and then, on the basis of the inclusion crite-
ria, two review authors (DC and VS) independently ranked these
as ’relevant’, ’irrelevant’ or ’unsure’. We retrieved and reviewed the
full text articles for those ranked as relevant and those ranked as
unsure. We resolved disagreements by consensus, and consulted a
third review author (RG) if disagreements persisted.
We have documented the reasons for the exclusion of studies in
Characteristics of excluded studies. When studies published in
non-English languages appeared relevant, we retrieved the full text
and asked a native speaker to translate it in order to ascertain
whether the study met the inclusion criteria.
Data extraction and management
Four review authors (DC, VS, GC and RG) independently ex-
tracted data. We recorded all data on a standardised checklist, in-
corporating:methods (e.g. randomisation, blinding, completeness
of follow-up, reliability and validity of scales), details of partici-
pants (e.g. age, sex, time since stroke, side affected), interventions,
inclusion and exclusion criteria, and all assessed outcomes. We
resolved disagreements by consensus. In some cases we contacted
study authors by email for clarification. When not clearly reported
or imputable, we extracted numeric data from graphs through the
use of Engauge Software 5.1.
Assessment of risk of bias in included studies
We assessed the risk of bias in the included studies using the criteria
in the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011).
Methods of randomisation
We regarded a randomisation method as appropriate if it meant
that each study participant had the same chance of receiving each
intervention. We considered the following methods of allocation
appropriate: using random number tables, a computer random
number generator, coin tossing, or card shuffling.
Allocation concealment (when the investigators cannot
predict which treatment comes next)
We scored this as:
• low risk of bias - when the method of allocation was clearly
described (e.g. central randomisation, serially numbered opaque,
sealed envelopes);
• unclear risk of bias - when the authors did not report any
allocation concealment approach at all, or did not describe it
clearly;
• high risk of bias - when the method of allocation was not
concealed.
Potential for selection bias after allocation
We scored this as:
• low risk of bias - trials where an intention-to-treat analysis
was possible and there were few losses to follow up;
• unclear risk of bias - trials reporting exclusions (less than
10% exclusions);
• high risk of bias - no reporting of exclusions, or more than
10% exclusions, or wide differences in exclusions between
groups.
Blinding with reference only to the outcome assessor
We scored this as:
• low risk of bias - blinded;
• unclear risk of bias - information not reported;
• high risk of bias - not blinded.
Follow-up
We scored this as:
• low risk of bias - if the numbers and reasons for dropouts
and withdrawals in all intervention groups were described and if
90% or more of the randomised participants were included in
the analysis, or if it was specified that there were no dropouts or
withdrawals;
• unclear risk of bias - if the report gave the impression there
were no dropouts or withdrawals, but it was not specifically
stated;
• high risk of bias - if less than 90% of the randomised
participants were included in the analysis or the number or
reasons for dropouts and withdrawals were not described.
Scales to measure outcomes
Scales had to be supported by studies about their psychometric
properties. We classified the scales as:
• low risk of bias - if studies support the reliability and
validity of the scale;
• unclear risk of bias - if supporting data were not provided,
or the scale has never been tested;
• high risk of bias - if there was evidence of insufficient
reliability or validity.
Measures of treatment effect
Two review authors (DC and VS) independently classified out-
come measures in terms of the domain assessed (disability, arm
motor function, perceived arm motor function, arm motor im-
pairment, quality of life and dexterity). When a study presented
more than one outcome measure for the same domain, we used
themeasure most frequently utilised across studies for the analysis.
We converted continuous data to mean difference (MD) and, if
different scales were used, we first computed a standardised mean
difference (SMD), and second, an overall MD and overall SMD.
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Dealing with missing data
When standard deviations of the changes were not reported, we
estimated them in the treatment and control groups from the
variances, or through the use of Engauge Software 5.1 as needed
for data analysis.
If data for the estimation of standard deviation of changes were
unreported, we contacted study authors by email to request the
information. If we did not receive a reply, we contacted the study
authors again.
Assessment of heterogeneity
We did a statistical summary of treatment effects only if there was
no major clinical heterogeneity in terms of participants’ charac-
teristics. We assessed the degree of heterogeneity among the trials
by the I2 statistic for each outcome. We judged an I2 value greater
than 50% to be indicative of substantial heterogeneity (Higgins
2011). We calculated overall estimates using the fixed-effect or
random-effects model, depending on the I2 heterogeneity test re-
sults and on clinical heterogeneity related to the implementation
of interventions and to the characteristics of the participants.
Assessment of reporting biases
We addressed publication bias by means of visual inspection of
funnel plots for signs of asymmetry, and generated the funnel plots
using Review Manager 5 (RevMan 2014). We explored publica-
tion bias on armmotor function instead of disability, as armmotor
function was the most frequent outcome assessed by the included
studies.
Data synthesis
We pooled outcomes measured with different instruments using
SMD. In all analyses with the exception of the subgroup analyses,
we used the random-effects model with 95% CI using Review
Manager 5 in order to take into account the clinical heterogeneity
among studies (RevMan 2014).
Subgroup analysis and investigation of heterogeneity
There were four possible post-hoc subgroup analyses (Table 1).
• ’Dosage of task practice’: on the basis of the cut-off of three
hours, which is the difference between CIMT and mCIMT (see
’Types of interventions’), we calculated the dosage of exercise by
multiplying the number of weeks by the number of sessions per
week by the session duration in hours. We divided trials into
those providing more than 30 hours of training, and those
providing 30 hours of training or less.
• Anatomical region restraint: we divided studies in to those
constraining the unaffected arm only at the hand by a mitt, and
those constraining both hand and arm by a sling and mitt.
• Restraint effect: we included only the studies where the
only independent variable between groups was restraint (e.g.
where constraint was not accompanied by additional exercise, or
the number of hours and type of treatment in the control and
constraint groups were the same).
• Time since stroke: we used mean time since stroke at
recruitment to classify trials into three categories: zero to three
months, three months to nine months, and over nine months.
To investigate differences between subgroups, we used the ap-
proach for a significance test described by Deeks 2001. This
method is implemented in the ReviewManager software for fixed-
effect analyses based on the inverse-variance method (RevMan
2014).
Sensitivity analysis
We conducted sensitivity analyses for the primary outcome to
explore the effects of the methodological quality of the included
studies on overall effect.
R E S U L T S
Description of studies
See Characteristics of included studies, Characteristics of excluded
studies.
Results of the search
The database searches identified 5863 records, while the searches
of the trial registers identified nine records of ongoing, completed
or terminated studies.
On the basis of information presented in titles and abstracts, we
identified 33 studies as potentially relevant and we obtained the
full text papers. Seven papers did not meet at least one of our
inclusion criteria: firstly, most studies compared different forms
of CIMT, and secondly, they reported data from trials already
included in the review.
We included 24 papers that reported 23 trials, and added these
to the 19 trials identified in the previous version of this review to
give a total of 42 included trials (Figure 1).
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Figure 1. Study flow diagram.
Included studies
A total of 42 published RCTs met the inclusion criteria (Alberts
2004; Atteya 2004; Azab 2009; Boake 2007; Bergheim 2010;
Brogårdh 2009; Brunner 2012; Dahl 2008; Dromerick 2000;
Dromerick 2009; Hammer 2009; Hayner 2010; Huseyinsinoglu
2012; Khan 2011; Kim 2008; Krawczyk 2012; Lin 2007; Lin
2009a; Lin 2010;Myint 2008; Page 2001; Page 2002b; Page 2004;
Page 2005b; Page 2008; Ploughman 2004; Singh 2013; Smania
2012; Suputtitada 2004; Tariah 2010; Taub 1993; Treger 2012;
Van Delden 2013;Wang 2011;Wittenberg 2003;Wolf 2006;Wu
2007a; Wu 2007b;Wu 2007c;Wu 2011,Wu 2012a; Yoon 2014).
In 13 studies, participants were randomised to three interventions:
• mCIMT, traditional rehabilitation (training without
restriction of the sound limb), and no treatment (Atteya 2004;
Page 2001; Page 2002b ; Page 2004; Page 2008);
• CIMT at low dose versus CIMT at high dose versus control
(Dromerick 2009);
• mCIMT versus conventional therapy versus therapeutic
climbing (Khan 2011);
• mCIMT versus bilateral arm training (BAT) versus control
(Lin 2009a);
• mCIMT versus modified bilateral arm training with
rhythmic auditory cueing (BATRAC) versus dose-matched
conventional treatment Van Delden 2013);
• CIMT plus mirror therapy versus CIMT versus control
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(Yoon 2014);
• mCIMT versus conventional treatment versus intensive
conventional treatment (Wang 2011);
• mCIMT versus BAT versus control (Wu 2011);
• mCIMT plus trunk restraint versus mCIMT versus control
(Wu 2012a).
In order to reduce the heterogeneity among studies and to pre-
serve the equipoise principle, we considered only the data from
arms comparing CIMT or mCIMT of FU with traditional reha-
bilitation (Edwards 1998). For Dromerick 2009 we combined the
two experimental groups working at two different regimens into
a single group performing mCIMT; in Wang 2011 we considered
the intensive conventional group to be the control group.
For more details, see the Characteristics of included studies table.
The studies were conducted in the USA (14 studies), Asia (14
studies) and Europe (14 studies).
Nine were identified as pilot RCTs (Alberts 2004; Brogårdh 2009;
Dromerick 2000; Hammer 2009; Khan 2011; Myint 2008; Page
2002b; Page 2005b; Ploughman 2004), although it is not clear
whether ’pilot’ referred to examination of new CIMT characteris-
tics, to the feasibility of the study, or to the small sample and lack
of sample size calculation. Nineteen studies were multicentre.
Participants
A total of 1453 participants were enrolled in the 42 trials. There
weremoremen (n = 934; 64%) thanwomen. Themean age ranged
from 37 years to 87 years (Page 2004; Wu 2007c, respectively),
with the majority between 55 and 70 years. Time since stroke was
zero to three months for 13 trials (Azab 2009; Bergheim 2010;
Boake 2007; Brogårdh 2009; Brunner 2012; Dromerick 2000;
Dromerick 2009; Myint 2008; Page 2005b; Ploughman 2004;
Singh 2013; Treger 2012; Yoon 2014); three to ninemonths for six
trials (Alberts 2004; Atteya 2004;Hammer 2009; Page 2001; Page
2002b;Wolf 2006), andmore than nine months for five trials (Lin
2007; Page 2004; Page 2008; Taub 1993;Wittenberg 2003). Eight
studies reported time since stroke onset vaguely: in the next days
(Khan 2011), more than 1.5months (Krawczyk 2012), more than
two months (Tariah 2010), more than three months (Lin 2010),
more than six months (Hayner 2010; Lin 2009a; Wu 2011), and
more than one year (Kim 2008). One trial considered participants
inwhich stroke onset varied between0 to sixmonths (Wang 2011),
three trials between one to 37 months (Wu 2007a; Wu 2007b;
Wu 2007c), one between one to six months (Van Delden 2013),
two between three to 24 months (Huseyinsinoglu 2012; Smania
2012), one study between six to 59 months (Wu 2012a), one trial
considered people in which the stroke onset varied between one
to 92 months (Dahl 2008), and one between one and 10 years
(Suputtitada 2004).
Thirty-six studies with a total of 1298 participants described the
type of stroke: 15 studies included only people with ischaemic
stroke (Alberts 2004; Bergheim 2010; Dromerick 2000; Hammer
2009; Hayner 2010; Krawczyk 2012; Lin 2010; Page 2001; Page
2002b; Page 2004; Page 2005b; Page 2008; Tariah 2010; Taub
1993; Treger 2012), while the remaining 21 trials enrolled people
with haemorrhagic and ischaemic stroke (Boake 2007; Brunner
2012; Dahl 2008; Dromerick 2009; Huseyinsinoglu 2012; Kim
2008; Lin 2007; Lin 2009a;Myint 2008; Ploughman 2004; Singh
2013; Smania 2012; Suputtitada 2004; Van Delden 2013; Wang
2011; Wolf 2006; Wu 2007b; Wu 2007c; Wu 2011; Wu 2012a;
Yoon 2014).
Fifty-six per cent (n = 729) of the participants had an ischaemic
stroke, the remaining 44% (n = 569) had a haemorrhagic stroke.
Thirty-three studies, with a total of 1011 participants, reported
the number of people with the right-side affected (n = 627;
62%; Alberts 2004; Atteya 2004; Azab 2009; Boake 2007;
Bergheim 2010; Brogårdh 2009; Brunner 2012; Dromerick 2000;
Dromerick 2009; Hammer 2009; Khan 2011; Krawczyk 2012;
Lin 2007; Lin 2009a; Lin 2010; Myint 2008; Page 2001; Page
2002b; Page 2004; Page 2005b; Page 2008; Ploughman 2004;
Smania 2012; Suputtitada 2004; Tariah 2010; Taub 1993; Van
Delden 2013; Wu 2007a; Wu 2007b; Wu 2007c; Wu 2011; Wu
2012a; Yoon 2014).
Nine studies, with a total of 524 participants, reported the number
of people presenting with paresis of pre-stroke dominant side (n
= 260; 50%; Alberts 2004; Huseyinsinoglu 2012; Myint 2008;
Taub 1993; VanDelden 2013;Wolf 2006;Wu 2007a;Wu 2007b;
Wu 2007c).
The main inclusion criteria reported were as follows.
• Movement capacity of the upper arm:
◦ ability to extend actively the metacarpophalangeal and
interphalangeal joints at least 10°, and the wrist 20° (Alberts
2004; Atteya 2004; Bergheim 2010; Boake 2007; Dahl 2008;
Hammer 2009; Huseyinsinoglu 2012; Lin 2010; Myint 2008;
Page 2001; Page 2002b; Page 2004; Page 2005b; Page 2008;
Taub 1993; Suputtitada 2004; Tariah 2010; Wang 2011;
Wittenberg 2003; Wolf 2006; Wu 2007a);
◦ ability to extend actively the metacarpophalangeal and
interphalangeal joints and the wrist at least 10° (Singh 2013;
Smania 2012);
◦ ability to extend the metacarpophalangeal and
interphalangeal joints of two digits and the wrist 10°, plus 10° of
thumb abduction/extension (Alberts 2004; Brogårdh 2009;
Brunner 2012; Smania 2012; Van Delden 2013; Wolf 2006;
Yoon 2014);
◦ trace of movements of the hand and some fingers
dexterity preserved (Azab 2009; Hayner 2010; Kim 2008);
◦ ability to lift a floppy disc off the table top and to
release it afterwards (Krawczyk 2012);
◦ score 1 to 3 on the motor arm items of the National
Institute of Health Stroke Scale (NIHSS; Boake 2007;
Dromerick 2000);
◦ stage 3 or above in the reach Brunnstrom for the
proximal part of the upper extremity (Lin 2007; Lin 2009a; Wu
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2007b; Wu 2007c; Wu 2012a);
◦ stage 2 to 6 on the Chedoke McMaster Impairment
Inventory (CMII; Khan 2011; Ploughman 2004);
◦ score 0 to 2 on Modified Rankin Scale before the
stroke (Dahl 2008).
• Absence of cognitive impairment:
◦ Mini Mental State Examination (MMSE) or modified
MMSE more than 24 or 70 respectively (Alberts 2004; Atteya
2004; Brogårdh 2009; Brunner 2012; Dahl 2008; Dromerick
2009; Hammer 2009; Hayner 2010; Huseyinsinoglu 2012;
Krawczyk 2012; Lin 2007; Lin 2009a; Lin 2010; Myint 2008;
Page 2001; Page 2002b; Page 2004; Page 2005b; Page 2008;
Ploughman 2004; Singh 2013; Smania 2012; Suputtitada 2004;
Tariah 2010; Taub 1993; Van Delden 2013; Wang 2011; Wolf
2006; Wu 2007a; Wu 2007b; Wu 2007c; Wu 2011; Wu 2012a);
◦ no neglect or speech comprehension difficulties
(Boake 2007; Brogårdh 2009; Dahl 2008; Hammer 2009;
Huseyinsinoglu 2012; Kim 2008; Krawczyk 2012; Singh 2013;
Suputtitada 2004; Taub 1993; Treger 2012; Van Delden 2013;
Wang 2011; Yoon 2014);
◦ score ≤ 1 on the consciousness, communication and
neglect item of the NIHSS (Dromerick 2000).
• Non-use of the affected arm in the real world: score < 2.5
on the MAL (Alberts 2004; Huseyinsinoglu 2012; Lin 2007; Lin
2009a; Page 2005b; Page 2008; Smania 2012; Tariah 2010;
Wittenberg 2003; Wolf 2006; Wu 2007a; Wu 2007b; Wu 2011;
Wu 2012a).
• No balance problems including walking (Alberts 2004;
Brogårdh 2009; Hammer 2009; Hayner 2010; Huseyinsinoglu
2012; Kim 2008; Krawczyk 2012; Lin 2007; Lin 2009a; Myint
2008; Smania 2012; Suputtitada 2004; Tariah 2010; Taub 1993;
Wang 2011; Wolf 2006; Wu 2007a; Wu 2007b; Wu 2011; Wu
2012a).
• No excessive pain in the affected arm: score < 4 on the
visual analogue scale (Alberts 2004; Atteya 2004;
Huseyinsinoglu 2012; Khan 2011; Myint 2008; Page 2001; Page
2002b; Page 2004; Page 2005b; Page 2008; Singh 2013; Tariah
2010; Wang 2011; Wolf 2006).
• No excessive spasticity: score ≤ 2 (in any joint) respectively
on the Ashworth Scale or on the modified Ashworth Scale
(Atteya 2004; Hammer 2009; Huseyinsinoglu 2012; Lin 2007;
Page 2001; Page 2002b; Page 2004; Page 2005b; Page 2008;
Singh 2013; Tariah 2010; Taub 1993; Wang 2011; Wu 2007a;
Wu 2007c).
• No joint limitation of the affected arm (Alberts 2004;
Boake 2007; Wolf 2006).
Intervention
Nine studies, with a total of 416 participants, focused on the effi-
cacy of CIMT (Alberts 2004; Dahl 2008; Hayner 2010; Krawczyk
2012; Myint 2008; Taub 1993; Wang 2011; Wittenberg 2003;
Wolf 2006), while 29 studies, with a total of 943 participants,
focused on the efficacy of mCIMT (Atteya 2004; Azab 2009;
Bergheim 2010; Boake 2007; Brunner 2012; Dromerick 2000;
Dromerick 2009; Huseyinsinoglu 2012; Khan 2011; Lin 2007;
Lin 2009a; Lin 2010; Page 2001; Page 2002b; Page 2004; Page
2005b; Page 2008; Singh 2013; Smania 2012; Suputtitada 2004;
Tariah 2010; Treger 2012; Van Delden 2013; Wu 2007a; Wu
2007b; Wu 2007c; Wu 2011; Wu 2012a; Yoon 2014). Four stud-
ies, with 94 participants, investigated the efficacy of FU (Brogårdh
2009; Hammer 2009; Kim 2008; Ploughman 2004).
Time of restraint:
• During waking hours for one study (Wittenberg 2003);
• 90% of waking hours for eleven studies (Alberts 2004;
Boake 2007; Brogårdh 2009; Dahl 2008; Huseyinsinoglu 2012;
Myint 2008; Singh 2013; Smania 2012; Taub 1993; Wang
2011; Wolf 2006);
• from six hours per day to 90% of waking hours for one
study (Dromerick 2009);
• from six to seven hours per day for two studies (Azab 2009;
Bergheim 2010);
• six hours per day for 14 studies (Dromerick 2000; Hammer
2009; Hayner 2010; Lin 2007; Lin 2009a; Lin 2010;
Suputtitada 2004; Van Delden 2013; Wu 2007a; Wu 2007b;
Wu 2007c; Wu 2011; Wu 2012a; Yoon 2014);
• five hours per day for eight studies (Atteya 2004; Kim
2008; Krawczyk 2012; Page 2001; Page 2002b; Page 2004; Page
2005b; Page 2008);
• four to five hours per day for one study (Khan 2011);
• four hours per day for two studies ( Brunner 2012; Treger
2012);
• two hours per day for one study (Tariah 2010);
• a mean effective restraint time of 2.7 hours per day was
reported by one study (Ploughman 2004).
Time of exercise with the affected arm:
• between 30 and 45 hours/week in seven studies (Alberts
2004; Dahl 2008; Hayner 2010; Suputtitada 2004; Taub 1993;
Wittenberg 2003; Wolf 2006);
• between 10 and 25 hours/week in 20 studies (Boake 2007;
Brunner 2012; Dromerick 2000; Dromerick 2009;
Huseyinsinoglu 2012; Khan 2011; Krawczyk 2012; Lin 2007;
Lin 2009a; Lin 2010; Myint 2008; Singh 2013; Smania 2012;
Tariah 2010; Wang 2011; Wu 2007a; Wu 2007b; Wu 2007c;
Wu 2011; Yoon 2014);
• five hours/week or less in 11 studies (Atteya 2004; Azab
2009; Bergheim 2010; Page 2001; Page 2002b; Page 2004; Page
2005b; Page 2008; Ploughman 2004; Treger 2012; Van Delden
2013).
Treatment duration:
• two weeks in 19 studies (Alberts 2004; Bergheim 2010;
Boake 2007; Brogårdh 2009; Dahl 2008; Dromerick 2000;
Dromerick 2009; Hammer 2009; Hayner 2010; Huseyinsinoglu
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2012; Myint 2008; Singh 2013; Smania 2012; Suputtitada
2004; Taub 1993; Treger 2012; Wittenberg 2003; Wolf 2006;
Yoon 2014);
• three weeks for nine studies (Krawczyk 2012; Lin 2007; Lin
2009a; Lin 2010; Wu 2007a; Wu 2007b; Wu 2007c; Wu 2011;
Wu 2012a);
• four weeks for three studies (Azab 2009; Brunner 2012;
Wang 2011);
• six weeks for one study (Van Delden 2013);
• eight weeks for two studies (Kim 2008; Tariah 2010);
• 10 weeks for six studies (Atteya 2004; Page 2001; Page
2002b; Page 2004; Page 2005b; Page 2008).
One study did not report the treatment duration (Khan 2011).
Types of exercise:
• all studies used functional or ADL tasks: in 19 studies this
was done through shaping techniques (Alberts 2004; Bergheim
2010; Brunner 2012; Boake 2007; Dromerick 2009; Hayner
2010; Huseyinsinoglu 2012; Kim 2008; Lin 2010; Myint 2008;
Page 2002b; Page 2004; Page 2005b; Page 2008; Smania 2012;
Tariah 2010; Van Delden 2013; Wolf 2006; Wu 2007a);
• two studies included proprioceptive neuromuscular
facilitation (PNF; Atteya 2004; Page 2001);
• one study used conventional treatment for upper extremity,
which involved the facilitation of proximal motor control
progressing to skilled-task training, without shaping therapy
(Ploughman 2004).
Anatomical region restraint:
• both hand and arm in 12 studies (Atteya 2004; Hammer
2009; Myint 2008; Page 2001; Page 2002b; Page 2004; Page
2008; Ploughman 2004; Taub 1993; Wang 2011; Wittenberg
2003; Yoon 2014);
• only the hand in the remaining 30 studies.
Intervention delivery
In all studies the interventions were delivered and supervised by
trained physiotherapists or occupational therapists, and each par-
ticipant assigned to an intervention group participated in individ-
ual therapy sessions, except in Dahl 2008 and Suputtitada 2004
where the participants exercised in groups of four. The wear-
ing of the constraint was checked by questioning the partici-
pants every two weeks about satisfaction with the protocol (Atteya
2004), keeping a log of the hours of restraint per day (Azab 2009;
Brogårdh 2009; Brunner 2012; Hammer 2009; Lin 2009a; Myint
2008; Page 2002a; Page 2004; Page 2005b; Ploughman 2004;
Singh 2013; Smania 2012; Tariah 2010; Treger 2012;Wang 2011;
Wu 2011; Wu 2012a), and through a physical sensor and timer
placed in the mitt and by a home diary (Wolf 2006). Supervision
of the constraint was not described in the other studies.
Twenty-four studies included outpatients (Alberts 2004; Atteya
2004; Azab 2009; Hayner 2010; Huseyinsinoglu 2012; Kim
2008; Lin 2007; Lin 2009a; Lin 2010; Myint 2008; Page 2001;
Page 2002b; Page 2004; Page 2005b; Page 2008; Smania 2012;
Suputtitada 2004; Tariah 2010; Taub 1993; Wang 2011; Wolf
2006; Wu 2007b; Wu 2011; Wu 2012a), 11 studies included
only inpatients (Bergheim 2010; Brogårdh 2009; Dahl 2008;
Dromerick 2000; Dromerick 2009; Khan 2011; Krawczyk 2012;
Singh 2013; Treger 2012; Wittenberg 2003; Yoon 2014), six
studies included both inpatients and outpatients (Boake 2007;
Brunner 2012; Hammer 2009; Ploughman 2004; Wu 2007a; Wu
2007c), and one study did not specify (Van Delden 2013).
Outcomes
All studies considered pre-treatment and post-treatment outcome
measures. Seventeen studies had longer follow-up:
• one month (Van Delden 2013);
• one and three months (Hammer 2009);
• three months (Bergheim 2010; Boake 2007; Brogårdh
2009; Dromerick 2009; Smania 2012);
• four months (Tariah 2010);
• six months (Azab 2009; Dahl 2008; Hayner 2010; Khan
2011; Wittenberg 2003);
• 12 months (Krawczyk 2012; Myint 2008);
• at four, eight and 12 months (Wolf 2006);
• up to three years (Taub 1993).
The 42 included trials considered similar outcome categories. We
attributed measures used in the studies to each outcome category
as detailed below and in Table 2.
Primary outcomes
• Disability:
◦ Functional Independence Measure (FIM): nine studies
(Dahl 2008; Dromerick 2009; Huseyinsinoglu 2012; Lin 2007;
Lin 2009a; Ploughman 2004; Treger 2012; Wu 2007a; Wu
2007c);
◦ Barthel Index (BI): three studies (Azab 2009; Myint
2008; Yoon 2014).
Secondary outcomes
• Arm motor function:
◦ Action Research Arm Test (ARAT): 14 studies (Atteya
2004; Brunner 2012; Dromerick 2000; Dromerick 2009;
Hammer 2009; Myint 2008; Page 2001; Page 2002b; Page
2004; Page 2005b; Page 2008; Ploughman 2004; Van Delden
2013; Wu 2012a);
◦ Wolf Motor Function Test (WMFT): 14 studies
(Alberts 2004; Atteya 2004; Dahl 2008; Hayner 2010;
Huseyinsinoglu 2012; Khan 2011; Singh 2013; Smania 2012;
Tariah 2010; Wittenberg 2003; Wang 2011; Wolf 2006; Wu
2011; Yoon 2014);
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◦ Emory Motor Function test (EMF): one study (Taub
1993);
◦ Manual Function Test (MFT): two studies (Kim
2008; Treger 2012);
◦ The Rivermead Motor Assessment Arm scale: one
study (Krawczyk 2012);
◦ Motor Assessment Scale: one study (Brogårdh 2009).
• Perceived motor function, amount of use and quality of use:
◦ Motor Activity Log (MAL): 29 studies (Atteya 2004;
Boake 2007; Brogårdh 2009; Dahl 2008; Hammer 2009;
Huseyinsinoglu 2012; Khan 2011; Kim 2008; Krawczyk 2012;
Lin 2007; Lin 2009a; Lin 2010; Myint 2008; Page 2001; Page
2002b; Page 2004; Page 2005b; Page 2008; Smania 2012; Tariah
2010; Taub 1993; Van Delden 2013; Wittenberg 2003; Wolf
2006; Wu 2007a; Wu 2007b; Wu 2007c; Wu 2011; Wu 2012a).
• Arm motor impairment:
◦ Fugl-Meyer Assessment (FMA): 17 studies (Alberts
2004; Atteya 2004; Boake 2007; Hammer 2009; Lin 2009a; Lin
2010; Page 2001; Page 2002b; Page 2004; Page 2005b; Page
2008; Singh 2013; Tariah 2010; Van Delden 2013; Wu 2007b;
Wu 2007c; Yoon 2014);
◦ Chedoke McMaster Impairment Inventory (CMII):
three studies (Ploughman 2004; Tariah 2010; Van Delden 2013);
◦ Birgitta Lind Marks Assessment Motor (BLMA): one
study (Krawczyk 2012);
◦ Jamar hand dynamometer: one study (Ploughman
2004);
◦ maximal grip strength with a force transducer: three
studies (Alberts 2004; Van Delden 2013; Yoon 2014);
◦ shoulder and elbow isometric force: one study (Khan
2011).
• Dexterity:
◦ Grooved Pegboard Test (GPT): one study (Boake
2007);
◦ Nine-Hole Peg Test (NHPT): four studies (Brunner
2012; Myint 2008; Van Delden 2013; Yoon 2014);
◦ Sixteen-Hole Peg Test: one study (Hammer 2009);
◦ Box and block test: one study (Yoon 2014);
◦ Perdue Pegboard Test: one study (Kim 2008).
• Quality of life:
◦ Stroke Impact Scale (SIS): seven studies (Dahl 2008;
Dromerick 2009; Lin 2009a; Van Delden 2013; Wolf 2006; Wu
2007c; Wu 2012a).
Excluded studies
We excluded 12 studies after reading the full text as they did not
meet our inclusion criteria. We have provided all the reasons for
these exclusions in Characteristics of excluded studies.
Risk of bias in included studies
Refer to Figure 2 or Figure 3 and Characteristics of included
studies. If required, we contacted the corresponding author of the
relevant studies for further information.
Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
Randomisation
The sequence of randomisation was described and appropriate
in 27 studies (Alberts 2004; Bergheim 2010; Brogårdh 2009;
Brunner 2012; Dromerick 2000; Hammer 2009; Huseyinsinoglu
2012; Khan 2011; Krawczyk 2012; Lin 2007; Lin 2009a; Page
2004; Page 2005b; Page 2008; Ploughman 2004; Singh 2013;
Smania 2012; Suputtitada 2004; Treger 2012; Van Delden 2013;
Wang 2011;Wittenberg 2003;Wolf 2006;Wu 2007b;Wu2007c;
Wu 2011; Yoon 2014). Lin 2007 used a randomisation stratified
by side of stroke; Alberts 2004 and Wolf 2006 balanced the ran-
domisation with respect to gender, premorbid handedness, side
of stroke and level of function; Boake 2007 stratified by age and
NIHSS score, andDromerick 2009 balanced for age, total NIHSS
score, pretest ARAT and days from stroke onset. Prestratification
was applied to the participants based on whether they had received
botulinum A injection inHuseyinsinoglu 2012. VanDelden 2013
stratified the participants according to whether they had higher
functional ability or lower functional ability of the arm. In Hayner
2010 study participants were stratified into more and less affected.
We considered one study at high risk of bias because only a key-
word of the article referred to randomisation (Azab 2009). We
considered other studies at unclear risk of bias mainly because they
provided insufficient data.
Allocation concealment
Allocation concealment was described and appropriate in 10 stud-
ies (Alberts 2004; Brunner 2012; Dahl 2008; Hammer 2009;
Khan 2011; Lin 2009a; Smania 2012; Treger 2012; Van Delden
2013; Wolf 2006); the remaining studies did not report sufficient
information.
Blinding
Outcome assessors were blinded in 34 studies. In Hammer 2009
and Hayner 2010 the assessor was not blinded, and blinding was
not described in the remaining six studies (Kim 2008; Lin 2009a;
Lin 2010; Singh 2013; Van Delden 2013; Wu 2010).
Incomplete outcome data
Sixteen studies provided complete information about participants
who withdrew and their reasons (Boake 2007; Brunner 2012;
Hammer 2009; Hayner 2010; Huseyinsinoglu 2012; Khan 2011;
Kim 2008; Krawczyk 2012; Lin 2007; Myint 2008; Ploughman
2004; Singh 2013; Smania 2012; Treger 2012; Van Delden 2013;
Wolf 2006); four studies provided numbers of withdrawals but not
reasons (Azab 2009; Dromerick 2000; Dromerick 2009; Tariah
2010); 16 studies presented unclear information about with-
drawals: none of these clearly stated that there were no drop-
outs (Alberts 2004; Atteya 2004; Brogårdh 2009; Lin 2009a; Lin
2010; Page 2001; Page 2002b; Page 2004; Page 2005b; Page 2008;
Suputtitada 2004; Tariah 2010; Taub 1993; Wang 2011; Wu
2011; Yoon 2014 ). In one study one participant was excluded
from the analyses post-hoc because he had received botulinum
toxin type A in the more affected limb less than three months
before the study (Page 2004).
The remaining six studies had no drop-outs.
By post-treatment follow-up nine studies had lost less than 10%
of participants (Brogårdh 2009; Brunner 2012; Dromerick 2009;
Hayner 2010; Huseyinsinoglu 2012; Khan 2011; Lin 2007; Van
Delden 2013; Wolf 2006); six studies had lost between 10% and
20% of participants (Dromerick 2000; Hammer 2009; Krawczyk
2012; Myint 2008; Ploughman 2004; Smania 2012); and two
studies had lost more than 20% of participants (Boake 2007; Kim
2008).
At long-term follow-up, Myint 2008 and Hammer 2009 had lost
less than 10% of participants, while Azab 2009, Boake 2007,
Brogårdh 2009, Krawczyk 2012, and Wolf 2006 had lost between
10% and 20% of participants.
Three studies performed intention-to-treat analyses (Alberts 2004;
Smania 2012; Wolf 2006). Twenty-five studies that did not have
apparent withdrawals performed analyses on all included partici-
pants (Atteya 2004; Azab 2009; Bergheim 2010; Brogårdh 2009;
Brunner 2012; Dromerick 2009; Dahl 2008; Krawczyk 2012;
Lin 2009a; Lin 2010; Page 2001; Page 2002b; Page 2005b; Page
2008; Singh 2013; Suputtitada 2004; Treger 2012; Wang 2011;
Wittenberg 2003; Wu 2007a; Wu 2007b; Wu 2007c; Wu 2011;
Wu 2012a; Yoon 2014). One study mixed intention-to-treat and
per-protocol analyses (Boake 2007). The others performed per-
protocol analyses (Dromerick 2000;Hammer 2009;Hayner 2010;
Huseyinsinoglu 2012; Khan 2011; Kim 2008; Lin 2007; Myint
2008; Page 2004; Ploughman 2004;Taub 1993; Tariah 2010; Van
Delden 2013).
Validity of scales
All scales used in the studies for primary and secondary outcomes
were supported by references to their psychometric properties, and
were considered able to quantify performance in individuals after
stroke with motor characteristics similar to the people enrolled
in the included studies. The study on clinimetric properties of
the MAL scale reports relatively stable internal consistency in a
population of chronic stroke patients, a correlation with ARAT
score at baseline (Spearman’s rho was 0.63 for AoU and QoU),
but considerable doubts remain about the longitudinal construct
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validity of the instrument, and the study does not recommend its
use as a primary outcome measure in trials (Van der Lee 2004).
Other potential sources of bias
Six trials based their sample size on prior statistical power calcula-
tions (Brogårdh 2009; Brunner 2012; Smania 2012; Treger 2012;
Van Delden 2013; Wolf 2006). Most studies were very small; the
median sample size was 29 randomised participants (interquar-
tile range 16 to 44). Small sample sizes are related to type 2 er-
rors (Altman 1990; Hotopf 1997; Hotopf 1999), so if the median
number of participants randomised is 29, then the complete anal-
ysis will only include around 15 participants per group.
Publication bias and small study effects
Visual inspection of the funnel plot indicated that pooled data
might have been influenced by publication bias (Figure 4). Slight
asymmetry of the plot is possible, with few studies characterised by
extreme statistically significant results, largely favouring CIMT. It
is also possible that others studies are ’missing’ from the opposite
area, which is in favour of the control. Another possible reason
for slight asymmetry could be related to the large number of small
trials we identified. Theirmethodological components for random
sequence generation, allocation concealment and double blinding
might have been inadequate. The reporting of most studies was
largely unsatisfactory, preventing us from making full judgements
of methods. These potential methodological shortcomings can be
associated with exaggerated estimates of benefits of treatment.
Figure 4. Funnel plot of comparison: 3 Constraint versus control: secondary outcomes, outcome: 3.1 Arm
Motor Function.
Studies awaiting assessment
Six studies are awaiting assessment because information that is
currently available about them is insufficient to determine whether
they would be eligible for inclusion in this review. Five studies
are labelled as ’completed’ or ’terminated’ on ClinicalTrials.gov
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(Barzel 2015; Boe 2014; Dos Santos 2012; Olivier 2012; Uswatte
2014), and one has been published as a poster (Jansa 2007).
Three studies are ongoing and recruiting (Gautier 2015; Padovani
Do Santos 2015; Pereira 2015).
Effects of interventions
See: Summary of findings for the main comparison
We conducted meta-analyses when at least two studies provided
sufficient data. We included trials that compared the intervention
versus no treatment, or no active treatment, in a specific subgroup
to show how the estimated overall effect was based on information
provided by these studies (Alberts 2004; Kim 2008; Taub 1993;
Wittenberg 2003). In consideration of the clinical heterogeneity
among studies, which related to variability in the interventions
included and in the patient case-mix, we considered it appropriate
to perform random-effects meta-analyses to incorporate hetero-
geneity, except within subgroup analyses.
Fourteen trials monitored the presence of adverse events or med-
ical complications leading to dropouts (Boake 2007; Brunner
2012; Dahl 2008; Dromerick 2000; Dromerick 2009; Hammer
2009; Khan 2011; Kim 2008; Krawczyk 2012; Myint 2008; Page
2008; Ploughman 2004; Smania 2012; Wolf 2006). Six of these
studies monitored and reported on adverse events (Boake 2007;
Dahl 2008; Dromerick 2000; Page 2008; Ploughman 2004; Wolf
2006), and four stated that none occurred (Boake 2007; Dahl
2008; Page 2008; Ploughman 2004). Rates of adverse events
among these studies appeared not to differ between CIMT and
the comparison groups, and CIMT appeared to have no adverse
effects.
Primary outcomes
Comparison 1.1: Disability post-intervention
Twelve studies with 411 participants measured disability immedi-
ately after the experimental and control interventions (Azab 2009;
Dahl 2008;Dromerick 2009;Huseyinsinoglu 2012; Lin 2007; Lin
2009a; Myint 2008; Ploughman 2004; Treger 2012; Wu 2007a;
Wu 2007c; Yoon 2014). Data were available for 344 participants
(84%) from 11 studies. The impact of CIMT on disability indi-
cated a non-significant effect (SMD 0.24, 95% CI -0.05 to 0.52;
Analysis 1.1).
Sixty-nine participants contributing to this meta-analysis were re-
cruited from studies with more than a 10% loss to follow-up.
Comparison 1.2: Disability at three- and six-month follow-up
Three studies recruiting 125 participants measured disability at
three months (Dromerick 2009; Myint 2008), or at six months
after treatment (Dahl 2008). The impact of CIMT on disability
indicated a non-significant effect (SMD -0.21, 95% CI -0.57 to
0.16, Analysis 1.2).
Subgroup analysis: Disability
We carried out analyses for the following three subgroups consid-
ering data availability.
• ’Dosage of task practice’: we grouped trials according to
whether they provided 30 or more hours of exercise, or up to 30
hours of exercise.
• Anatomical region restraint: we grouped trials according to
whether both arm and hand were restrained, or only the hand.
• Time since stroke: we grouped trials according to whether
they recruited within three months, three to nine months, or
more than nine months post stroke.
Comparison 2.1: Amount of task practice
Three studies with 91 participants reported over 30 hours of ex-
ercise (Dahl 2008; Myint 2008; Yoon 2014); eight studies with
253 participants reported 30 hours or less of exercise (Dromerick
2009; Huseyinsinoglu 2012; Lin 2007; Lin 2009a; Ploughman
2004; Treger 2012; Wu 2007a; Wu 2007c). Longer exercise for
upper limb function showed no statistically significant effect size
(SMD 0.25, 95% CI -0.18 to 0.67); shorter exercise had a non-
significant effect size (SMD 0.18, 95% CI -0.07 to 0.44; Analysis
2.1). The difference between the two groups of trials was not sig-
nificant (P value 0.8).
Comparison 2.2: Anatomical region restraint
Two studies with 61 participants reported both arm and hand
restriction (Myint 2008; Yoon 2014); nine studies including
283 participants reported only hand restriction (Dahl 2008;
Dromerick 2009; Huseyinsinoglu 2012; Lin 2007; Lin 2009a;
Ploughman 2004; Treger 2012; Wu 2007a; Wu 2007c). The re-
striction of both arm and hand for upper limb function showed
a non-statistically significant effect size (SMD 0.35, 95% CI -
0.17 to 0.87); restriction of the hand only was non-statistically
significant (SMD 0.17, 95% CI -0.08 to 0.41; Analysis 2.2). The
difference between the effect estimates for the two groups of trials
was not significant (P value 0.53).
Comparison 2.3: Time since stroke
Five studies with 164 participants measured disability on people
with stroke at zero to three months (Myint 2008; Ploughman
2004; Treger 2012; Yoon 2014); five studies with 176 par-
ticipants measured it at more than nine months (Dahl 2008;
Huseyinsinoglu 2012; Lin 2007; Lin 2009a; Wu 2007a).
No studies measured disability on people with subacute stroke at
three to nine months. We did not include four studies in this sub-
group analysis because of the wide range of chronicity of partici-
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pants (Dahl 2008; Huseyinsinoglu 2012; Lin 2009a; Wu 2007c).
People with acute and chronic stroke showed no statistically sig-
nificant effect size: for zero to three months (SMD 0.07, 95% CI
-0.26 to 0.39) or more than nine months (SMD 0.49 CI -0.02
to 1.00; Analysis 2.3). The difference between the effect estimates
for the two groups of trials was not significant (P value 0.17). We
did not find heterogeneity among studies (I2 = 47.2%).
The comparison for the restraint effect could not be performed
because of insufficient data.
Secondary outcomes
Comparison 3.1: Arm motor function
Thirty-four studies with 988 participants measured arm motor
function (Alberts 2004; Atteya 2004; Bergheim 2010; Brogårdh
2009; Brunner 2012; Dahl 2008; Dromerick 2000; Dromerick
2009; Hammer 2009; Hayner 2010; Huseyinsinoglu 2012; Khan
2011; Kim 2008; Krawczyk 2012; Myint 2008; Page 2001; Page
2002b; Page 2004; Page 2005b; Page 2008; Ploughman 2004;
Singh 2013; Smania 2012; Tariah 2010; Taub 1993; Treger 2012;
Van Delden 2013; Suputtitada 2004; Wang 2011; Wittenberg
2003; Wolf 2006; Wu 2011; Wu 2012a; Yoon 2014). Data were
available for 858 participants (87%). The impact of CIMT on
upper limb function indicated a significant effect size (SMD 0.34,
95% CI 0.12 to 0.55; Analysis 3.1). We found moderate hetero-
geneity among studies (I2 = 47%).
Comparison 3.2: Perceived arm motor function (quality of
use (QoU))
Twenty-nine studies with 1086 participants measured perceived
arm motor function QoU (Atteya 2004; Boake 2007; Brogårdh
2009; Brunner 2012; Dahl 2008; Hammer 2009; Huseyinsinoglu
2012; Khan 2011; Kim 2008; Krawczyk 2012; Lin 2007; Lin
2009a; Lin 2010;Myint 2008; Page 2001; Page 2002b; Page 2004;
Page 2005b; Page 2008; Smania 2012; Tariah 2010; Taub 1993;
Van Delden 2013; Wolf 2006; Wu 2007a;Wu 2007b; Wu 2007c;
Wu 2011; Wu 2012a); data were available for 891 participants
(82%). The impact of CIMT on perceived upper limb function
QoU indicated a large and significant effect (MD 0.68, 95% CI
0.47 to 0.88; Analysis 3.2). We found considerable heterogeneity
among studies (I2 = 74%).
Comparison 3.3: Perceived arm motor function (amount of
use (AoU))
Twenty-eight studies with 1046 participants measured perceived
arm motor function (AoU; Atteya 2004; Boake 2007; Brogårdh
2009; Brunner 2012; Dahl 2008; Hammer 2009; Huseyinsinoglu
2012; Khan 2011; Kim 2008; Lin 2007; Lin 2009a; Lin 2010;
Myint 2008; Page 2001; Page 2002b; Page 2004; Page 2005b; Page
2008; Smania 2012; Tariah 2010; Van Delden 2013; Wittenberg
2003; Wolf 2006; Wu 2007a; Wu 2007b; Wu 2007c; Wu 2011;
Wu 2012a); data were available for 851 participants (81%). The
impact of CIMT on perceived upper limb function AoU indicated
a large and significant effect (MD 0.79, 95% CI 0.50 to 1.08;
Analysis 3.3).We found considerable heterogeneity among studies
(I2 = 87%).
Comparison 3.4: Arm motor impairment
Eighteen studies with 451 participants measured arm motor im-
pairment (Alberts 2004; Atteya 2004; Boake 2007; Hammer
2009; Lin 2009a; Lin 2010; Page 2001; Page 2002b; Page 2004;
Page 2005b; Page 2008; Ploughman 2004; Singh 2013; Tariah
2010; VanDelden 2013;Wu 2007b;Wu 2007c; Yoon 2014); data
were available for 372 participants (82%). The impact of CIMT
on upper limb impairment indicated a significant effect (SMD
0.82, 95% CI 0.31 to 1.34; Analysis 3.4). We found considerable
heterogeneity among studies (I2 = 77%).
Comparison 3.5: Quality of life
Eight studies with 537 participants measured quality of life (Dahl
2008;Dromerick 2009; Lin 2009a; VanDelden 2013;Wolf 2006;
Wu 2007b;Wu 2007c;Wu 2012a); data were available for 96 par-
ticipants (18%). The impact of CIMT on quality of life indicated
a non-significant effect (MD 6.54, 95%CI -1.2 to 14.28; Analysis
3.5). We found no statistical heterogeneity (I2 = 0%).
Comparison 3.6: Dexterity
Seven studieswith 229participants included ameasure of dexterity
(Boake 2007; Brunner 2012; Hammer 2009; Kim 2008; Myint
2008; Van Delden 2013; Yoon 2014); data were available for 113
participants (49%). The impact of CIMT on upper limb dexterity
indicated a significant effect (SMD 0.42, 95% CI 0.04 to 0.79;
Analysis 3.6). We found no statistical heterogeneity (I2 = 0%).
D I S C U S S I O N
Summary of main results
This work updates the previous Cochrane review published in
2008 on the efficacy of CIMT, mCIMT and FU. The review now
includes 42 trials with 1453 participants. All studies enrolled peo-
ple who had compromised, but residual, ability of upper arm and
hand, participants were able to extend the wrist and the metacar-
pophalangeal joints at least 10° and 20° respectively, or presented
a Brunnstrom stage > 3 and with limited pain or spasticity. More-
over, people with cognitive impairment were excluded.
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Results of this review show a superiority of CIMT in comparison
with other rehabilitation approaches on the recovery from motor
impairment and motor function (secondary outcomes) but not in
disability (primary outcome).
Effect of CIMT on disability
Eleven trials with 344 participants measured disability and we
included their results in the analysis.
The impact of CIMT on disability indicates a non-significant ef-
fect if compared with active rehabilitation approaches (SMD0.24,
95%CI -0.05 to 0.52). Also, at the longest follow-up, no superior-
ity of CIMT is documented and subgroup analyses do not show in-
teractions between disability and amount of task practice, anatom-
ical region restraint or time since stroke. The main active rehabili-
tation approaches used by the control groups consisted of occupa-
tional therapy and techniques of adaptation to motor impairment
(Dahl 2008; Dromerick 2009; Lin 2009a; Myint 2008), func-
tional task practice (Lin 2007; Ploughman 2004; Treger 2012;Wu
2007a;Wu2007c), Bobath principles (Huseyinsinoglu 2012), and
unspecified conventional rehabilitation (Yoon 2014). The treat-
ment duration was well balanced among studies except in that
of Huseyinsinoglu 2012, in which CIMT treatment lasted three
times as long as the treatment performed by the control group,
and in the Yoon 2014 study, in which there was a similar four-fold
imbalance between the groups.
In summary, these studies showed that the use of constraining
approaches (CIMT, mCIMT and FU) compared with a similar
dose of rehabilitation targeting the practice of functional tasks did
not result in a demonstrable improvement in disability.
Secondary outcomes
Twenty-eight studies with a total of 848 participants measured
arm motor function and we included them in the analysis. CIMT
was always compared with active rehabilitation approaches, and
showed a limited effect in improving arm motor function.
The majority of trials used a mCIMT, eight studies used CIMT
(Dahl 2008; Hayner 2010; Khan 2011; Myint 2008; Taub 1993;
Wittenberg 2003; Wolf 2006; Yoon 2014), and only three studies
used FU (Hammer 2009; Kim 2008; Ploughman 2004). Com-
parison groups performed the same dose of treatment with the ex-
ception of five studies in which the control groups’ dose was lower
(Dromerick 2009;Taub 1993;Wittenberg 2003;Wolf 2006; Yoon
2014), one study in which the dose was smaller in the treatment
group (Huseyinsinoglu 2012), and two studies in which it was not
clearly specified (Dahl 2008; Kim 2008).
Twenty-three and 24 of the included studies with a total of 851
and 891 participants, respectively, measured the perceived arm
motor function (AoU and QoU, respectively) and we included
them in the analysis. In three studies the control groups did not
perform treatments (Kim 2008, Taub 1993, Wittenberg 2003).
The estimated effect of CIMT led to a significant and clinically
relevant improvement in the perceived arm motor function of the
paretic arm (Lang 2008).
Sixteen of the included studies with a total of 372 participants
measured arm motor impairment and we included them in the
analysis. In one study the control groupdidnot perform treatments
(Kim 2008). The estimated effect of CIMT was considered to be
large in modifying the armmotor impairment of the affected arm.
Four of the included studies with a total of 113 participants mea-
sured dexterity and we included them in the analysis. The esti-
mated effect of CIMT led to a significant small effect in improving
upper limb dexterity.
CIMT does not appear to have a better effect than other rehabili-
tation approaches in improving quality of life; this was measured
in three studies.
It is worth noting the considerable heterogeneity of the studies
included in the review, regarding the way in which CIMT was
applied and the characteristics of the control treatments. Consid-
ering this heterogeneity, and some differences among the outcome
measures used by the authors, the results of these analyses should
be interpreted with caution.
When reported, rates of adverse events among included studies do
not appear to differ between CIMT and the comparison groups,
and CIMT appears to have no adverse effects.
Sixteen studies declared dropout levels of 4% to 23%, including
losses for non-medical reasons, with the exception of one study in
which four of the 13 participants in the experimental group did
not complete the programme due to difficulties in performing the
ADLs (Kim 2008).
Overall completeness and applicability of
evidence
In 2009 this review concluded that “the impact of CIMT on dis-
ability indicated a modest significant benefit”. With the increase
in the number of included studies, the effect of CIMT on disabil-
ity decreased and became non-significant (SMD 0.24, 95% CI -
0.05 to 0.52; Analysis 1.1). We classified the magnitude of effect
sizes as proposed by Juni 2006. The effect size of 0.24 standard
deviation units obtained for disability is considered small. It corre-
sponds to an overlap in the distribution of participants allocated in
the experimental or control interventions of about 85% of cases,
indicating that only 15% of people would benefit from CIMT
treatment after stroke. Also, the sample sizes of the 42 included
studies were generally small.
It has been argued that only individuals presenting with mild to
moderate paresis of the upper limb (Nijland 2010; Smania 2007),
as well as those who are more motivated, would be eligible for
CIMT treatment (Wissink 2014). Actually, from reports of in-
cluded trials there is a clear difficulty in finding eligible partici-
pants. Sixty-one per cent for Lin 2010, and 93% for Smania 2012,
of people assessed for eligibility were excluded because they did not
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fit the inclusion criteria. Moreover, about 20% of eligible people
refused to participate in the study. This means that only a small
number of the people who were screened were included in these el-
igible trials.Moreover, the presence of movement requested as part
of the inclusion criteria could have allowed for selection of those
people with less severe stroke. Transcranial magnetic stimulation
and diffusion tensor imaging studies show that voluntary wrist
and finger extension are associated with the integrity of the corti-
cospinal tract system (Butler 2007; Stinear 2007; Stinear 2010).
Consequently, the characteristics of people to include in these tri-
als raise questions about the application of this intervention in a
wide range of stroke survivors.
The included studies were heterogeneous in participant and in-
tervention characteristics for both CIMT and the control group.
However, none of the subgroup analyses performed in this review
(dose of treatment, time since stroke, anatomical region restraint)
revealed a group of better responders. Although no evidence exists
that the dose of CIMT influences the results, it does not imply
that it is not important. Consequently, it is not possible to exclude
the possibility that the high dose of CIMT reported in the Yoon
2014 study introduced heterogeneity in the analysis, thus provid-
ing overestimation of the effect of CIMT on disability. Finally, the
results of this meta-analysis do not show that the first weeks after
stroke onset are the most important for the application of CIMT,
as studies on neuroplasticity might suggest (Sunderland 2005).
Improvements introduced by CIMT are mainly based on learning
to optimise the use of end-effectors through compensatory strate-
gies. The effects documented in this meta-analysis involve motor
impairment and motor function without a translation in disabil-
ity. This could be considered as surprising, as the rationale for
CIMT is based on decreasing the learned non-use phenomenon,
however, it could be due to the characteristics of the measures of
disability.
The number of RCTs and the data that inform this review have
increased over the past few years. However, the included studies
were generally poor in terms of relevance of findings and quality
of reporting. Only 11 out of 42 studies (with 344 participants)
reported data on the most relevant clinical outcome - disability -
comparing CIMT with an active control intervention. Reporting
was often incomplete, which made some studies uninformative.
The applicability of cumulative evidence characterised by a large
number of small trials of uncertain quality challenges definitive
conclusions about the role of CIMT; however, the findings of this
review suggest that CIMT does not show relevant benefits for the
outcomes that may matter most to people after their stroke.
Quality of the evidence
Three-quarters of the included trials can be considered to be at
unclear risk of bias (see Risk of bias in included studies) for at least
one key bias area. In fact, key methodological information was of-
ten not reported for sequence generation, allocation concealment,
blinding, and missing data. Blinding of study personnel, particu-
larly outcome assessors, was reported in the majority of studies.
Many trials were likely to be underpowered, likely to approach
analyses on a per protocol basis, and had a strong inclination to
perform multiple testing on function scales.
Recent meta-reporting studies showed promising improvements
in the reporting of rehabilitation trials (Abdul Latif 2011; Villamar
2013), and reviews (DiSilvestro 2015; Gianola 2013). In the co-
hort of trials that have evaluated the effectiveness of CIMT, there
were a few recent trials that adopted robust methods and accurate
reporting of clinical and methodological aspects (Brunner 2012;
Smania 2012; Treger 2012; Wolf 2006). These trials represent the
next generation in terms of methodological issues, and a major
step forward in research to understand fully the benefit and safety
of rehabilitation techniques in comparative studies.
Potential biases in the review process
We chose disability as the primary outcome, although it was con-
sidered by a minority of eligible studies (11 studies with a total
of 344 participants), whereas arm motor function was used as the
primary outcome in the majority of included studies (28 studies
with 858 participants).
Although the analysis showed the largest effect of CIMT on per-
ceived arm motor function, caution is needed in interpreting this
result, because of the lack of consistency in the MAL scale, as de-
scribed in the Risk of bias in included studies section. Its clinimet-
ric properties need further investigation in order to define its use
in longitudinal studies.
Most trials were small, with some trials enrolling only six or 10
participants. This is unacceptable, given the high incidence of
stroke and the opportunity to recruit a large sample. Our sample
of trials may therefore have been influenced by publication bias,
which tends to exaggerate the effect of treatment. The randomi-
sation methods were described only in about half of the included
trials. It is not possible to determine if some studies excluded par-
ticipants after randomisation, or whether blinding was not ade-
quately maintained. These weaknesses could be expected to lead
to bias in favour of a treatment effect. The reporting of the data
was poor; for example, many trials only reported that there were
no significant differences between the intervention and the con-
trol groups. This lack of proper reporting could also be expected
to lead to bias in favour of a treatment effect. It should also be
noted that many authors of trials have a cultural and professional
interest in disseminating positive results about the rehabilitative
techniques they propose.
Finally, only one author of the review scanned the titles obtained
from electronic databases searching in order to exclude irrelevant
studies and this could have introduced bias.
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A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Compared with traditional rehabilitation, constraint-induced
movement therapy (CIMT) is associated with limited improve-
ments in motor impairment and motor function, but these bene-
fits do not convincingly reduce disability. These results differ from
our previous meta-analysis, which suggested a possible improve-
ment in disability with CIMT. The recent studies included in this
review did not confirm these findings, and data about the long-
term effects of CIMT are limited.
CIMT can be considered a multifaceted intervention where the
restriction of the less affected limb is accompanied by an increase
in the amount and quality of exercise for the affected limb. The
impact on arm impairment and motor function may not be due
solely to the constraint, but also to the type and amount of exercise.
However, this review could not identify which of these factors is
more important.
The selection of participants for the included studies focused on
people with stroke who had at least some active extension of the
wrist and fingers, with limited pain or spasticity, plus good com-
pliance with rehabilitation treatment. It appears that the review
results apply most appropriately to this patient group. Many stud-
ies were underpowered with a high risk of small trial bias and
publication bias. It is not clear if the apparent benefits on motor
impairment and motor function can be translated into improve-
ments in activities of daily living. Moreover, it is not possible to
comment on the long-term effects of CIMT.
Implications for research
It is likely that additional randomised controlled trials (RCTs) in-
vestigating CIMT as a rehabilitation technique would be worth-
while if they:
• involve a control group under active treatment, since
CIMT involves a certain amount of exercise;
• consider disability or arm motor function as the primary
outcomes;
• include a validated quality of life measure as one of the
outcomes; and
• determine and report the sample size and power analysis
transparently.
CIMT trials do not make it clear which people might most benefit
from this treatment. Participants in the RCTs were those with at
least some active extension of wrist and fingers and with limited
pain or spasticity. Researchers involved in future studies should
analyse the correlation between participant characteristics and out-
come improvements in order to identify responders to CIMT.
Clinicians who aspire to offer their patients a tailored programme
of CIMT need to examine individual characteristics carefully to
identify potential factors that are likely to increase the limited
chance of success of CIMT.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Alberts 2004
Methods Randomisation automated and balanced with respect to sex, premorbid handedness, side
of stroke and level of function
Blinded outcome assessor
No information about withdrawals
Multicentre, outpatients
Participants USA
Recruited from 247 facilities spanning the 7 participating sites participating in a multi-
site trial
10 participants: 5 intervention, 5 control
Inclusion criteria: cerebrovascular accident between 3 and 9 months, 10° of active exten-
sion to the metacarpophalangeal and interphalangeal joints and 20° at wrist, minimum
passive range of motion of 90° for shoulder flexion and abduction
Exclusion criteria: score of < 24 on the MMSE, physician-determined major medical
problems that would interfere with participation
Mean age (SD): intervention group: 65 (8.2) years, control group: 63.4 (15.5) years
% women: intervention group 60%, control group: 40%
Stroke details: only ischaemic, 20% with right hemiparesis in each group
Time since stroke, mean (SD): intervention group 6.4 (1.1) months, control group 5.6
(1.5) months
Interventions CIMT versus no treatment
CIMT: shaping or adaptive task practice and repetitive task practice techniques
Amount of restraint: 90% of waking hours per day
Anatomical region restraint: hand
Session duration: 6 hours per day, 5 days per week for 2 weeks
Outcomes Measures pre/post treatment
• Arm motor function: WMFT
• Arm motor impairment: FMA, grip/force
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Sequence generation by random auto-
mated generator
Quote: “Ten patients were randomly as-
signed to 1 of 2 groups”
Allocation concealment (selection bias) Low risk Central allocation
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Alberts 2004 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
Low risk Quote: “An evaluator blinded to group
assignment performed pre- and post-
WMFT and FMA assessments”
Incomplete outcome data addressed? (Post-
treatment)
Unclear risk The study provided no information about
withdrawals
Atteya 2004
Methods Randomisation details were not reported
Blinded outcome assessor
No information about withdrawals
Single centre, outpatients
Participants Saudi Arabia
Recruited via the King Saud Univerity
6 participants: 2 intervention, 2 control, 2 no treatment
Inclusion criteria: cerebrovascular accident between 1 and 6 months; 10° of active ex-
tension to the metacarpophalangeal and interphalangeal joints and 20° at wrist
Exclusion criteria: significant cognitive impairment, haemorraghic lesion, significant
spasticity, significant pain of the upper limb
Mean age (SD): intervention group: 55 (2.8) years, control group: 52 (4.2) years, no
treatment group: 56 (15.5) years
% women: intervention group 50%, control group: 50%, no treatment group: 50%
Stroke details: only ischaemic, 50% with right hemiparesis in each group
Time since stroke, mean (SD): intervention group 5.6 (0.3) months, control group 3.
95 (2.3) months, no intervention group 4.65 (1.2) months
Interventions mCIMT versus control versus no treatment
CIMT: physical and occupational therapy focused on PNFwith emphasis on ADL tasks,
compensatory techniques with the unaffected side, 2 functional tasks of the WMFT
with shaping techniques
Amount of restraint: 5 waking hours per day
Anatomical region restraint: arm and hand
Control: physical and occupational therapy focused on PNF with emphasis on ADL
tasks, compensatory techniques with the unaffected side
Session duration: 1 hour per day, 3 days per week, 10 weeks for each treatment group
Outcomes Measures pre/post treatment
• Arm motor function: ARAT, WMFT2
• Perceived arm motor function: MAL
• Arm motor impairment: FMA
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Atteya 2004 (Continued)
Random sequence generation (selection
bias)
Unclear risk Quote: “all subjects were randomly as-
signed ... with an equal probability”
Comment: insufficient information to
make a judgment
Allocation concealment (selection bias) Unclear risk No information provided
Blinding (performance bias and detection
bias)
All outcomes
Low risk Blinding of outcome assessor
Incomplete outcome data addressed? (Post-
treatment)
Unclear risk The study provided no information about
withdrawals
Azab 2009
Methods Randomisation details were not reported
Blinded outcome assessor
No withdrawals
Single centre, outpatients
Participants Jordan
Recruited from King Abudallah University Hospital
37 participants: 20 intervention, 17 control
Inclusion criteria: ability to voluntarily extend fingers and wrist slightly
Exclusion criteria: severe cognitive disabilities
Mean age (SD): 56 (9.9) years for all participants
% women: 24% of all participants
Stroke details: only ischaemic, 57% with right hemiparesis
Time since stroke, mean (SD): 2.75 (0.7) months for all participants
Interventions mCIMT versus control
mCIMT: active range of motion of bilateral upper extremities, stretching exercises, hand-
eye co-ordination activities, ambulation, and strengthening exercises for bilateral upper
extremities
Amount of restraint: 6 to 7 hours per day
Anatomical region restraint: hand
Control: active range of motion of bilateral upper extremities, stretching exercises, hand-
eye co-ordination activities, ambulation, and strengthening exercises for bilateral upper
extremities
Session duration: 4 hours per week (in 3 day/week) for 4 weeks for both groups
Outcomes Measures pre/post treatment and follow-up at 6 months
• ADL measure: BI
Notes
Risk of bias
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Azab 2009 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Information provided only in the abstract
Quote: “Key words: Barthel Index, CIMT,
stroke randomized control study”
Allocation concealment (selection bias) Unclear risk No information provided
Blinding (performance bias and detection
bias)
All outcomes
Low risk Quote: “The occupational therapist and
the two physical therapists were double-
blinded to the therapy and group assign-
ment of the patients”
Incomplete outcome data addressed? (Post-
treatment)
Unclear risk Quote: “The BI was measured at the be-
ginning of the rehabilitation program and
at the discharge from rehabilitation. The
BI was also re-evaluated at 6 months post
discharge in 18 patients (64% of the initial
experimental group)”
Bergheim 2010
Methods Randomisation by computer
Blinded outcome assessor
No withdrawals
Single centre, inpatients
Participants Norway
Recruited from stroke unit and the neurological department of geriatric medicine of
Ullevaal University Hospital
4 participants: 2 intervention, 2 control
Inclusion criteria: cerebrovascular accident between 14 and 21 days; 10° of active exten-
sion in the finger and 20° in the wrist; ability to walk indoors without the use of walking
aids; sufficient cognitive function
Exclusion criteria: cerebral haemorrhage, prior stroke, unstable medical status, second
cerebral diseases that were difficult to differentiate from a stroke, and previous illness/
injury that significantly impaired function in arms
Mean age (SD): intervention group: 70.5 (13.4) years, control group: 76.5 (4.9) years
% women: intervention group 50%, control group: 50%
Stroke details: only ischaemic, 0% with right hemiparesis with 0% paresis of the domi-
nant side in treatment group, 50% with right hemiparesis with 50% paresis of the dom-
inant side in control group
Time since stroke: 14-21 days after stroke onset
Interventions mCIMT versus control
mCIMT: functional activities through shaping approach
Amount of restraint: 6-7 hours per day
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Bergheim 2010 (Continued)
Anatomical region restraint: hand
Control: mono and bilateral activities
Session duration: 1 hour per day, 5 days/week, 2 weeks for both groups
Outcomes Measures pre/post treatment and follow-up at 3 months
• Arm motor function: BLMA, WMFT
• Everyday motor function: MAS
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “the randomisation was performed
from a computer generated list”
Allocation concealment (selection bias) Unclear risk Quote: “Enrolled patients consented in
writing and orally and were randomized by
closed numbered envelopes participation
respectively group mCIMT or TF [tradi-
tional physiotherapy]”
Blinding (performance bias and detection
bias)
All outcomes
Low risk Quote: “The outcome was examined by a
physiotherapist blinded to therapy patients
received”
Incomplete outcome data addressed? (Post-
treatment)
Unclear risk No missing outcome data
Boake 2007
Methods Randomisation: stratified by age and NIHSS, other details were not reported
Blinded outcome assessor
Post-treatment withdrawals 22%, follow-up withdrawals: 11%
Single centre, inpatients and outpatients
Participants USA
Recruited from admissions to the University Hospital of Memorial Hermann
23 participants: 10 intervention, 13 control
Inclusion criteria: cerebrovascular accident within 14 days; score 1 to 3 on the motor
arm item of the NIHSS; 10° of active movement in the thumb and 2 or more fingers of
the affected hand
Exclusion criteria: not reported
Mean age (SD): intervention group: 63.1 (14.3)years, control group: 58.9 (14) years
% women: intervention group 30%, control group: 38%
Stroke details: ischaemic or haemorrhagic, 40% with right hemiparesis in treatment
group, 54% with right hemiparesis in control group
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Boake 2007 (Continued)
Time since stroke, mean (range): intervention group 3.3 (3 to 4.1) months, control
group 3.3 (3 to 4.3) months
Interventions mCIMT versus control
mCIMT: functional tasks with shaping techniques
Amount of restraint: 90% of waking hours per day
Anatomical region restraint: hand
Control: ADL with either hand, improvement of strength, muscle tone and range of
motion of the affected arm
Session duration: 3 hours per day, 6 days per week, 2 weeks for each group
Outcomes Measures pre/post treatment, follow up at 3 to 4 months
• Perceived arm motor function: MAL
• Dexterity: GPT
• Arm motor impairment: FMA2
• Neurophysiological test: TMS
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “patients underwent baseline test-
ing and were randomly allocated to either
CIMT or traditional therapy”
Allocation concealment (selection bias) Unclear risk No information provided
Blinding (performance bias and detection
bias)
All outcomes
Low risk Quote: “Outcome evaluations were per-
formed by personnel from outside ... who
were blind to treatment assignment”
Incomplete outcome data addressed? (Post-
treatment)
High risk 1/10missing from intervention group (due
to incomplete data), 4/13 missing from
control group (due incomplete data and in-
juries). Reasons for missing data outcomes
possibly related to the true effect, with
imbalance across intervention and control
groups
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Brogårdh 2009
Methods Randomisation by computer
Blinded outcome assessor
Follow-up withdrawals: < 5%
Single centre, inpatients
Participants Sweden
Recruited from the Department of Rehabilitation at Lund University Hospital
24 participants: 12 intervention, 12 control
Inclusion criteria: stroke onset between 1 and 3 months; 10° of active extension at wrist
at least 10° of active extension of 2 fingers and 10° of active movement in the thumb
Exclusion criteria: deformity of themore affected arm due to previous injury, drug abuse,
epilepsy, mental disorder and botulinum toxin injections for spasticity treatment
Mean age (SD): intervention group: 58.5 (6.3) years, control group: 56.7 (10.5) years
% women: intervention group 17%, control group: 33%
Stroke details: 58% with right hemiparesis with 75% paresis of the dominant side in
treatment group, 75% with right hemiparesis with 83% paresis of the dominant side in
control group
Time since stroke, mean (SD): intervention group 1.56 (0.53) months, control group
1.7 (0.7) months
Interventions mCIMT versus control
mCIMT: task practise, fine motor practise, muscle strength training, muscle stretching,
swimming pool training, general activity training. Activity of upper arm was delivered
through shaping approach
Amount of restraint: 90% of waking hours per day
Anatomical region restraint: hand
Control: task practise, fine motor practise, muscle strength training, muscle stretching,
swimming pool training, general activity training. Activity of upper arm was delivered
through shaping approach
Session duration: 3 hours per day for 2 weeks for both groups
Outcomes Measures pre/post treatment, follow-up at 3 months
• Everyday arm motor function: MAS2
• Hand Function: SHFT
• Perceived arm motor function: MAL
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Randomization was performed
from a computer-generated list of consec-
utive random numbers”
Allocation concealment (selection bias) Unclear risk No information provided
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Brogårdh 2009 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
Low risk Quote: “All patients were assessed by inde-
pendent and blinded assessors”
Incomplete outcome data addressed? (Post-
treatment)
Unclear risk 1 participant missed the three months fol-
low-up
Brunner 2012
Methods Randomisation by computer
Blinded outcome assessor
Post-treatment withdrawals 6%
Multicentre, inpatients and outpatients
Participants Norway
Recruited from 2 hospitals in the City of Bergen
30 participants: 14 intervention, 16 control
Inclusion criteria: cerebrovascular accident between 2 and 16 weeks; ability to extend
the affected wrist and fingers at least 10°
Exclusion criteria: additional neurological diseases, unstable medical conditions, mus-
culoskeletal disorders affecting arm mobility and severe cognitive impairment
Mean age (SD): intervention group: 61 (10) years, control group: 64.8 (12.8) years
% women: intervention group 21%, control group: 50%
Stroke details: ischaemic or haemorrhagic; 43% with right hemiparesis in treatment
group, 37% with right hemiparesis in control group
Time since stroke, mean (SD): intervention group 1.6 (1.3) months, control group 1.
23 (0.8) months
Interventions mCIMT versus control
mCIMT: task-related arm training, strength training, mobility training with shaping
approach and self training focusing on unilateral activities
Amount of restraint: 4 hours per day
Anatomical region restraint: hand
Control: task-related arm training, strength training, mobility training with shaping
approach and self training focusing on bilateral activities
Session duration: 4 hours a week with physiotherapist plus 2-3 hours everyday of self-
training for 4 weeks for both groups
Outcomes Measures pre/post treatment
• Arm motor function: ARAT
• Dexterity: 9HPT
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Brunner 2012 (Continued)
Random sequence generation (selection
bias)
Low risk Quote: “A randomized controlled trial was
applied. A computerized random numbers
generator was used for randomising the pa-
tients in blocks of four patients into amodi-
fied constraint-induced movement therapy
or a bimanual training group”
Allocation concealment (selection bias) Low risk Quote: “Opaque, sealed envelopes were
prepared by a person not involved in the
study, classifying the patients into one of
the two groups”
Blinding (performance bias and detection
bias)
All outcomes
Low risk Quote: “The randomizations led to a bal-
anced allocation, andblinded raters secured
unbiased assessments”
Incomplete outcome data addressed? (Post-
treatment)
Low risk Quote: “There was two drop-outs, one in
each group, due to othermedical problems”
Dahl 2008
Methods Block randomisation, other details were not reported
Blinded outcome assessor
No withdrawals
Single centre, inpatients
Participants Norway
Recruited from the Stroke Unit at TrondheimUniversity Hospital and by announcement
at hospitals and rehabilitation institutions in the neighbouring countries
30 participants: 18 intervention, 12 control
Inclusion criteria: time from onset of stroke > two weeks; score 0 to 2 points before the
stroke on themodifiedRanking Scale; 10° of active extension to themetacarpophalangeal
and interphalangeal joints and 20° at wrist
Exclusion criteria: presence of other neurological diseases, unstable cardiovascular disease,
severe depression (> 12 points on Montgomery and Aasberg Depression Rating Scale)
, marked neglect (line bisection more than 2 cm over the midline), life expectancy < 6
months, sequel from a previous stroke and clinically evaluated insufficient endurance to
participate
Mean age (SD): intervention group: 62 (8) years, control group: 60 (12) years
% women: intervention group 11%, control group: 42%
Stroke details: ischaemic or haemorrhagic; 78% paresis of dominant side in treatment
group, 58% paresis of the dominant side in control group
Time since stroke, mean (SD): intervention group 21 (18) months, control group 26
(27) months
Interventions CIMT versus control
CIMT: personalisedADL task training of the paretic limb, training difficultywas updated
with daily progress
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Dahl 2008 (Continued)
Amount of restraint: 90% of waking hours per day
Anatomical region restraint: hand
Control: treatment given according to each patient’s need, involving both upper and
lower extremity with various occupational and physical therapy approaches
Session duration: 6 hours per day in the CIMT group, unspecified duration for control
group for 10 consecutive weekdays
Outcomes Measures pre/post treatment and follow-up at 6 months
• Motor function: WMFT
• Perceived arm motor function: MAL
• ADL measure: FIM2
• Quality of life: SIS
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Eligible patients were block-ran-
domised into a CIMT group or a control
group”
Allocation concealment (selection bias) Low risk Quote: “Sealed opaque envelopeswere used
for randomisation and the procedure was
carried out by an external office”
Blinding (performance bias and detection
bias)
All outcomes
Low risk Quote: “Two independent and blinded as-
sessors performed the assessments”
Incomplete outcome data addressed? (Post-
treatment)
Low risk No missing data
Dromerick 2000
Methods Randomisation by random number table, other details were not reported
Blinded outcome assessor
Post-treatment withdrawals: 13%
Single centre, inpatients
Participants USA
Recruited from the acute stroke and brain injury rehabilitation service
20 participants: 11 intervention, 9 control
Inclusion criteria: admission to inpatient rehabilitation within 14 days of ischemics
stroke; score 1 or 2 on the motor arm item of the NIHSS; preserved cognitive function
Exclusion criteria: no upper extremity injury or conditions that limited use before the
stroke
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Dromerick 2000 (Continued)
Mean age (SD): intervention group: 61.5 (13.7) years, control group: 71.4 (5.3) years
% women: intervention group 25%, control group: 63%
Stroke details: only ischaemic; 75% with right hemiparesis in treatment group, 63%
with right hemiparesis in control group
Time since stroke, mean (SD): 6 (2.6) days for both groups (range 4 to 14 days)
Interventions CIMT versus control
CIMT: ADL and functional tasks with the affected limb
Amount of restraint: at least 6 hours per day
Anatomical region restraint: hand
Control: compensatory techniques for ADL, upper extremity strength, range of motion
and traditional positioning
Session duration: 2 hours per day, 5 days per week, 2 weeks for both groups
Outcomes Measures pre/post treatment
• Motor function: ARAT
Measures post-treatment only
• ADL measure: BI, FIM
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Subjects were individually ran-
domized into experimental or control
groups by using a table of random num-
bers”
Allocation concealment (selection bias) Unclear risk No information provided
Blinding (performance bias and detection
bias)
All outcomes
Low risk Quote: “All posttreatment assessments
were performed by blinded testers”
Incomplete outcome data addressed? (Post-
treatment)
High risk 3/23 dropouts, reasons not reported
Dromerick 2009
Methods Randomisation balanced for age, total NIHSS score, ARAT score and days from stroke
onset, other details were not reported
Blinded outcome assessor
Follow-up withdrawals: < 4%
Single centre, inpatients
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Dromerick 2009 (Continued)
Participants USA
Recruitment from acute stroke admissions at Barnes-Jewish Hospital in St Louis
52 participants: 35 intervention, 17 control
Inclusion criteria: cerebrovascular accident within 28 days; score ≥ 3 on the upper arm
item of the MAS, but no necessary movements in the hand
Exclusion criteria: inability to give informed consent; clinically significant fluctuations in
mental status within 3 days of enrolment; not independent prior to stroke; hemispatial
neglect; sensory loss; not expected to survive 1 year due to other illnesses
Mean age (SD): intervention group: 63.6 (14.38) years, control group: 64.7 (14.6) years
% women: intervention group 57%, control group: 63%
Stroke details: ischaemic or haemorrhagic; 51% with right hemiparesis with 45% paresis
of the dominant side in treatment group, 52.9% with right hemiparesis with 44.2%
paresis of the dominant side in control group
Time since stroke, mean (SD): intervention group 9.3 (4.6) days, control group 10.4 (5.
7) days
Interventions This trial had 3 arms: 2 of the intervention groups performedmCIMT; 1 of the mCIMT
groups performed a low intensity treatment (Low mCIMT) and the other group per-
formed a high intensity treatment (High mCIMT)
mCIMT (Low mCIMT versus High mCIMT) versus control
mCIMT: functional activities of basic ADL with shaping approach for both groups
Amount of restraint: LowmCIMT 6 hours per day, High mCIMT 90% of waking hours
Anatomical region restraint: hand
Control: traditional occupational therapy, involving compensatory techniques for ADL
range of motion, and strengthening and upper extremity bilateral training activities
Session duration: 2 hours per day for Low mCIMT, 3 hours per day for High mCIMT
and 2 hours per day for control group for 5 days a week for 2 weeks
Outcomes Measures pre/post treatment, follow-up at 3 months
• Overall stroke severity: NIHSS
• Arm motor function: ARAT
• ADL measure: FIM
• Quality of life: SIS (only at post-treatment)
• Pain at shoulder: Wong-Baker Faces Scale
• Depression: Geriatric Depression-15 Scale
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “... we adaptively randomized the
groupbalancing for age, totalNIHSS score,
pretest ARAT and days from stroke onset”
Allocation concealment (selection bias) Low risk Quote: “The study clinical team met
weekly to assure adherence to protocols”
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Dromerick 2009 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
Low risk Quote: “Trained raters performed all
blinded evaluations”
Incomplete outcome data addressed? (Post-
treatment)
Low risk Quote: “All but twoparticipantswere avail-
able for assessment at the 90-day primary
endpoint”
Hammer 2009
Methods Randomisation through marked ballots of paper
Unblinded outcome assessor
Post-treatment withdrawals 13%
Single centre, inpatients and outpatients
Participants Sweden
Recruited from the departments of rehabilitation medicine, geriatrics, and neurology at
a university hospital in central Sweden
30 participants: 15 intervention, 15 control
Inclusion criteria:cerebrovascular accident between 1 and 6 months; 10° of active exten-
sion in the finger and 20° in the wrist
Exclusion criteria: no severe cognitive impairment (score of 20 points in the MMSE);
ability to understand and follow instructions
Mean age (SD): intervention group: 66.3 (10.3) years, control group: 60.4 (11.1) years
% women: intervention group 7%, control group: 40%
Stroke details: 73% with right hemiparesis with 80% paresis of the dominant side in
treatment group, 53% with right hemiparesis with 46% paresis of the dominant side in
control group
Time since stroke, mean (SD): intervention group 2.6 (1.5) months, control group 2.3
(1.2) months
Interventions mCIMT versus control
mCIMT: conventional rehabilitation consisting of task-oriented activities, facilitation of
proximal and distal motor control and improvement of strength and endurance, skilled
task training (moving objects, writing or typing) and daily tasks
Amount of restraint: 6 hours per day, 5 days a week
Anatomical region restraint: arm and hand
Control: conventional rehabilitation consisting of task-oriented activities, facilitation of
proximal and distal motor control and improvement of strength and endurance, skilled
task training (moving objects, writing or typing) and daily tasks
Session duration: 3 hours per day, 5 days per week, 2 weeks for both groups
Outcomes Measures pre/post treatment and follow-up at 1 and 3 months:
• Arm motor function: ARAT
• Arm motor impairment: FMA, grip/force
• Spasticity: MASh
• Dexterity: 16HPT
• Everyday arm motor function: MAS
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• Perceived arm motor function: MAL
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “a restricted block randomisation
was used. Thirty pieces of paper had been
prepared with the letter E (experimental
group ...) on 15 of them and the letter K
(conventional group ...) on the other 15. A
block size of 10 was used (5 ”E“ plus 5 ”K“)
”
Allocation concealment (selection bias) Low risk Quote: “The pieces of paper were folded
twice, and the first block of 10 was placed
in a metal box, while the rest were stored in
2 sealed envelopes with 1 block in each. For
each participant in the study, the metal box
was shaken, and an arbitrarily chosen staff
member drew a piece of paper to determine
the group allocation”
Blinding (performance bias and detection
bias)
All outcomes
High risk Quote: “ ... the present study had ... lack of
blinding”
Incomplete outcome data addressed? (Post-
treatment)
Low risk Quote: “There were a total of 4 dropouts
during the study. Two participants in the
FU group discontinued the 2-week inter-
vention period; one dropped out on the
first day of intervention because of refusal
to continue, and the other was discharged
on day 5 of the intervention. The other 2
participants dropped out before follow-up
because of illness (forced-use group) and
because of refusal to continue (standard
training group)”
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Hayner 2010
Methods Randomisation balanced for WMFT score, other details were not reported
Unblinded outcome assessor
Post-treatment withdrawals 8%
Single centre, outpatients
Participants Canada
Recruited through information disseminated to participants in a free clinic at Samuel
Merritt University, clinics in the vicinity, and a local CVA support group
12 participants: 6 intervention, 6 control
Inclusion criteria: cerebrovascular accident least 6 months; ability to place the affected
hand on a table surface, trace movements in the hand and had sufficient endurance to
participate in therapy 6 hours per day for 10 consecutive weekdays
Exclusion criteria: inability to refrain from smoking (because a smoking area was un-
available), inability to tolerate a regular diet (because making lunch was a part of the
therapeutic design)
Mean age (SD): intervention group: 54 (11.62) years, control group: 559.5 (11.77) years
% women: intervention group 67%, control group: 50%
Stroke details: ischaemic
Time since stroke, mean (SD): intervention group 21.1 (13.8) months, control group
67 (30.4) months
Interventions CIMT versus control
CIMT: functional activities with 1 hand
Amount of restraint: at least 6 hours per day
Anatomical region restraint: hand
Control: functional activities with 2 hands
Session duration: 6 hours per day for 10 consecutive weekdays for both groups
Outcomes Measures pre/post treatment and follow-up at 6 months
• Arm motor function: WMFT
• Global function: COPM
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Participants were stratified into
more and less affected UE [upper extrem-
ity] groups as determined by the WMFT
total score and then blindly randomized
into the CIMT or bilateral group”
Allocation concealment (selection bias) Unclear risk Quote: “Participants were ... blindly ran-
domized into the CIMT or bilateral group”
Quote: “To ensure that intervention was
truly of the same intensity and to avoid
organizational confounds, all participants
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Hayner 2010 (Continued)
were treated simultaneously, in the same lo-
cation, and by the same therapists”
Blinding (performance bias and detection
bias)
All outcomes
High risk Quote: “Raters were not blinded”
Incomplete outcome data addressed? (Post-
treatment)
Low risk Quote: “One participant, randomized to
the CIMT group, injured his affected UE
at home before posttesting during a non-
study-related activity and was dropped
from the study”
Huseyinsinoglu 2012
Methods Randomisation by computer, stratified by people who received injections of botulinum
toxin-A
Blinded outcome assessor
Post-treatment withdrawals: 8%
Single centre, outpatients
Participants Turkey
Recruited from the outpatient clinic of the Stroke Unit of the Florence Nightingale
Hospital
24 participants: 13 intervention, 11 control
Inclusion criteria: cerebrovascular accident between 3 and 24 months; 10° of active
extension to the metacarpophalangeal and interphalangeal joints and 20° at wrist
Exclusion criteria: no serious cognitive disorders; no excessive pain that would interfere
with the ability to participate in the treatment; no excessive spasticity in any joint of the
affected arm
Mean age (SD): intervention group: 49.1 (13.7) years, control group: 48.2 (15.4) years
% women: intervention group 36%, control group: 54%
Stroke details: ischaemic or haemorrhagic; 64% paresis of dominant side in treatment
group, 27% paresis of the dominant side in control group
Time since stroke, mean (SD): intervention group 10.6 (6.1) months, control group 13.
1 (6.3) months
Interventions mCIMT versus control
mCIMT: behavioural techniques, shaping and task activities
Amount of restraint: 90% of waking hours for 12 consecutive days
Anatomical region restraint: hand
Control: control muscle, tone quality of movements, weight bearing and stability of
trunk arm activity in functional situation following Bobath principles
Session duration: mCIMT: 3 hours per day for 10 consecutive days; control group: 1
hour per day for 10 consecutive days
Outcomes Measures pre/post treatment
• ADL measures: FIM
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Huseyinsinoglu 2012 (Continued)
• Arm motor function: WMFT
• Perceived arm motor function: MAL 3
• Arm performance after stroke: MESUPES
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Subjects ... were randomly as-
signed to either ... group by using a
randomisation function of Microsoft Of-
fice Excel software. Blocked randomisation
was used. Treatment and random num-
ber columns were created and each part
of the treatment column was (pre-assigned
as B and C subjects, respectively) given
a random number between 0 and 1 by
theMicrosoft Excel software random num-
ber generator. The sort and filter menu
was used to sort the random number row
from smallest to largest so that treatment
groups were randomly ordered. Pre-stratifi-
cation was applied to the subjects based on
whether they had received injections of bo-
tulinum toxin-A within past three months”
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Low risk Quote: “Before and after the interven-
tions, measurements were obtained by a
rater blinded to the group assignment.
The blinded rater was trained to adminis-
ter these tests before the beginning of the
study”
Incomplete outcome data addressed? (Post-
treatment)
Low risk Quote: “Two dropped out of the con-
straint-induced movement therapy group
during the intervention period; both were
personal choice. 22 participants completed
the two-week treatment”
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Khan 2011
Methods Randomisation with stratification by age, time since stroke, arm/hand function
Blinded outcome assessor
Post-treatment withdrawals 4%, follow-up withdrawals: 7%
Single centre, inpatients
Participants Switzerland
Recruitment from stroke patients referred for inpatient rehabilitation in the Neuroreha-
bilitation Center Valens
42 participants: 13 intervention, 14 control, 15 therapeutic climbing
Inclusion criteria: people with acute, subacute and chronic stroke; minimal to moderate
arm and hand function stage 2-6 on the Chedoke McMaster Impairment Inventory sub
scale and hand control
Exclusion criteria: shoulder pain, other neurological disorders or other serious co-mor-
bidities
Mean age (SD): intervention group: 60.4 (16.1) years, control group: 60.4 (14.8) years,
therapeutic climbing 62.2 (13.5) years
% women: intervention group 23%, control group: 50%, therapeutic climbing 33%
Stroke details: 61% with right hemiparesis with 61% paresis of the dominant side in
treatment group, 43% with right hemiparesis with 50% paresis of the dominant side in
control group, and 67% with right hemiparesis with 73% paresis of the dominant side
in therapeutic climbing group
Time since stroke, mean (SD): intervention group 5.2 (10.9) months, control group 15.
7 (40.4) days, therapeutic climbing 11 (21.3) months
Interventions This trial had 3 arms: the intervention group performed CIMT; a comparison group
performed therapeutic climbing (TC) and the control group
CIMT versus control versus TC
CIMT: task-oriented training
Amount of restraint: during the exercises
Anatomical region restraint: hand
Control: postural control, inhibition of synergistic movements, facilitation of economic
movements, conventional therapy
TC: climbing-specific exercises performed at the climbing wall inside the clinic
Session duration:
CIMT: 5 hours of individual physiotherapy and occupational therapy per week plus 5
hours of group exercises and 5 hours of self training per week;
Control group: 7.5 hours of individual physiotherapy and occupational therapy plus 5
hours of group exercises per week;
TC: 3,5 hours of individual physiotherapy and occupational therapy plus 4 hours of TC
per week plus 5 hours of group exercises per week
Total duration of treatment was not reported
Outcomes Measures pre/post treatment and follow-up at 6 months:
• Arm motor function: WMFT
• Perceived arm motor function: MAL
• Shoulder pain: CMII (subscale for shoulder pain)
Notes
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “An independent and blinded re-
search assistant performed concealed ran-
domization using a randomization sched-
ule with blocks of three generated by the
primary researcher”
Allocation concealment (selection bias) Unclear risk Quote: “An independent and blinded re-
search assistant performed concealed ran-
domization using a randomization sched-
ule with blocks of three generated by the
primary researcher”
Blinding (performance bias and detection
bias)
All outcomes
Low risk Quote: “The same independent and
blinded assessor performed all outcome
measurements”
Incomplete outcome data addressed? (Post-
treatment)
Low risk 1/15 missing participant from conven-
tional neurological therapy (thrombosis)
1/14 missing participant from CIMT
(home sickness)
3/15 missing participants from climbing at
6 months follow-up (1 participant died, 1
suffered another stroke, 1 refused to turn
up)
Kim 2008
Methods Randomisation details were not reported
Blinding of outcome assessor not reported
Post-treatment withdrawals: 23%
Single centre, outpatients
Participants Republic of Korea
Participant recruitment information not provided
17 participants: 9 intervention, 8 control
Inclusion criteria: cerebrovascular accident > 12 months; mild weakness of the affected
upper limb (key muscle can move against some resistance) some fine motor ability of
the affected hand
Exclusion criteria: balance problems, severe visual impairments, cognitive deficits and
aphagia
Mean age (SD): intervention group: 51.7 (9.5) years, control group: 59.6 (10.3) years
% women: intervention group 44%, control group: 50%
Stroke details: ischaemic or haemorrhagic
Time since stroke, mean (SD): intervention group 23.8 (7) months, control group 33.
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3 (18.5) months
Interventions Forced use versus control
Forced use: no exercises
Amount of restraint: 5 hours day, 7 days per week
Anatomical region restraint: hand
Control: no exercises
Total duration of treatment: 8 weeks
Outcomes Measures pre/post treatment
• Arm motor function: MFT
• Dexterity: Purdue Pegboard Test
• Perceived arm motor function: MAL
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “patients were randomly assigned
to either the control group or the CIMT
group”
Allocation concealment (selection bias) Unclear risk Information not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Information not reported
Incomplete outcome data addressed? (Post-
treatment)
High risk Quote: “Four of the 13 patients in the
CIMT group did not complete [the] pro-
gram. It seems that all 4 patients discontin-
ued participation due to difficulties in per-
forming some ADLs such as eating, dress-
ing, dialling the phone, opening a door or
operating a remote control”
Krawczyk 2012
Methods Randomisation by computer, stratified by age, gender, affected side of the body, time
between the onset of stroke and the beginning of the study and severity of the armmotor
deficit
Blinded outcome assessor
Follow-up withdrawals: 19%
Single centre, inpatients
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Participants Poland
Recruited stroke patients consecutively admitted to the inpatient neurorehabilitation
unit in the Institute of Psychiatry and Neurology Hospital
47 participants: 24 intervention, 23 control
Inclusion criteria: cerebrovascular accident more than 6 weeks before starting the study,
presence of a motor deficit in the arm as assessed with the RMAAS
Exclusion criteria: permanent use of the involved arm in life situations and coexisting
lack of well-defined treatment goals by the patient; excessive pain, spasticity or ataxia;
presence of a severe or uncontrolled medical condition; orthopaedic or neurological
limitations prior to the stroke that could affect outcome; bilateral or brainstem stroke
Mean age (SD): intervention group: 48 (14) years, control group: 46 (13) years
% women: intervention group 21%, control group: 25%
Stroke details: ischaemic or haemorrhagic; 46% with right hemiparesis in treatment
group, 43% with right hemiparesis in control group
Time since stroke: 53% of participants were within 6 months post stroke
Interventions mCIMT versus control
mCIMT: task-oriented training MAL activities applied with shaping
Amount of restraint: 5 hours per day
Anatomical region restraint: arm plus hand
Control: task-oriented training MAL activities applied with shaping
Session duration: 6 hours per day, 5 days a week for 3 weeks each group
Outcomes Measures pre/post treatment and follow-up at 1 year
• Arm motor function: RMAAS
• Perceived arm motor function: MAL
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “patients were randomly allocated
by a computer program”
Allocation concealment (selection bias) Unclear risk Information not reported
Blinding (performance bias and detection
bias)
All outcomes
Low risk Quote: “A trained investigator who was
blinded to the study group … carried out
all three clinical assessments”
Incomplete outcome data addressed? (Post-
treatment)
Low risk At 1 year follow-up 3/24 in CIMT group
(1 died, 1 changed address, 1 refused to
participate) and 6/23 participants in vol-
untary-constraint group (1 died, 3 changed
address, 2 refused to participate) did not
participate
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Lin 2007
Methods Randomisation by random number table stratified by side of stroke, allocation by sealed
envelopes
Blinded outcome assessor
Post-treatment withdrawals: 6%
Multicentre, outpatients
Participants Taiwan
Recruited from rehabilitation departments of 3 medical centres
32 participants: 17 intervention, 15 control
Inclusion criteria: cerebrovascular accident > 12 months; Brunnstrom Stage > 3 on arm
section; amount of use < 2.5 on the MAL, no serious cognitive deficits, no excessive
spasticity in any joints of the affected upper limb
Exclusion criteria: history of stroke or other neurological, neuromuscular or orthopaedic
disease
Mean age (SD): intervention group: 57.11 (18.3) years, control group: 58.77 (15.5)
years
% women: intervention group 35%, control group: 33%
Stroke details: ischaemic or haemorrhagic; 53% with right hemiparesis in treatment
group, 60% with right hemiparesis in control group
Time since stroke, mean (SD): intervention group 15.97 (3.46) months, control group
16.61 (2.89) months
Interventions mCIMT versus control
mCIMT: ADL activity with the affected arm
Amount of restraint: 6 hours per day
Anatomical region restraint: hand
Control: strength, balance, finemotor dexterity training, functional task practice, stretch-
ing/weight-bearing by the affected arm
Session duration: 2 hours per day, 5 days per week, 3 weeks for each group
Outcomes Measures pre/post treatment
• Perceived arm motor function: MAL
• Global function measure: FIM2
• Kinematic variables
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Using a table of random numbers,
10 randomly selected numbers in the range
from 1 to 20 were assigned to [the] modi-
fied constraint-induced movement therapy
group and the remaining 10 numbers to
[the] traditional rehabilitation group”
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Allocation concealment (selection bias) Unclear risk Quote: “Patients with left stroke were ran-
domized using two sets of sealed envelopes
and those with right stroke using another
two sets of sealed envelopes. For each two
sets of envelopes, one unmarked set of 20
envelopes were presented to a patient to
choose one. The unmarked envelopes con-
tained a single sheet of paper with a number
ranging from 1 to 20. In the second set of
envelopes, which were marked with num-
bers from 1 to 20, modified constraint-in-
duced movement therapy or traditional re-
habilitation sheets were sealed”
Comment: insufficient information to per-
mit judgment
Blinding (performance bias and detection
bias)
All outcomes
Low risk Quote: “Two occupational therapists blind
to group allocation provided the evalua-
tions”
Incomplete outcome data addressed? (Post-
treatment)
Low risk 2/17 missing participants from the control
group (due to unstable medical condition)
Lin 2009a
Methods Randomisation by computer stratified according to participating hospital
Blinded outcome assessor
No information about withdrawals
Multicentre, outpatients
Participants Taiwan
Recruited on the basis of brain imaging identifying unilateral stroke in 3 medical centres
60 participants: 20 intervention, 20 control, 20 bilateral arm training group
Inclusion criteria:cerebrovascular accident > 12 months; Brunnstrom Stage > 3 on arm
section; amount of use < 2.5 on the MAL, no serious cognitive deficits, no excessive
spasticity in any joints of the affected upper limb
Exclusion criteria: not reported
Mean age (SD): intervention group: 55.28 (9.34) years, control group: 58.77 (15.5)
years, bilateral arm training group 51.58 (8.67) years
% women: intervention group 45%, control group: 45%, bilateral arm training group
40%
Stroke details: ischaemic or haemorrhagic; 40% with right hemiparesis in treatment
group, 60% with right hemiparesis in control group; 55% with right hemiparesis in
bilateral arm training group
Time since stroke, mean (SD): intervention group 21.25 (21.59) months, control group
21.9 (20.51) months, bilateral arm training group 18.5 (17.4) months
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Interventions This trial had 3 arms: the intervention group performed mCIMT; a comparison group
that performed bilateral arm training; and the control group
mCIMT versus bilateral arm training versus control
mCIMT: functional tasks by shaping techniques with the affected arm
Amount of restraint: 6 hours per day
Anatomical region restraint: hand
Control: training for hand function, co-ordination, balance and compensatory practice
on functional tasks
Bilateral arm training: simultaneous movements of both upper extremities in functional
tasks
Session duration: 2 hours per day, 5 days per week, 3 weeks for each group
Outcomes Measures pre/post treatment:
• Arm motor impairment: FMA
• Activities of daily living measure: FIM
• Perceived arm motor function: MAL
• Quality of life: SIS
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “... participants were individu-
ally randomized into the distributed CIT,
BAT, or control intervention groups, with
the computerized (block) randomizations
scheme, including pre stratification accord-
ing to participating hospital”
Allocation concealment (selection bias) Low risk Quote: “One set of opaque, numbered en-
velopes was prepared for each site contain-
ing cards indicating the allocated group.
When a new patient was registered, a card
was extracted and the relevant occupational
therapist informed of the group allocation”
Blinding (performance bias and detection
bias)
All outcomes
Low risk Quote: “... raters were blinded to the par-
ticipant group and trained to properly ad-
minister the outcome measures”
Incomplete outcome data addressed? (Post-
treatment)
Unclear risk The study provided no information about
withdrawals
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Methods Randomisation details were not reported
Blinding of outcome assessor not reported
No information about withdrawals
Multicentre, outpatients
Participants Taiwan
Recruited from 2 medical centres
13 participants: 5 intervention, 8 control
Inclusion criteria: cerebrovascular accident > 3 months; ability to extend actively at least
20° at the wrist and 10° at the metacarpophalangeal and interphalangeal joints on the
last 4 fingers of the affected hand; sufficient cognitive ability
Exclusion criteria: not reported
Mean age (SD): intervention group: 46.04 (26) years, control group: 51.06 (12.4) years
% women: intervention group 40%, control group: 0%
Stroke details: ischaemic or haemorrhagic; 20% with right hemiparesis in treatment
group, 62% with right hemiparesis in control group
Time since stroke, mean (SD): intervention group 21.5 (12.3) months, control group
16.3 (18.3) months
Interventions mCIMT versus control
mCIMT: functional tasks delivered through shaping approach
Amount of restraint: 6 hours per day
Anatomical region restraint: hand
Control: neurodevelopmental treatments focusing on balance training, stretching and
weight-bearing with the affected limb, fine-motor tasks and practice of compensatory
activities of daily living
Session duration: 2 hours per day, 5 days per week, 3 weeks for each group
Outcomes Measures pre/post treatment
• Arm motor impairment: FMA
• Perceived arm motor function: MAL
• Functional magnetic resonance (fMRI) measures
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Participants were randomized to
the dCIT [distributed Constraint-induced
therapy] or the CI [control intervention]
group”
Allocation concealment (selection bias) Unclear risk Information not provided
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Information not provided
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Incomplete outcome data addressed? (Post-
treatment)
Unclear risk Information not provided
Myint 2008
Methods Randomisation by drawing sealed envelopes, other details were not provided
Blinded of outcome assessor
Post-treatment withdrawals: 10%; follow-up withdrawals: 7.5%
Single centre, outpatients
Participants China
Recruited from 3 hospitals with rehabilitation facilities
43 participants: 23 intervention, 20 control
Inclusion criteria: cerebrovascular accident between 2 to 16weeks; 10° of active extension
to the metacarpophalangeal and interphalangeal joints 20° at wrist
Exclusion criteria: severe aphasia, high risk of fall, cerebellar stroke and severe shoulder
pain affecting therapy
Mean age (SD): intervention group: 63.4 (13.6) years, control group: 63.9 (12.2) years
% women: intervention group 56%, control group: 60%
Stroke details: ischaemic or haemorrhagic; 48% with right hemiparesis in treatment
group, 70% with right hemiparesis in control group
Time since stroke, mean (SD): intervention group 1.27 (0.7) months, control group 1.
5 (0.95) months
Interventions CIMT versus control
CIMT: adaptive task practice (shaping)
Amount of restraint: 90% of waking hours
Anatomical region restraint: arm and hand
Control: bimanual task, compensatory techniques for ADL strength, range of motion,
positioning and mobility training
Session duration: 4 hours per day, 5 days per week, 2 weeks for each group
Outcomes Measures pre/post treatment and follow-up at 12 months
• Motor function: functional test for hemiparetic upper extremity, ARAT
• Perceived arm motor function: MAL
• Dexterity: 9HPT
• ADL measure: modified BI
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “subjects were randomized by
drawing sealed envelopes which were filled
at random with indication of which inter-
vention group the patient was allocated to”
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Allocation concealment (selection bias) Unclear risk Insufficient information to permit judg-
ment
Blinding (performance bias and detection
bias)
All outcomes
Low risk Quote: “The observer was blinded”
Incomplete outcome data addressed? (Post-
treatment)
High risk 5/28missing from intervention group (due
to transport problem, inadequate home
support; others changed their mind about
trial participation); 0/20 missing partici-
pants in the control group. Reasons for
missing data outcomes possibly related to
the true effect, with imbalance across inter-
vention and control groups
Page 2001
Methods Randomisation details were not provided
Blinded outcome assessor
No information about withdrawals
Multicentre, outpatients
Participants USA
Recruited through letters sent to people who experienced a cerebrovascular accident and
were discharged from outpatients therapy provided at 4 rehabilitation hospitals
6 participants: 2 intervention, 2 control, 2 no treatment
Inclusion criteria: stroke between 4 weeks and 6 months, 10° of active extension to the
metacarpophalangeal and interphalangeal joints and 20° at wrist
Exclusion criteria: severe cognitive impairment, excessive spasticity and pain
Mean age (SD): intervention group: 55 (4.24) years, control group: 52 (5.65) years, no
intervention group 60.5 (23.33) years
% women: intervention group 50%, control group 50%, no treatment group 50%
Stroke details: ischaemic or haemorrhagic; 50% with right hemiparesis in treatment
group, 50% with right hemiparesis in control group, 100% with right hemiparesis in no
treatment group
Time since stroke, mean (SD): intervention group 5.65 (0.21) months, control group
3.75 (2.47) months, no treatment group 4.5 (0.7) months
Interventions This trial had 3 arms: the intervention group performed mCIMT; a control group
performed usual care; and the third group performed no treatment
mCIMT versus control versus no treatment
mCIMT: physical and occupational therapy focused on PNF with emphasis on ADL
tasks, compensatory techniques with the unaffected side, two functional task of the
WMFT with shaping techniques
Amount of restraint: 5 waking hours per day
Anatomical region restraint: arm and hand
Control: physical and occupational therapy focused on PNF with emphasis on ADL
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tasks, compensatory techniques with the unaffected side
Session duration: 1 hour per day, 3 days per week, 10 weeks for each group
Outcomes Measures pre/post treatment
• Arm motor function: ARAT, WMFT2
• Perceived arm motor function: MAL
• Arm motor impairment: FMA
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “all subjects were randomly as-
signed ... with an equal probability”
Comment: insufficient information to per-
mit judgment
Allocation concealment (selection bias) Unclear risk No information provided
Blinding (performance bias and detection
bias)
All outcomes
Low risk Quote: “A blinded examiner administered
all instruments”
Incomplete outcome data addressed? (Post-
treatment)
Unclear risk The study provided no information about
withdrawals
Page 2002b
Methods Randomisation details were not provided
Blinded outcome assessor
No information about withdrawals
Multicentre, outpatients
Participants USA
Recruited through letters sent to people who experienced a cerebrovascular accident and
were discharged from outpatients therapy provided at 4 rehabilitation hospitals
14 participants: 4 intervention, 5 control, 5 no treatment
Inclusion criteria: stroke between 4 weeks and 6 months; 10° of active extension to the
metacarpophalangeal and interphalangeal joints and 20° at wrist
Exclusion criteria: severe cognitive impairment, excessive spasticity and pain
Mean age (SD): intervention group: 73.5 (6.35) years, control group: 67.4 (13.8) years,
no intervention group 68.2 (14.13) years
% women: intervention group 0%, control group 20%, no treatment group 80%
Stroke details: only Ischaemic; 50% with right hemiparesis in treatment group, 20%
with right hemiparesis in control group, 60% with right hemiparesis in no treatment
group
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Time since stroke, mean (SD): intervention group 5 (0.8) months, control group 4.9 (0.
9) months, no treatment group 4.3 (0.67) months
Interventions This trial had 3 arms: the intervention group performed mCIMT; a control group
performed usual care; and the third group performed no treatment
mCIMT versus control versus no treatment
mCIMT: physical therapy and occupational therapy focused on functional tasks by the
more affected limb, stretching, stand/balance, gait training, shaping techniques on 2 or
3 functional tasks
Amount of restraint: 5 waking hours per day
Anatomical region restraint: arm and hand
Control: physical and occupational therapy focused on functional tasks by the more
affected limb and PNF
Session duration: 1 hour per day, 3 days per week, 10 weeks for each group
Outcomes Measures pre/post treatment
• Motor function: ARAT
• Perceived arm motor function: MAL
• Arm motor impairment: FMA
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “... all subjects randomly assigned .
.. with equal probability”
Comment: insufficient information to per-
mit judgment
Allocation concealment (selection bias) Unclear risk No information provided
Blinding (performance bias and detection
bias)
All outcomes
Low risk Quote: “...a blinded rater again adminis-
tered the instruments to all subjects”
Incomplete outcome data addressed? (Post-
treatment)
Unclear risk The study provided no information about
withdrawals
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Page 2004
Methods Randomisation by computer random number table, other details were not provided
Blinded outcome assessor
No information about withdrawals
Multicentre, outpatients
Participants USA
Recruited thorough advertisements placed in therapy clinics and given to therapists in
hospitals
17 participants: 7 intervention, 4 control, 6 no treatment
Inclusion criteria: stroke > 1 year; 10° of active extension to the metacarpophalangeal
and interphalangeal joints and 20° at wrist
Exclusion criteria: severe cognitive impairment, excessive spasticity and pain
Mean age (SD): intervention group: 54.6 (12.77) years, control group: 60.75 (13.6)
years, no intervention group 63.6 (9.81) years
% women: intervention group 29%, control group 0%, no treatment group 17%
Stroke details: only ischaemic; 71% with right hemiparesis in treatment group, 50%
with right hemiparesis in control group, 50% with right hemiparesis in no treatment
group
Time since stroke, mean (SD): intervention group 25.42 (6.53) months, control group
38 (23.9) months, no treatment group 36.5 (26) months
Interventions This trial had 3 arms: the intervention group performed mCIMT; a control group
performed usual care; and the third group performed no treatment
mCIMT versus control versus no treatment
mCIMT: functional task with the affected arm, strengthening, stretching, compensatory
techniques, shaping techniques on 2 or 3 functional tasks
Amount of restraint: 5 waking hours per day
Anatomical region restraint: arm and hand
Control: physical and occupational therapy focused on PNF, stretching and compen-
satory techniques
Session duration: 1 hour per day, 3 days per week, 10 weeks for both treatment groups
Outcomes Measures pre/post treatment
• Arm motor function: ARAT
• Perceived arm motor function: MAL
• Arm motor impairment: FMA
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “...patients were randomly assigned
to 1 of 3 condition groups with equal prob-
ability by using a computer-generated ran-
dom numbers table”
Allocation concealment (selection bias) Unclear risk No information provided
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Page 2004 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
Low risk Quote: “examiner was blinded in that he
was unaware of the patients’ randomized
grouping”
Incomplete outcome data addressed? (Post-
treatment)
Unclear risk One participant had received botulinum
toxin type A in the more affected limb < 3
months before the study and was excluded
from post hoc analysis
Page 2005b
Methods Randomisation by random number table, other details were not provided
Blinded outcome assessor
No information about withdrawals
Multicentre, outpatients
Participants USA
Recruited volunteers; other details not provided
10 participants: 5 intervention, 5 control
Inclusion criteria: stroke < 14 days; 10° of active extension to the metacarpophalangeal
and interphalangeal joints and 20° at wrist, more affected limb non use, defined as an
amount of use score of < 2.5 on the MAL
Exclusion criteria: severe cognitive impairment, excessive spasticity and pain
Mean age (SD): intervention group: 58.6 (6.35) years, control group: 62.2 (10.3) years
% women: intervention group 20%, control group 20%
Stroke details: only Ischaemic; 80% with right hemiparesis in each group
Time since stroke, mean (SD): intervention group 4 (1.6) days, control group 4.8 (3.
03) days
Interventions mCIMT versus control
mCIMT: shaping techniques on 3 functional tasks, range of motion
Amount of restraint: 5 waking hours per day
Anatomical region restraint: hand
Control: stretching, weight bearing, manual dexterity exercise with the affected arm,
compensatory techniques
Session duration: 1 hour per day, 3 days per week, 10 weeks for each treatment group
Outcomes Measures pre/post treatment
• Arm motor function: ARAT
• Perceived arm motor function: MAL
• Arm motor impairment: FMA
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Page 2005b (Continued)
Random sequence generation (selection
bias)
Low risk Quote: “Using a random numbers table,
patients were then randomly assigned to ei-
ther 1) mCIT (n = 5) or 2) traditional re-
habilitation (TR) (n = 5)”
Allocation concealment (selection bias) Unclear risk No information provided
Blinding (performance bias and detection
bias)
All outcomes
Low risk Quote: “The Fugl-Meyer, ARA, and MAL
were administered by the same examiner
who performed pretests, blinded to group
assignment”
Incomplete outcome data addressed? (Post-
treatment)
Unclear risk The study provided no information about
withdrawals
Page 2008
Methods Randomisation by computer-generated random numbers table, other details were not
provided
Blinded outcome assessor
No information about withdrawals
Multicentre, outpatients
Participants USA
Recruited thorough advertisements placed in neurology and physical therapy clinics
35 participants: 13 intervention, 12 control, 10 no treatment
Inclusion criteria: stroke > 12months; 10° of active extension to themetacarpophalangeal
and interphalangeal joints and 20° at wrist; more affected limb non-use, defined as an
amount of use score of < 2.5 on the MAL
Exclusion criteria: severe cognitive impairment, excessive spasticity and pain
Mean age (SD): 57.9 (8.4) years for all groups
% women: 37% for all groups
Stroke details: only ischaemic; 66% with right hemiparesis
Time since stroke, mean: 39.8 months
Interventions This trial had 3 arms: the intervention group performed mCIMT; a control group
performed usual care; and the third group performed no treatment
mCIMT versus control versus no treatment
mCIMT: functional task by shaping techniques
Amount of restraint: 5 waking hours per day
Anatomical region restraint: arm and hand
Control: PNF, stretching
Session duration: 30 minutes per day, 3 days per week, 10 weeks for each group
Outcomes Measures pre/post treatment
• Arm motor function: ARAT
• Perceived arm motor function: MAL
• Arm motor impairment: FMA
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Page 2008 (Continued)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Subjects were randomly assigned
to 1 of 3 groups with equal probability of
assignment to any of the groups using a
computer-generated random numbers ta-
ble”
Allocation concealment (selection bias) Unclear risk No information provided
Blinding (performance bias and detection
bias)
All outcomes
Low risk Blinding of outcome assessor
Incomplete outcome data addressed? (Post-
treatment)
Unclear risk The study provided no information about
withdrawals
Ploughman 2004
Methods Randomisation by random number generation, other details were not provided
Blinded outcome assessor only on admission to treatment
Post-treatment withdrawals: 11%
Single centre, inpatients and outpatients
Participants Canada
Recruited from people admitted to multidisciplinary rehabilitation services from June
2001 to February 2003
23 participants: 10 intervention, 13 control
Inclusion criteria: no more than 16 weeks post-stroke at inclusion; > stage 2 but ≤ stage
6 on the CMII for the arm and hand
Exclusion criteria: evidence of cognitive impairment
Mean age (SD): intervention group: 57.8 (10.65) years, control group: 61.62 (5.68)
years
% women: intervention group 30%, control group 38%
Stroke details: ischaemic or haemorrhagic; 60% with right hemiparesis in treatment
group, 31% with right hemiparesis in control group
Time since stroke, mean (SD): intervention group 1.2 (0.75) months, control group 1.
3 (0.78) months
Interventions FU therapy (’FUT’ in trial report) plus usual care versus usual care
Usual care: facilitation of the proximal motor control progressing to skilled-task training,
strength and endurance training, functional electric stimulation, gait training
Amount of restraint: average 2.7 hours per day
Anatomical region restraint: hand (only thumb)
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Ploughman 2004 (Continued)
Session duration: mean therapy 58.9 ± 41.45 minutes per day control group, and 61.74
± 23.68 minutes per day intervention group, duration of study not specified
Outcomes Measures pre/post treatment
• Arm motor function: ARAT
• Arm motor impairment: CMII for arm, hand, postural control and shoulder pain,
grip strength
• ADL measure: FIM3
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Subjects were randomly assigned,
by using random number generation, to ei-
ther conventional rehabilitation or conven-
tional rehabilitation plus FUT”
Allocation concealment (selection bias) Unclear risk No information provided
Blinding (performance bias and detection
bias)
All outcomes
High risk Quote: “The ARAT admission and dis-
charge assessments were performed by the
principal investigator who was blinded to
the treatment condition only on admission
assessment”
Incomplete outcome data addressed? (Post-
treatment)
Low risk 3/13 missing from intervention group due
to assessment being too stressful; 1/14miss-
ing from control group for same reason
Singh 2013
Methods Randomisation through lottery method
Unblinded outcome assessor
No withdrawals
Single centre, inpatients
Participants India
Recruited via Central Referral Hospital and STNM Hospital in Sikkim
40 participants: 20 intervention, 20 control
Inclusion criteria: cerebrovascular accident between2 and4weeks; 10° of active extension
to the metacarpophalangeal and interphalangeal joints and 10° at wrist
Exclusion criteria: severe aphasia, severe shoulder pain affecting therapy or any comorbid
condition that could limit upper extremity function
Mean age (SD): intervention group: 55.2 (9.27) years, control group: 21.9 (20.51) years
% women: intervention group 30%, control group: 45%
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Singh 2013 (Continued)
Stroke details: ischaemic or haemorrhagic
Time since stroke, mean (SD): intervention group 0.6 (0.11) months, control group 0.
65 (0.13) months
Interventions mCIMT versus control
mCIMT: shaping
Amount of restraint: 10 hours per day
Anatomical region restraint: hand
Control: standard physical therapy, compensatory technique for daily activities, strength-
ening, and range of motion exercises for the affected arm
Session duration: 2 hours per day, 5 days per week, 3 weeks for each group
Outcomes Measures pre/post treatment
• Arm motor function: WMFT
• Arm motor impairment: FMA
• Spasticity: MASh (only at baseline)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Subjects were individually ran-
domized into intervention and control
groups by using lottery method”
Allocation concealment (selection bias) Unclear risk No information provided
Blinding (performance bias and detection
bias)
All outcomes
Low risk Quote: “the rater ... was not blinded to the
study”
Incomplete outcome data addressed? (Post-
treatment)
Low risk Quote: “Since no follow-up and less time
was kept for restraint of the unaffected up-
per extremity so no drop out during the
study”
Smania 2012
Methods Randomisation automated
Blinded outcome assessor
Post-treatment withdrawals 10%, follow-up withdrawals: 35%
Multicentre, outpatients
Participants Italy
Recruited from 9 clinical sites.
66 participants: 34 intervention, 32 control
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Smania 2012 (Continued)
Inclusion criteria: cerebrovascular accident occurred between 3 to24 months earlier; 10°
of active wrist extension, at least 10° of thumb abduction/extension, and at least 10° of
extension at the level of the metacarpophalangeal and interphalangeal joints in at least 2
digits
Exclusion criteria: severe cognitive impairment, amount of use ≥ 2.5 on the MAL
Mean age (SD): intervention group: 63.93 (9.56) years, control group: 68.25 (12.68)
years
% women: intervention group 13%, control group: 21%
Stroke details: ischaemic or haemorrhagic; 47% with right hemiparesis with 53% paresis
of the dominant side in treatment group, 45% with right hemiparesis with 48% paresis
of the dominant side in control group
Time since stroke, mean (SD): intervention group 11.1 (8.91) months, control group
9.38 (7.78) months
Interventions mCIMT versus control
mCIMT: passive mobilisation, task practise, ADL activities through shaping approach
and household activities consisting in functional activities
Amount of restraint: 12 hours per day
Anatomical region restraint: hand
Control: passive mobilisation and stretching, active motility tasks, ADL activities and
household activities consisting in functional activities
Session duration: 2 hours per day, 5 days per week, 2 weeks for each group
Outcomes Measures pre/post treatment and follow-up at 3 months
• Arm motor function: WMFT
• Perceived arm motor function: MAL
• Spasticity: MASh
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “If eligible, patients were allocated
to the experimental group (EG) or the con-
trol group (CG) by means of an automated
randomizations system”
Allocation concealment (selection bias) Low risk Quote: “The group allocation was con-
cealed using sealed numbered envelopes
that were sent to the clinical hospital where
the treatment was delivered. The random-
izations list was locked in a desk drawer ac-
cessible only to the main investigator”
Blinding (performance bias and detection
bias)
All outcomes
Low risk Quote: “At each research centre the same
examiner, who was blinded with regard to
treatment allocation, evaluated patients en-
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Smania 2012 (Continued)
rolled in the study”
Quote: “ Examiners were requested to in-
form their research coordinator if they dis-
covered to which group a patient belonged,
and they were periodically questioned by
the coordinator about this”
Incomplete outcome data addressed? (Post-
treatment)
Low risk 4/30missing participants frommCIMT (1
for unco-operativeness, 3 for medical com-
plications)
3/32 missing participants from control
group (1 for unco-operativeness, 2 formed-
ical complications)
Quote: “An intention-to-treat analysis was
used”
Suputtitada 2004
Methods Randomisation by random-number table, other details were not provided
Blinded outcome assessor
No information about withdrawals
Single centre, outpatients
Participants Thailand
Recruited from the Department of Rehabilitation Medicine of King Chulalongkorn
Memorial Hospital
69 participants: 36 intervention, 33 control
Inclusion criteria: 20° of active extension at wrist, 10° at metacarpophalangeal and in-
terphalangeal joints
Exclusion criteria: balance problems; severe aphasia; sensory disorder; severe cognitive
impairments
Mean age (SD): intervention group: 60.1 (4.8) years, control group: 58.7 (4.2) years
% women: intervention group 33.3%, control group: 30.6%
Stroke details: ischaemic or haemorrhagic; 91% with right hemiparesis in treatment
group, 94% with right hemiparesis in control group
Time since stroke: 1-3 years in both groups
Interventions CIMT versus control
mCIMT: not described
Amount of the restraint: 6 hours per day plus time not structured at home
Anatomical region restraint: hand
Control: neurodevelopmental treatment
Session duration: 2 hours per day, 5 days per week, 2 weeks for each group
Outcomes Measures pre/post treatment
• Arm motor function: WMFT
• Perceived arm motor function: MAL
• Motor impairment: ARAT
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Suputtitada 2004 (Continued)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “ ... patients were randomized in-
dividually into 2 groups by using the table
of randomizations”
Allocation concealment (selection bias) Unclear risk No information provided
Blinding (performance bias and detection
bias)
All outcomes
Low risk Quote: “This was a[n] ... observer-blinded
clinical trial”
Incomplete outcome data addressed? (Post-
treatment)
Unclear risk No information provided
Tariah 2010
Methods Randomisation details were not reported
Blinded outcome assessor
No information about withdrawals
Single centre, home-based treatment for experimental group and outpatients for control
group
Participants Jordan
Participant recruitment information not provided
18 participants: 10 intervention, 8 control
Inclusion criteria: > 2 months post-stroke at inclusion, 20° of active extension at wrist,
10° at metacarpophalangeal and interphalangeal joints
Exclusion criteria: cognitive impairment; amount of use ≥ 2.5 on the MAL; excessive
spasticity and pain
Mean age (SD): intervention group: 54.8 (10.9) years, control group: 60.6 (4.9) years
% women: intervention group 20%, control group: 50%
Stroke details: only ischaemic; 70% with right hemiparesis in treatment group, 50%
with right hemiparesis in control group
Time since stroke, mean (SD): intervention group 9.2 (5.79) months, control group 9.
4 (4) months
Interventions mCIMT versus control
mCIMT: training activities focused on patients’ ADLs, instrumental activities of daily
living, and leisure activities (e.g. playing cards, chess, crafts, gardening)
Amount of restraint: 4 hours per day
Anatomical region restraint: hand
Control: weight-bearing and facilitation of arm movement based on conventional neu-
rodevelopmental procedures
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Tariah 2010 (Continued)
Session duration: 2 hours per day, 7 days per week, 2 months for both groups
Outcomes Measures pre/post treatment
• Arm motor function: WMFT
• Perceived arm motor function: MAL
• Arm motor impairment: FMA
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “participants ... were randomly
numbered from one to twenty. Partici-
pants with odd numbers were allocated to
CIMT group and those with even num-
bers were allocated toNeurodevelopmental
Treatment NDT [control] group”
Allocation concealment (selection bias) Unclear risk No information provided
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Quote: “The investigators, who were blind
to the allocation of the groups, provided
the evaluation tests”
Incomplete outcome data addressed? (Post-
treatment)
High risk 2/10 in the NDT group dropped out after
randomisation. Reasons not provided
Taub 1993
Methods Randomisation details were not reported
Blinded outcome assessor
No information about withdrawals
Multicentre, outpatients
Participants USA
Recruited from the Spain Rehabilitation Center and the Departement of Neurology of
the University of Alabama
9 participants: intervention 4, control 5
Inclusion criteria: stroke > 1 year; 10° of active extension to the metacarpophalangeal
and interphalangeal joints and 20° at wrist
Exclusion criteria: balance problems, extensive use of the affected arm, cognitive deficits,
medical problems, > 75 years of age, left dominance or left hemiplegia
Median age: intervention group: 65 years, control group: 63 years
% women: intervention group 75%, control group: 80%
Stroke details: only right side affected and right arm dominance for each group
Median time since stroke: intervention 4.1 years, control: 4.5 years
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Taub 1993 (Continued)
Interventions CIMT versus usual care
CIMT: functional activity with the affected arm
Amount of restraint: 90% of waking hours per day
Anatomical region restraint: arm and hand
Usual care: exhorted to focus attention on using the affected arm; range of self-movement
with the aid of the unaffected arm
Session duration:
Intervention: 6 hours per day, 5 days per week, 2 weeks
Control: 15 minutes per day, 5 days per week, 2 weeks
Outcomes Measures pre/post treatment
• Motor function: AMAT, EMF
• Perceived arm motor function: MAL2
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information provided
Allocation concealment (selection bias) Unclear risk No information provided
Blinding (performance bias and detection
bias)
All outcomes
Low risk Blinding of outcome assessor
Incomplete outcome data addressed? (Post-
treatment)
Unclear risk The study provided no information about
withdrawals
Treger 2012
Methods Randomisation by computer random numbers table, other details not provided
Blinded outcome assessor
No withdrawals
Single centre, inpatients
Participants Israel
Recruited from people admitted to the Department of Neurological Rehabilitation, the
Loewenstein Hospital Rehabilitation Center
28 participants: 9 intervention, 19 control
Inclusion criterion: active movement in most joints of the affected upper limb (grade ≥
16 of the manual function test)
Exclusion criteria: neurological or orthopedic disorders prohibiting the use of the paretic
arm, neglect, apraxia, and cognitive disorders impeding collaboration
Mean age (SD): intervention group: 62 (28.4) years, control group: 61.5 (8.4) years
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Treger 2012 (Continued)
% women: intervention group 55%, control group: 16%
Stroke details: only ischaemic
Time since stroke, mean (SD): intervention group 1.32 (0.94) months, control group
0.77 (0.8) months
Interventions mCIMT versus control
mCIMT: training of the affected upper limb based on a task-oriented approach, empha-
sising repetitive practice of functional activities and behavioural shaping
Amount of restraint: 4 hours per day
Anatomical region restraint: hand
Control: training of the affected upper limb based on a task-oriented approach, empha-
sizing repetitive practice of functional activities and behavioural shaping
Session duration: 1 hour and 45 minutes per day, 5 days per week, 2 weeks for both
groups
Outcomes Measures pre/post treatment:
• ADL measures: FIM
• Hand function: MFT
• Overall stroke severity: NIHSS
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Concealed allocation was per-
formed by a computer-generated random-
ized table of numbers created prior to the
study”
Allocation concealment (selection bias) Low risk Quotes: “Concealed allocation was per-
formed by a computer-generated random-
ized table of numbers created prior to the
study”
“Individual, sequentially numbered index
cards with the random assignment were
prepared, folded, and placed in sealed
opaque envelopes”
Blinding (performance bias and detection
bias)
All outcomes
Low risk Quote: “The assessor of the upper limb
function tests was blinded to the type of
intervention. The same assessor performed
baseline and follow-up tests”
Incomplete outcome data addressed? (Post-
treatment)
Low risk No participants lost to follow-up
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Van Delden 2013
Methods Randomisation by using the minimisation method
Blinding of outcome assessor not reported
Follow-up withdrawals: 8%
Single centre
Participants The Netherlands
Recruited from the Reade rehabilitation centre in Amsterdam
60 participants: 22 intervention, 19 control, 19 bilateral arm training with rhythmic
auditory cueing
Inclusion criteria: cerebrovascular accident between 1 and 6 months; 10° of active wrist
extension, 10° af active thumb abduction/extension and 10° active extension in at least
2 additional digits; motivated to participate
Exclusion criteria: upper-limb orthopaedic limitations; cognitive impairment
Mean age (SD): intervention group: 59.8 (13.8) years, control group: 56.9 (12.7) years,
bilateral arm training with rhythmic auditory cueing 62.6 (9.8) years
% women: intervention group 36%, control group: 58%, bilateral arm training with
rhythmic auditory cueing 42%
Stroke details: ischaemic or haemorrhagic; 45% with right hemiparesis with 50% paresis
of the dominant side in treatment group, 58% with right hemiparesis with 37% paresis
of the dominant side in control group, 58% with right hemiparesis with 47% paresis of
the dominant side in bilateral arm training with rhythmic auditory cueing (BATRAC)
group
Time since stroke, mean (SD): intervention group 2.14 (1.6) months, control group 2.
6 (1.6) months, BATRAC group 1.8 (1.14) months
Interventions This trial had 3 arms: the intervention group performed mCIMT; a comparison group
performed bilateral arm training with rhythmic auditory cueing (BATRAC); and the
control group
mCIMT versus BATRAC versus control
mCIMT: functionally oriented task practice;
Amount of restraint: 6 hours per day
Anatomical region restraint: hand
Control: exercise therapy based on existing guidelines for upper extremity treatment after
stroke as presented by the Dutch Society of Occupational Therapy
BATRAC: bilateral movements that targeted rhythmic flexion and extension movements
about the wrist rather than movements of proximal parts of the upper limb
Session duration: 1 hour per day, 3 days per week, 6 weeks for each group
Outcomes Measures pre/post treatment and follow up at 1 months
• Arm motor function: ARAT
• Dexterity: 9HPT
• Motor impairment: FMA, MI
• Perceived arm motor function: MAL
• Sensory: EmNSA
• Quality of life: SIS
Notes
Risk of bias
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Van Delden 2013 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quoted from supplementary materials:
“After stratification, participants were ran-
domized in permuted blocks and allocated
to 1 of the 3 intervention groups”
“Concealed allocation was effectuated on-
line using the minimization method”
Allocation concealment (selection bias) Low risk Quote: “Concealed allocation was effec-
tuated online using the minimization
method”
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Information not provided
Incomplete outcome data addressed? (Post-
treatment)
Low risk 1/22 participants lost from mCIMT
(moved to another place)
1/19 participants lost from BATRAC (in-
tervention refused after allocation)
3/19 participants lost from control (moved
to another place)
Wang 2011
Methods Randomisation by computer random-numbers table, other details were not provided
Blinded outcome assessor
No information about withdrawals
Single centre, outpatients
Participants China
Recruited from people admitted to the Affiliated Hospital of Medical School Qingdao
University
30 participants: 10 intervention, 10 control high-intensity, 10 control low-intensity
Inclusion criteria: 20° of active extension at wrist, 10° at metacarpophalangeal and in-
terphalangeals joints
Exclusion criteria: excessive pain in the affected limb; aphasia; cognitive impairment
Mean age (SD): intervention group: 59.4 (10.89) years, control group high-intensity:
63.5 (9.63) years, control group control low-intensity: 67 (7.45) years
% women: intervention group 50%, control group high-intensity 60%, control group
control low-intensity 30%
Stroke details: ischaemic or haemorrhagic; 53% with right hemiparesis in treatment
group, 60% with right hemiparesis in control group
Time since stroke, mean (SD): intervention group 2.7 (2.2) months, control group high-
intensity: 2.9 (2.2), control group control low-intensity: 2.2 (1.2) months
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Wang 2011 (Continued)
Interventions This trial had 3 arms: the intervention group performed mCIMT; a control group per-
formed high-intensity training; and the another control group performed low-intensity
training
mCIMT versus high-intensity training group versus low-intensity training group
mCIMT: functional activities through shaping approach
Amount of restraint: 90% of waking hours
Anatomical region restraint: hand
Low-intensity and high-intensity groups: strength, balance, manual dexterity exercises,
functional task practice, stretching and weight-bearing exercises
Session duration: mCIMT and high-intensity group: 3 hours per day; low-intensity
group: 45 minutes per day, all groups: 5 days a week for 4 weeks
Outcomes Measures pre/post treatment:
• Arm motor function: WMFT
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Participants ... were subsequently
assessed at random (using a random num-
bers table) into 3 groups”
Allocation concealment (selection bias) Unclear risk No information provided
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Quote: “The Wolf Motor Function Test
(WMFT) was administered before therapy,
and 2 and 4 weeks after the intervention
period by the same rater, who was blinded
to the group assignment”
Incomplete outcome data addressed? (Post-
treatment)
Unclear risk The study provided no information about
withdrawals
Wittenberg 2003
Methods Randomisation by random-numbers table, other details were not provided
Blinded outcome assessor
No withdrawals
Single centre, inpatients
Participants USA
Recruited mainly from referral by community physicians and therapists
16 participants: 9 intervention, 7 control
Inclusion criteria: cerebrovascular accident > 12 months, 10° of active extension to the
metacarpophalangeal and interphalangeal joints and 20° at wrist
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Wittenberg 2003 (Continued)
Exclusion criteria: not reported
Mean age (range): intervention group: 65 (41-81) years, control group: 63 (50-75) years
% women: intervention group 11%, control group: 28%
Stroke details: only ischaemic
Time since stroke, mean (SD): intervention group 34 (16-86) months, control group
28 (12-48) months
Interventions CIMT versus control
CIMT: task-oriented exercise of the affected arm
Amount of restraint: waking hours
Anatomical region restraint: arm and hand
Control: task performance with the unaffected side, passive therapy for the affected arm
Session duration:
Intervention: 6 hours per day, 4 days per week, 4 hours on weekend days, 2 weeks
Control: 3 hours per day, 5 days per week, for 2 weeks
Outcomes Measures pre/post treatment and follow up at 6 months
• Arm motor function: WMFT
• Perceived Arm motor function: MAL
• Neurophysiologic test: AMPS, PET, TMS
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Using a random number table, pa-
tients were randomized into 2 groups”
Allocation concealment (selection bias) Unclear risk No information provided
Blinding (performance bias and detection
bias)
All outcomes
Low risk Quote: “... thoroughly blinded raters”
Incomplete outcome data addressed? (Post-
treatment)
Low risk No missing data
Wolf 2006
Methods Randomisation automated, balanced with respect to sex, premorbid handedness, side of
stroke and level of function
Blinded outcome assessor
Post-treatment withdrawals: 8%; follow-up withdrawals: 17%
Multicentre, outpatients
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Wolf 2006 (Continued)
Participants USA
Recruited from 247 facilities spanning the 7 participating sites
222 participants: 106 intervention, 116 control
Inclusion criteria: cerebrovascular accident between 3 and 9 months; 10° of active ex-
tension to the metacarpophalangeal and interphalangeal joints and 20° at wrist or 10°
of active extension to the metacarpophalangeal and interphalangeal joints of two digits,
and at wrist, 10° of thumb abduction/extension
Exclusion criteria: scored less than 24 on the MMSE; physician-determined medical
problems could interfere with participation; excessive pain of the paretic extremity;
substantial use of the paretic arm in daily life as determined by a score ≥ 2.5 on the
Motor Activity Log
Mean (SD) age: intervention group: 61 (13.5), control group: 63.43 (12.6) years
% women: intervention group 34.9, control group: 37.1
Stroke details: ischaemic or haemorrhagic; 47.2% with hemiparesis of the dominant side
in treatment group, 51.75% with hemiparesis of the dominant side in control group
Time since stroke, mean (SD): intervention group 5.9 (2.1), control group 6.2 (2.3)
months
Interventions CIMT versus control
CIMT: adaptive task practice (shaping) and standard task training of the paretic limb
Amount of restraint: 90% of waking hours
Anatomical region restraint: hand
Control: usual and customary care ranged from no treatment to the application of
mechanical interventions or various occupational and physical therapy approaches in the
home
Session duration: CIMT: 6 hours per day, 7 days per week, 2 weeks; control: not provided
Outcomes Measures pre/post treatment and follow up at 4, 8, and 12 months
• Motor function: WMFT
• Perceived arm motor function: MAL
• Quality of life: SIS
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Participants were randomly as-
signed to the experimental (CIMT) or con-
trol condition using an automated, central-
ized system administered by the data man-
agement centre”
Allocation concealment (selection bias) Low risk Centralised
Blinding (performance bias and detection
bias)
All outcomes
Low risk Blinding of outcome assessor
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Wolf 2006 (Continued)
Incomplete outcome data addressed? (Post-
treatment)
Low risk 8/106 missing from intervention group (5
withdrew, 1moved, 1 stroke, 1 poor health)
, 15/116 missing from control group (7
withdrew, 2 moved, 2 died)
Wu 2007a
Methods Randomisation details were not reported
Blinded outcome assessor
No withdrawals
Multicentre, inpatients/outpatients
Participants Taiwan
Recruited from the rehabilitation departments of 2medical centres (ChangGungMemo-
rial Hospital and National Taiwan University Hospital)
30 participants: 15 intervention, 15 control
Inclusion criteria: cerebrovascular accident between 12 and 36 months; 10° of active
extension to the finger and 20° at wrist; non-use of the more affected upper extremity
(AoU score < 2.5 on the MAL); no serious cognitive deficits
Exclusion criteria: balance problems sufficient to compromise safety when wearing the
study’s constraint device; excessive spasticity in any joint of the affected upper extremity
Mean age (SD): intervention group: 54.66 (8.63) years, control group: 53.31 (6.29)
years
% women: intervention group 47%, control group: 40%
Stroke details: 40% with right hemiparesis in treatment group, 33% with right hemi-
paresis in control group
Time since stroke, mean (SD): intervention group 18.53 (6.92) months, control group
17.61 (7.55) months
Interventions mCIMT versus control
mCIMT: functional tasks by shaping techniques with the affected arm, normalisation
of muscle tone
Amount of restraint: 6 hours per day
Anatomical region restraint: hand
Control: neurodevelopmental therapy emphasising balance training, stretching/weight
bearing of the affected arm, fine-motor dexterity training in addition to practice on ADL
with the less affected side
Session duration: 2 hours per day, 5 days per week, 3 weeks for each group
Outcomes Measures pre/post treatment
• Perceived arm motor function: MAL
• ADL measure: FIM
• Kineatic variables
Notes
Risk of bias
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Wu 2007a (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “... subjects were randomized with
equal probability”
Comment: insufficient information to per-
mit judgment
Allocation concealment (selection bias) Unclear risk No information provided
Blinding (performance bias and detection
bias)
All outcomes
Low risk Quote: “A certified occupational therapist
blind to study hypothesis and subject allo-
cation was trained to administer the assess-
ments”
Incomplete outcome data addressed? (Post-
treatment)
Low risk No missing data
Wu 2007b
Methods Randomisation by random-numbers table, other details were not provided
Blinded outcome assessor
No withdrawals
Multicentre, outpatients
Participants Taiwan
Recruited from 2 stroke rehabilitation units
47 participants: 24 intervention, 23 control
Inclusion criteria: cerebrovascular accident between 3weeks and 37months; Brunnstrom
stage > 3 on arm section; non-use of the more affected upper extremity (amount-of-use
score < 2.5 on the MAL); no serious cognitive deficits
Exclusion criteria: balance problems sufficient to compromise safety when wearing the
study’s constraint device
Mean age (SD): intervention group: 53.93 (11.2) years, control group: 56.77 (12.9)
years
% women: intervention group 33%, control group: 30%
Stroke details: ischaemic or haemorrhagic; 46% with right hemiparesis in treatment
group, 48% with right hemiparesis in control group, all participants had right-hand
dominance
Time since stroke, mean (SD): intervention group 12.51 (9.64) months, control group
11.98 (11.72) months
Interventions mCIMT versus control
mCIMT: ADL training with the affected arm
Amount of restraint: 6 hours per day
Anatomical region restraint: hand
Control: neurodevelopmental therapy emphasising functional task practice, stretching/
weight-bearing, fine-motor dexterity training
Session duration: 2 hours per day, 5 days per week, 3 weeks for each group
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Wu 2007b (Continued)
Outcomes Measures pre/post treatment
• Arm motor impairment: FMA
• Perceived arm motor function: MAL
• ADL measure: FIM
• Kinematic variables
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Subjects were randomly assigned
to the CIMT or traditional intervention
group by using a random numbers table”
Allocation concealment (selection bias) Unclear risk No information provided
Blinding (performance bias and detection
bias)
All outcomes
Low risk Quote: “Clinical evaluation were adminis-
tered in random order by a blinded rater”
Incomplete outcome data addressed? (Post-
treatment)
Low risk No missing data
Wu 2007c
Methods Randomisation by random-numbers table, other details were not provided
Blinded outcome assessor
No withdrawals
Multicentre, inpatients/outpatients
Participants Taiwan
Recruited from the rehabilitation departments of 3 medical centres
26 participants: 13 intervention, 13 control
Inclusion criteria: cerebrovascular accident between 0.5 and 31 months; Brunnstrom
stage > 3 on arm section; non use of the more affected upper extremity (amount-of-use
score < 2.5 on the MAL); no serious cognitive deficits
Exclusion criteria: balance problems sufficient to compromise safety when wearing the
study’s constraint device
Mean age (SD): intervention group: 71.44 (6.42) years, control group: 71.94 (16.79)
years
% women: intervention group 38%, control group: 46%
Stroke details: ischaemic or haemorrhagic; 46% with right hemiparesis in treatment
group, 54% with right hemiparesis in control group, all participants had right hand
dominance
Time since stroke, mean (SD): intervention group 6.70 (8.99) months, control group
8.32 (7.97) months
78Constraint-induced movement therapy for upper extremities in people with stroke (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Wu 2007c (Continued)
Interventions mCIMT versus usual care
mCIMT: functional tasks by shaping techniques with the affected arm, normalisation
of muscle tone
Amount of restraint: 6 hours per day
Anatomical region restraint: hand
Usual care: neurodevelopmental therapy emphasising functional task practice, stretching/
weight-bearing, fine-motor dexterity training
Session duration: 2 hours per day, 5 days per week, 3 weeks for each group
Outcomes Measures pre/post treatment
• Perceived arm motor function: MAL
• Arm motor impairment: FMA
• ADL measure: FIM
• Quality of life: SIS
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Subjects were individually ran-
domized into the mCIMT or the tradi-
tional rehabilitation group by using a table
of random numbers”
Allocation concealment (selection bias) Unclear risk No information provided
Blinding (performance bias and detection
bias)
All outcomes
Low risk Quote: “Before and after the 3-week inter-
vention period, the tests were administered
in random order by a blinded rater”
Incomplete outcome data addressed? (Post-
treatment)
Low risk No missing data
Wu 2011
Methods Randomisation by computer
Blinded outcome assessor
No information about withdrawals
Multicentre, outpatients
Participants Taiwan
Recruited from 4 stroke rehabilitation units
66 participants: 22 intervention, 22 control, 22 BAT group
Inclusion criteria: cerebrovascular accident > 12 months; Brunnstrom Stage > 3 on arm
section; amount of use < 2.5 on the MAL, no serious cognitive deficits, no excessive
spasticity in any joints of the affected upper limb
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Wu 2011 (Continued)
Exclusion criteria: not reported
Mean age (SD): intervention group: 51.91 (11.93) years, control group: 55.19 (2.5)
years, bilateral arm training group 52.22 (10.72) years
% women: intervention group 32%, control group: 72%, BAT group 18%
Stroke details: ischaemic or haemorrhagic; 64% with right hemiparesis in treatment
group, 54%with right hemiparesis in control group; 45% with right hemiparesis in BAT
group
Time since stroke, mean (SD): intervention group 14.91 (12.04) months, control group
17.77 (12.45) months, BAT group 15.92 (13.74) months
Interventions This trial had 3 arms: the intervention group performed mCIMT; a comparison group
performed bilateral arm training; and the control group
mCIMT versus bilateral arm training versus control
mCIMT: functional tasks by shaping techniques with the affected arm
Amount of restraint: 6 hours per day
Anatomical region restraint: hand
Control: neurodevelopmental therapy emphasising functional task practice, stretching/
weight bearing, fine-motor dexterity training
BAT: simultaneous movements of both upper extremities in functional tasks
Session duration: 2 hours per day, 5 days per week, 3 weeks for each group
Outcomes Measures pre/post treatment
• Arm motor function: WMFT
• Perceived arm motor function: MAL
• Kinematic variables
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote. “Eligible participantswere random-
ized to ... treatment groups using the com-
puterized (block) randomizations scheme”
Allocation concealment (selection bias) Unclear risk No information provided
Blinding (performance bias and detection
bias)
All outcomes
Low risk Quote: “Before and after the 3-week inter-
vention period, ... outcome measures were
administered by 2 certified, trained occu-
pational therapists blinded to the partici-
pant group”
Incomplete outcome data addressed? (Post-
treatment)
Unclear risk The study provided no information about
withdrawals
Analyses were performed on 21/22 partici-
pants for kinematics in BAT group, 21/22
participants for WMFT in mCIMT and
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Wu 2011 (Continued)
control groups
Wu 2012a
Methods Randomisation prestratified on the basis of participating hospital
Blinded outcome assessor
No withdrawals
Multicentre, outpatients
Participants Taiwan
Recruited from the rehabilitation departments of 4 hospitals
57 participants: 19 intervention, 18 control, 20 arm plus trunk restraint
Inclusion criteria: cerebrovascular accident > 12 months; residual motor ability of the
affected upper extremity (score on the arm motor subscale of the FMA of≥15); amount
of use < 2.5 on the MAL, no serious cognitive deficits, no excessive spasticity in any
joints of the affected upper limb
Exclusion criteria: not reported
Mean age (SD): intervention group: 56.3 (12.2) years, control group: 58.6 (11.6) years,
arm plus trunk restraint group 54 (9.7) years
%women: intervention group 26%, control group: 22%, arm plus trunk restraint group
20%
Stroke details: ischaemic or haemorrhagic; 37% with right hemiparesis in treatment
group, 28% with right hemiparesis in control group; 60% with right hemiparesis in arm
plus trunk restraint group
Time since stroke, mean (SD): intervention group 13.7 (7.3) months, control group 17.
7 (13.4) months, arm plus trunk restraint 15.7 (13.5) months
Interventions This trial had 3 arms: the intervention group performed mCIMT; a comparison group
performed arm plus trunk restraint; and the control group
mCIMT versus arm plus trunk restraint versus control
mCIMT: functional tasks by shaping techniques with the affected arm
Amount of restraint: 6 hours per day
Anatomical region restraint: hand
Control: neurodevelopmental therapy emphasising functional task practice, stretching/
weight bearing, fine-motor dexterity training, arm plus trunk restraint: functional tasks
by shaping techniques with the affected arm with restraining of trunk anterior and
rotation movements
Session duration: 2 hours per day, 5 days per week, 3 weeks for each group
Outcomes Measures pre/post treatment
• Arm motor function: ARAT
• Perceived arm motor function: MAL
• Perceived instrumental ADL participation: FAI
• Quality of life: SIS
Notes
Risk of bias
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Wu 2012a (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “All participants were unaware of
the study hypotheses and were randomized
to the dCIT-TR [distribuited constraint-
induced therapy combined with trunk re-
straint], dCIT [distribuited constraint-in-
duced therapy], or control group by a pre
stratification strategy based on the partici-
pating site”
Allocation concealment (selection bias) Unclear risk No information provided
Blinding (performance bias and detection
bias)
All outcomes
Low risk Quote: “The outcome measures were ad-
ministered before and after a 3-week inter-
vention by 3 certified occupational thera-
pists who were unaware of group alloca-
tion”
Incomplete outcome data addressed? (Post-
treatment)
Low risk No missing data
Yoon 2014
Methods Randomisation by random card
Blinded outcome assessor
No information about withdrawals
Single centre, inpatients
Participants Korea
Recruited from theDepartment of RehabilitationMedicine at PusanNational University
Yangsan Hospital
26 participants: 9 intervention, 9 control, 8 arm restraint plus mirror therapy
Inclusion criteria: 10° of active wrist extension, 10° of active thumb abduction/extension
and 10° active extension in at least 2 additional digits; possibility of simple communi-
cation; patients who could maintain a sitting position for more than 30 minutes
Exclusion criteria: depression; inability to co-operate in the treatment; inability to per-
form the active task training for musculoskeletal problems; spasticity; complex regional
pain syndrome or secondary adhesive capsulitis
Mean age (SD): intervention group: 64.33 (8.54) years, control group: 60.56 (16.94)
years, arm restraint plus mirror therapy group 47.36 (14.4) years
% women: intervention group 33%, control group: 55%, arm restraint plus mirror
therapy group 25%
Stroke details: ischaemic or haemorrhagic; 67% with right hemiparesis in treatment
group, 44% with right hemiparesis in control group; 62% with right hemiparesis in arm
restraint plus mirror therapy group
Time since stroke, mean (SD): intervention group 0.6 (0.3) months, control group 0.8
(0.4) months, arm restraint plus mirror therapy group 0.8 (0.38) months
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Yoon 2014 (Continued)
Interventions This trial had 3 arms: the intervention group performed CIMT; a comparison group
performed CIMT plus mirror therapy; and the control group
CIMT versus CIMT plus mirror therapy versus control
CIMT: fine motor exercise under the supervision of occupational therapist plus conven-
tional physiotherapy plus self exercise
Amount of restraint: 6 hours per day
Anatomical region restraint: arm plus hand
CIMT plus mirror therapy: fine motor exercise under the supervision of occupational
therapist plus conventional physiotherapy plus mirror therapy with flexion/extension of
the shoulder, elbow, wrist, finger, and pronation/supination of the forearm
Control: self-exercise program
Session duration:
CIMT: 6 hours of exercise, plus 40 minutes of conventional physiotherapy plus 30
minutes of self exercise daily;
CIMT plus mirror therapy: 6 hours of exercise, plus 40 minutes of conventional phys-
iotherapy, plus 30 minutes of mirror therapy daily;
Control group: 60minutes of self exercise, plus 40minutes of conventional physiotherapy
All for 5 days a week for 2 weeks
Outcomes Measures pre/post treatment
• Arm motor function: WMFT
• Dexterity: 9HPT, Box and Block Test
• Motor impairment: grip force
• Activities of daily living measure: BI (Korean version)
• Arm motor impairment: FMA
• Brunnstrom stage
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “they were assigned into three
groups by picking a random card with
numbers on them”
Allocation concealment (selection bias) Unclear risk No information provided
Blinding (performance bias and detection
bias)
All outcomes
Low risk Quote: “... the results were compared be-
tween the three groups by the blinded ob-
servers”
Incomplete outcome data addressed? (Post-
treatment)
Unclear risk The study provided no information about
withdrawals
9HPT: Nine-Hole Peg Test, a test measuring finger-hand co-ordination in terms of the time it takes a patient to place nine pegs in a
5-in by 5-in board then remove them
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16HPT: Sixteen-Hole Peg Test: the time needed to place 16 pegs (2.15.9 cm) in a pegboard with 16 holes determined with a stopwatch
ADL: activities of daily living
AMAT: Arm Motor Activity Test, 16 timed items
AMPS: Assessment of Motor and Process Skills, a real-time test in which patients do prescribed functional tasks that are videotaped
and scored by a viewer
AoU: amount of use
ARAT: Action Research Arm Test, 19 items, 57-point test divided into four categories (grasp, grip, pinch and gross movement), each
item graded on a 4-point ordinal scale (anchored 0 = can perform no part of the test, 3 = performs the test normally)
BAT: Bilateral arm training
BATRAC: Bilateral arm training with rhythmic auditory cueing
BI: Barthel Index
BLMA: Birgitta Lindmarks Motor Assessment
Box and Block Test: assesses unilateral gross manual dexterity
CI: control intervention
CIMT: constraint-induced movement therapy
CIT: constraint-induced therapy
CMII: Chedoke-McMaster Impairment Inventory, a 7-point scale ranging from 1 to 7 that presents 7 stages of motor recovery for arm,
hand, postural control and shoulder pain, assessed with a severity scale
COPM: Canadian Occupational Performance Measure, a structured clinical assessment that allows participants to self-rate goals of
therapy in the categories of self-care, productivity, and leisure
CVA: Cerebrovascular accident
dCIT: distributed constraint-induced therapy
EMF: Emory Motor Function test, 16 timed items (2 strength items and 1 quality of movement item)
EmNSA: Erasmus modification of the Nottingham Sensory Assessment to measure the sense of touch, pressure, proprioception, and
sharp-blunt discrimination in the upper limb
FAI: Frenchay Activities Index, a self-report scale, measures a person’s perception of instrumental ADL participation at 3 or 6 months.
It contains 15 items that can be separated into 3 factors: domestic chores, leisure/work, and outdoor activities. Each item is scored on
a 0 to 3 point scale. Higher scores indicate better performance.
FIM: Functional Independence Measure, 5 items that specifically assess upper extremity function. Each item is scored on a 7-point
ordinal scale
FIM2: Functional Independence Measure, 18 items grouped into six sub scales. Each item is scored on a 7-point ordinal scale
FIM3: Functional Independence Measure, 6 items that specifically assess upper extremity function. Each item is scored on a 7-point
ordinal scale
FMA: Fugl-Meyer Assessment, a 66-point upper extremity section of the Fugl-Meyer Assessment ofMotor Recovery After Stroke which
assesses impairment using a 3-point ordinal scale ( 0 = cannot perform to 2 = can perform fully)
FMA2: Fugl-Meyer Assessment, a 33-point upper extremity section of the Fugl-Meyer Assessment of Motor Recovery After Stroke
Assessment, which assesses impairment using a 3-point ordinal scale (0 = cannot perform to 2 = can perform fully)
FU: Forced use
GPT: Grooved Pegboard Test, a test of dexterity that evaluates the speed with which the patient grasps and inserts 25 pegs (3 cm long,
5 mm diameter) into a grid of vertical holes in a horizontal 10 cm2 surface. It indicates the number of pegs placed per second for each
hand
MAL: Motor Activity Log, a semi-structured interview comprising 30 ADL tasks graded on a 6-point AoU scale and a 6-point Quality
of Movement (QoM) scale
MAL2: Motor Activity Log, a semi-structured interview comprising 14 ADL tasks graded on a 6-point AoU scale and a 6-point Quality
of Movement (QoM) scale
MAL3: Motor Activity Log, a semi-structured interview comprising 28 ADL tasks graded on a 6-point AoU scale and a 6-point Quality
of Movement (QoM) scale
MAS: Motor Assessment Scale, a performance-based scale developed for assessing everyday motor function in patients with stroke.
Eight areas of motor function are assessed using a 7-point scale (0 to 6)
MAS2: Modified Motor Assessment Scale, items used for upper extremity only; both arms were tested, consisting of 15 tasks from
gross arm to fine finger movements in a 0-5 point scale
MASh: Modified Ashworth Scale, grades spasticity on the International Classification of Functioning level of body functions (muscle
tone functions)
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mCIMT: modified constraint-induced movement therapy
MESUPES: Motor Evaluation Scale for Arm in Stroke Patients, a scale that takes the quality of upper limb movement into account
during the evaluation of arm performance after stroke
MFT: Manual Function Test, assess various functions of the paralysed upper limb in hemiplegic patients post stroke in performing
simple tasks
MI: Motricity Index, to measure strength in the upper limbs
MMSE: Mini Mental State Examination
NIHSS: The National Institute of Health Stroke Scale. assesses cognitive, sensory, and motor impairments as an indicator of overall
stroke severity
PET: positron emission tomography
PNF: proprioceptive neuromuscular facilitation
RMAAS: Rivermead Motor Assessment Arm Scale: motor performance test
SD: standard deviation
SHFT: Sollerman Hand Function Test, consisting of 20 sub-tests reflecting daily hand activities (type of grasp, quality of movement
and speed of performance assessed in a 0-4 point scale)
SIS: Stroke Impact Scale
TC: Therapeutic climbing
TF: Traditional physiotherapy
TMS: transcranical magnetic stimulation
UE: upper extremity
WMFT: Wolf Motor Function Test, 17 simple limb movements and tasks with the affected arm. 15 items are timed and two assess
strength
WMFT2: Wolf Motor Function Test, 19 simple limb movements and tasks with the affected arm. 17 items are timed and two assess
strength
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Brogårdh 2006 RCT; the study authors explored the extended mitt used alone after CIMT and 4-years follow-up
Fuzaro 2012 RCT; the study authors compare mCIMT and a modified FU
Gautier 2008 RCT; the study authors compare 2 different forms of CIMT
Lin 2008 RCT; the study authors compare mCIMT and a modified FU
Lin 2009b RCT; the study authors compare mCIMT and a modified FU
Sawaki 2014 RCT; some participants were also included in another study (Wolf 2006)
Tan 2012 Not an RCT, controls were matched to subject receiving CIMT
Van der Lee 1999 Not an RCT; computer-generated randomisation, but with 21 aberrations (11 participants who should have
received the experimental treatment were allocated to the reference group and 10 vice versa)
Wu 2012b RCT; it included participants from the included study of Wu 2012a
85Constraint-induced movement therapy for upper extremities in people with stroke (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
CIMT: constraint-induced movement therapy
FU: forced use
mCIMT: modified constraint-induced movement therapy
RCT: randomised controlled trial
Characteristics of studies awaiting assessment [ordered by study ID]
Barzel 2015
Methods RCT
Participants People with stroke
Interventions mCIMT
Outcomes MAL-QOM and WMFT
Notes Protocol for a completed study (clinicaltrials.gov)
Boe 2014
Methods RCT
Participants People with stroke
Interventions mCIMT
Outcomes ARAT, MAL, Satisfaction with Stroke Care Questionnaire, Re-integration to Normal Living Index
Notes
Dos Santos 2012
Methods RCT
Participants People with stroke
Interventions Restraint of the less affected upper limb
Outcomes Fugl-Meyer Scale, FIM
Notes
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Jansa 2007
Methods RCT
Participants People with stroke
Interventions CIMT
Outcomes Assesment of motor and process skills
Notes Presented as a poster at 11th Congress of the EFNS, Brussels, Belgium, 2007
Olivier 2012
Methods RCT
Participants People with stroke
Interventions Light constraint-induced therapy
Outcomes MAL-QOM and WMFT
Notes This study has been terminated (departure of the investigator co-ordinator to another country)
Uswatte 2014
Methods RCT
Participants People with stroke
Interventions Expanded Constraint Induced therapy
Outcomes MAL
Notes
ARAT: Action Research Arm Test
CIMT: constraint-induced movement therapy
FIM: Functional Independence Measure
MAL: Motor Activity Log
MAL-QOM: Motor Activity Log - Quality Of Movement
mCIMT: modified constraint-induced movement therapy
RCT: randomised controlled trial
WMFT: Wolf Motor Function Test
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Characteristics of ongoing studies [ordered by study ID]
Gautier 2015
Trial name or title Examining mechanisms of neuroplasticity following motor rehabilitation in stroke - examining how motor
rehabilitation promotes brain reorganization following stroke, an MRI Study
Methods RCT
Participants People with stroke
Interventions Constraint-induced therapy
Outcomes Brain structure, WMFT, ARAT, MAL
Starting date July 2012
Contact information Gauthier.33@osu.edu
Notes
Padovani Do Santos 2015
Trial name or title Checking a security protocol of modified forced use therapy and efficacy reducing the constriction of the
movement time in 12 hours
Methods RCT
Participants People with stroke
Interventions FU therapy
Outcomes Root mean square activity through surface electromyography and strength handgrip
Starting date May 2015
Contact information Tamyris Padovani dos Santos, University of Sao Paulo
Notes
Pereira 2015
Trial name or title Effects of constraint-induced therapy for the scapular kinematics and related to the quality of movement in
patients with severe chronic hemiparesis
Methods RCT
Participants People with stroke
Interventions Constraint-induced therapy
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Pereira 2015 (Continued)
Outcomes Movement of the scapula and trunk through kinematic, WMFT, MAL
Starting date January 2015
Contact information nat˙duarte@yahoo.com.br
Notes
ARAT: Action Research Arm Test
FU: forced use
MAL: Motor Activity Log
RCT: randomised controlled trial
WMFT: Wolf Motor Function Test
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D A T A A N D A N A L Y S E S
Comparison 1. Constraint versus control: primary outcome
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Disability postintervention 11 344 Std. Mean Difference (IV, Random, 95% CI) 0.24 [-0.05, 0.52]
2 Disability: 3 to 6-month
follow-up
3 125 Std. Mean Difference (IV, Random, 95% CI) -0.21 [-0.57, 0.16]
Comparison 2. Constraint versus control: subgroup analysis on primary outcome
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Amount of task practice 11 Std. Mean Difference (IV, Fixed, 95% CI) Subtotals only
1.1 ≤ 30 hours 8 253 Std. Mean Difference (IV, Fixed, 95% CI) 0.18 [-0.07, 0.44]
1.2 > 30 hours 3 91 Std. Mean Difference (IV, Fixed, 95% CI) 0.25 [-0.18, 0.67]
2 Anatomical region restraint 11 Std. Mean Difference (IV, Fixed, 95% CI) Subtotals only
2.1 Arm plus hand 2 61 Std. Mean Difference (IV, Fixed, 95% CI) 0.35 [-0.17, 0.87]
2.2 Hand only 9 283 Std. Mean Difference (IV, Fixed, 95% CI) 0.17 [-0.08, 0.41]
3 Time since stroke 7 Std. Mean Difference (IV, Fixed, 95% CI) Subtotals only
3.1 0 to 3 months 5 164 Std. Mean Difference (IV, Fixed, 95% CI) 0.07 [-0.26, 0.39]
3.2 3 to 9 months 0 0 Std. Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 More than 9 months 2 62 Std. Mean Difference (IV, Fixed, 95% CI) 0.49 [-0.02, 1.00]
Comparison 3. Constraint versus control: secondary outcomes
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Arm Motor Function 28 858 Std. Mean Difference (IV, Random, 95% CI) 0.34 [0.12, 0.55]
1.1 Constraint therapy versus
usual care
25 816 Std. Mean Difference (IV, Random, 95% CI) 0.31 [0.09, 0.52]
1.2 Constraint therapy versus
no treatment
3 42 Std. Mean Difference (IV, Random, 95% CI) 1.04 [-0.31, 2.40]
2 Perceived Arm Motor Function
(Quality of Use)
24 891 Mean Difference (IV, Random, 95% CI) 0.68 [0.47, 0.88]
2.1 CIMT versus usual care 22 865 Mean Difference (IV, Random, 95% CI) 0.65 [0.44, 0.86]
2.2 CIMT versus no treatment 2 26 Mean Difference (IV, Random, 95% CI) 0.94 [-0.32, 2.20]
3 Perceived Arm Motor Function
(Amount of Use)
23 851 Mean Difference (IV, Random, 95% CI) 0.79 [0.50, 1.08]
3.1 CIMT versus usual care 21 818 Mean Difference (IV, Random, 95% CI) 0.75 [0.44, 1.05]
3.2 CIMT versus no treatment 2 33 Mean Difference (IV, Random, 95% CI) 1.20 [0.78, 1.62]
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4 Arm Motor Impairment 16 372 Std. Mean Difference (IV, Random, 95% CI) 0.82 [0.31, 1.34]
4.1 Constraint therapy versus
usual care
15 355 Std. Mean Difference (IV, Random, 95% CI) 0.88 [0.33, 1.42]
4.2 Constraint therapy versus
no treatment
1 17 Std. Mean Difference (IV, Random, 95% CI) 0.25 [-0.70, 1.21]
5 Quality of life 3 96 Mean Difference (IV, Random, 95% CI) 6.54 [-1.20, 14.28]
5.1 Constraint therapy versus
usual care
3 96 Mean Difference (IV, Random, 95% CI) 6.54 [-1.20, 14.28]
6 Dexterity 4 113 Std. Mean Difference (IV, Random, 95% CI) 0.42 [0.04, 0.79]
6.1 Constraint therapy versus
usual care
4 113 Std. Mean Difference (IV, Random, 95% CI) 0.42 [0.04, 0.79]
Analysis 1.1. Comparison 1 Constraint versus control: primary outcome, Outcome 1 Disability
postintervention.
Review: Constraint-induced movement therapy for upper extremities in people with stroke
Comparison: 1 Constraint versus control: primary outcome
Outcome: 1 Disability postintervention
Study or subgroup Constraint Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Dahl 2008 18 1.16 (12.26) 12 0.75 (8.73) 9.2 % 0.04 [ -0.69, 0.77 ]
Dromerick 2009 35 5.4 (5.4) 17 7.35 (4.84) 11.9 % -0.37 [ -0.95, 0.22 ]
Huseyinsinoglu 2012 11 4.1 (16.72) 11 3.7 (17.27) 7.7 % 0.02 [ -0.81, 0.86 ]
Lin 2007 17 9.06 (17.21) 15 3.67 (23.83) 9.8 % 0.26 [ -0.44, 0.95 ]
Lin 2009a 20 2.65 (3.69) 20 2.35 (5.23) 11.2 % 0.06 [ -0.56, 0.68 ]
Myint 2008 23 5.9 (5.7) 20 5.8 (7.3) 11.6 % 0.02 [ -0.58, 0.61 ]
Ploughman 2004 10 21.33 (18.18) 13 12.58 (15.54) 7.7 % 0.50 [ -0.34, 1.34 ]
Treger 2012 9 16.3 (8) 19 18.5 (12.3) 8.3 % -0.19 [ -0.99, 0.60 ]
Wu 2007a 15 7.33 (8.88) 15 2.27 (2.55) 9.0 % 0.75 [ 0.01, 1.50 ]
Wu 2007c 13 9.77 (10.67) 13 2.54 (2.54) 8.0 % 0.90 [ 0.09, 1.72 ]
Yoon 2014 9 18 (10.9) 9 5.33 (5.36) 5.5 % 1.40 [ 0.35, 2.46 ]
Total (95% CI) 180 164 100.0 % 0.24 [ -0.05, 0.52 ]
Heterogeneity: Tau2 = 0.08; Chi2 = 15.96, df = 10 (P = 0.10); I2 =37%
Test for overall effect: Z = 1.64 (P = 0.10)
Test for subgroup differences: Not applicable
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Analysis 1.2. Comparison 1 Constraint versus control: primary outcome, Outcome 2 Disability: 3 to 6-
month follow-up.
Review: Constraint-induced movement therapy for upper extremities in people with stroke
Comparison: 1 Constraint versus control: primary outcome
Outcome: 2 Disability: 3 to 6-month follow-up
Study or subgroup Constraint Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Dahl 2008 18 3.39 (11.87) 12 2 (8.93) 24.8 % 0.13 [ -0.61, 0.86 ]
Dromerick 2009 35 7.04 (6.4) 17 9.63 (4.5) 38.6 % -0.44 [ -1.02, 0.15 ]
Myint 2008 23 10.9 (13.09) 20 13.9 (17.12) 36.7 % -0.20 [ -0.80, 0.41 ]
Total (95% CI) 76 49 100.0 % -0.21 [ -0.57, 0.16 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.38, df = 2 (P = 0.50); I2 =0.0%
Test for overall effect: Z = 1.12 (P = 0.26)
Test for subgroup differences: Not applicable
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Analysis 2.1. Comparison 2 Constraint versus control: subgroup analysis on primary outcome, Outcome 1
Amount of task practice.
Review: Constraint-induced movement therapy for upper extremities in people with stroke
Comparison: 2 Constraint versus control: subgroup analysis on primary outcome
Outcome: 1 Amount of task practice
Study or subgroup Constraint Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 ≤ 30 hours
Dromerick 2009 35 5.4 (5.4) 17 7.35 (4.85) 19.1 % -0.37 [ -0.95, 0.22 ]
Huseyinsinoglu 2012 11 4.1 (16.72) 11 3.7 (17.27) 9.3 % 0.02 [ -0.81, 0.86 ]
Lin 2007 17 9.06 (17.21) 15 3.67 (23.83) 13.4 % 0.26 [ -0.44, 0.95 ]
Lin 2009a 20 2.65 (3.69) 20 2.35 (5.23) 17.0 % 0.06 [ -0.56, 0.68 ]
Ploughman 2004 10 21.33 (18.18) 13 12.58 (15.54) 9.2 % 0.50 [ -0.34, 1.34 ]
Treger 2012 9 16.3 (8) 19 18.5 (12.3) 10.3 % -0.19 [ -0.99, 0.60 ]
Wu 2007a 15 7.33 (8.88) 15 2.27 (2.55) 11.8 % 0.75 [ 0.01, 1.50 ]
Wu 2007c 13 9.77 (10.67) 13 2.54 (2.54) 9.9 % 0.90 [ 0.09, 1.72 ]
Subtotal (95% CI) 130 123 100.0 % 0.18 [ -0.07, 0.44 ]
Heterogeneity: Chi2 = 10.41, df = 7 (P = 0.17); I2 =33%
Test for overall effect: Z = 1.39 (P = 0.16)
2 > 30 hours
Dahl 2008 18 1.16 (12.26) 12 0.75 (8.73) 33.8 % 0.04 [ -0.69, 0.77 ]
Myint 2008 23 5.9 (5.7) 20 5.8 (7.3) 50.2 % 0.02 [ -0.58, 0.61 ]
Yoon 2014 9 18 (10.9) 9 5.33 (5.36) 16.0 % 1.40 [ 0.35, 2.46 ]
Subtotal (95% CI) 50 41 100.0 % 0.25 [ -0.18, 0.67 ]
Heterogeneity: Chi2 = 5.48, df = 2 (P = 0.06); I2 =64%
Test for overall effect: Z = 1.13 (P = 0.26)
Test for subgroup differences: Chi2 = 0.06, df = 1 (P = 0.80), I2 =0.0%
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Analysis 2.2. Comparison 2 Constraint versus control: subgroup analysis on primary outcome, Outcome 2
Anatomical region restraint.
Review: Constraint-induced movement therapy for upper extremities in people with stroke
Comparison: 2 Constraint versus control: subgroup analysis on primary outcome
Outcome: 2 Anatomical region restraint
Study or subgroup Constraint Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Arm plus hand
Myint 2008 23 5.9 (5.7) 20 5.8 (7.3) 75.8 % 0.02 [ -0.58, 0.61 ]
Yoon 2014 9 18 (10.9) 9 5.33 (5.36) 24.2 % 1.40 [ 0.35, 2.46 ]
Subtotal (95% CI) 32 29 100.0 % 0.35 [ -0.17, 0.87 ]
Heterogeneity: Chi2 = 5.01, df = 1 (P = 0.03); I2 =80%
Test for overall effect: Z = 1.32 (P = 0.19)
2 Hand only
Dahl 2008 18 1.16 (12.26) 12 0.75 (8.73) 10.9 % 0.04 [ -0.69, 0.77 ]
Dromerick 2009 35 5.4 (5.4) 17 7.35 (4.85) 17.0 % -0.37 [ -0.95, 0.22 ]
Huseyinsinoglu 2012 11 4.1 (16.72) 11 3.7 (17.27) 8.3 % 0.02 [ -0.81, 0.86 ]
Lin 2007 17 9.06 (17.21) 15 3.67 (23.83) 11.9 % 0.26 [ -0.44, 0.95 ]
Lin 2009a 20 2.65 (3.69) 20 2.35 (5.23) 15.1 % 0.06 [ -0.56, 0.68 ]
Ploughman 2004 10 21.33 (18.18) 13 12.58 (15.54) 8.2 % 0.50 [ -0.34, 1.34 ]
Treger 2012 9 16.3 (8) 19 18.5 (12.3) 9.2 % -0.19 [ -0.99, 0.60 ]
Wu 2007a 15 7.33 (8.88) 15 2.27 (2.55) 10.5 % 0.75 [ 0.01, 1.50 ]
Wu 2007c 13 9.77 (10.67) 13 2.54 (2.54) 8.8 % 0.90 [ 0.09, 1.72 ]
Subtotal (95% CI) 148 135 100.0 % 0.17 [ -0.08, 0.41 ]
Heterogeneity: Chi2 = 10.55, df = 8 (P = 0.23); I2 =24%
Test for overall effect: Z = 1.35 (P = 0.18)
Test for subgroup differences: Chi2 = 0.40, df = 1 (P = 0.53), I2 =0.0%
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Analysis 2.3. Comparison 2 Constraint versus control: subgroup analysis on primary outcome, Outcome 3
Time since stroke.
Review: Constraint-induced movement therapy for upper extremities in people with stroke
Comparison: 2 Constraint versus control: subgroup analysis on primary outcome
Outcome: 3 Time since stroke
Study or subgroup Constraint Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 0 to 3 months
Dromerick 2009 35 5.4 (5.4) 17 7.35 (4.85) 30.5 % -0.37 [ -0.95, 0.22 ]
Myint 2008 23 5.9 (5.7) 20 5.8 (7.3) 29.0 % 0.02 [ -0.58, 0.61 ]
Ploughman 2004 10 21.33 (18.18) 13 12.58 (15.54) 14.8 % 0.50 [ -0.34, 1.34 ]
Treger 2012 9 16.3 (8) 19 18.5 (12.3) 16.5 % -0.19 [ -0.99, 0.60 ]
Yoon 2014 9 18 (10.9) 9 5.33 (5.36) 9.3 % 1.40 [ 0.35, 2.46 ]
Subtotal (95% CI) 86 78 100.0 % 0.07 [ -0.26, 0.39 ]
Heterogeneity: Chi2 = 9.72, df = 4 (P = 0.05); I2 =59%
Test for overall effect: Z = 0.40 (P = 0.69)
2 3 to 9 months
Subtotal (95% CI) 0 0 Not estimable
Heterogeneity: not applicable
Test for overall effect: not applicable
3 More than 9 months
Lin 2007 17 9.06 (17.21) 15 3.67 (23.83) 53.2 % 0.26 [ -0.44, 0.95 ]
Wu 2007a 15 7.33 (8.88) 15 2.27 (2.55) 46.8 % 0.75 [ 0.01, 1.50 ]
Subtotal (95% CI) 32 30 100.0 % 0.49 [ -0.02, 1.00 ]
Heterogeneity: Chi2 = 0.92, df = 1 (P = 0.34); I2 =0.0%
Test for overall effect: Z = 1.88 (P = 0.060)
Test for subgroup differences: Chi2 = 1.89, df = 1 (P = 0.17), I2 =47%
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Analysis 3.1. Comparison 3 Constraint versus control: secondary outcomes, Outcome 1 Arm Motor
Function.
Review: Constraint-induced movement therapy for upper extremities in people with stroke
Comparison: 3 Constraint versus control: secondary outcomes
Outcome: 1 Arm Motor Function
Study or subgroup Constraint Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Constraint therapy versus usual care
Atteya 2004 2 15.5 (6.36) 2 0 (9.89) 0.1 % 1.07 [ -5.27, 7.40 ]
Bergheim 2010 2 6.5 (4.94) 2 7 (2.82) 1.0 % -0.07 [ -2.07, 1.93 ]
Brog rdh 2009 12 1 (3.8) 12 4 (3.37) 3.8 % -0.81 [ -1.64, 0.03 ]
Brunner 2012 13 13.23 (8.18) 15 15.2 (10.7) 4.3 % -0.20 [ -0.94, 0.55 ]
Dahl 2008 18 0.34 (0.72) 12 0.16 (0.78) 4.4 % 0.24 [ -0.50, 0.97 ]
Dromerick 2000 11 25.5 (20.75) 9 16.4 (23.48) 3.5 % 0.40 [ -0.50, 1.29 ]
Dromerick 2009 35 14.44 (12.68) 17 16.7 (8.46) 5.5 % -0.19 [ -0.77, 0.39 ]
Hammer 2009 13 5 (8) 15 5.3 (7) 4.3 % -0.04 [ -0.78, 0.70 ]
Hayner 2010 6 5.5 (23.7) 6 6.5 (24.9) 2.6 % -0.04 [ -1.17, 1.09 ]
Huseyinsinoglu 2012 11 0.76 (1.24) 11 0.4 (1.42) 3.8 % 0.26 [ -0.58, 1.10 ]
Khan 2011 13 1.1 (2.05) 14 1.1 (1.98) 4.3 % 0.0 [ -0.75, 0.75 ]
Myint 2008 23 20.1 (9.3) 20 9.6 (12.4) 5.1 % 0.95 [ 0.31, 1.59 ]
Page 2001 2 14.5 (4.94) 2 5 (4.24) 0.1 % 1.18 [ -5.77, 8.13 ]
Page 2005b 5 21.4 (2.79) 5 4.6 (0.89) 0.2 % 7.33 [ 3.02, 11.64 ]
Page 2008 13 10.78 (10.94) 12 2.67 (13.64) 4.0 % 0.64 [ -0.17, 1.45 ]
Ploughman 2004 10 18.11 (12.89) 13 11.75 (12.54) 3.8 % 0.48 [ -0.36, 1.32 ]
Smania 2012 30 0.81 (1.17) 29 0.52 (1.18) 6.0 % 0.24 [ -0.27, 0.76 ]
Tariah 2010 10 0.66 (0.65) 8 -0.01 (0.74) 3.1 % 0.92 [ -0.07, 1.91 ]
Treger 2012 9 5.4 (3.4) 19 3.5 (2.2) 3.9 % 0.70 [ -0.12, 1.52 ]
Van Delden 2013 21 14.6 (12) 16 15.9 (12.5) 4.9 % -0.10 [ -0.75, 0.55 ]
Wang 2011 10 0.44 (0.25) 10 0.44 (0.4) 3.6 % 0.0 [ -0.88, 0.88 ]
Wolf 2006 96 0.29 (0.25) 103 0.12 (0.27) 7.8 % 0.65 [ 0.36, 0.94 ]
Wu 2011 22 0.52 (0.96) 22 -0.12 (1.24) 5.3 % 0.57 [ -0.04, 1.17 ]
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(. . . Continued)
Study or subgroup Constraint Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Wu 2012a 19 7 (20.88) 18 3.8 (28.36) 5.0 % 0.13 [ -0.52, 0.77 ]
Yoon 2014 9 5.22 (5.56) 9 -1.23 (2.05) 2.8 % 1.47 [ 0.39, 2.54 ]
Subtotal (95% CI) 415 401 93.3 % 0.31 [ 0.09, 0.52 ]
Heterogeneity: Tau2 = 0.11; Chi2 = 43.63, df = 24 (P = 0.01); I2 =45%
Test for overall effect: Z = 2.80 (P = 0.0052)
2 Constraint therapy versus no treatment
Kim 2008 9 1.34 (2.12) 8 0.37 (4.82) 3.2 % 0.25 [ -0.70, 1.21 ]
Taub 1993 4 0.8 (0.18) 5 0 (0.18) 0.6 % 3.95 [ 1.18, 6.72 ]
Wittenberg 2003 9 0.4 (0.36) 7 0.14 (0.36) 3.0 % 0.68 [ -0.34, 1.71 ]
Subtotal (95% CI) 22 20 6.7 % 1.04 [ -0.31, 2.40 ]
Heterogeneity: Tau2 = 0.89; Chi2 = 6.13, df = 2 (P = 0.05); I2 =67%
Test for overall effect: Z = 1.51 (P = 0.13)
Total (95% CI) 437 421 100.0 % 0.34 [ 0.12, 0.55 ]
Heterogeneity: Tau2 = 0.13; Chi2 = 50.53, df = 27 (P = 0.004); I2 =47%
Test for overall effect: Z = 3.08 (P = 0.0021)
Test for subgroup differences: Chi2 = 1.11, df = 1 (P = 0.29), I2 =10%
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Analysis 3.2. Comparison 3 Constraint versus control: secondary outcomes, Outcome 2 Perceived Arm
Motor Function (Quality of Use).
Review: Constraint-induced movement therapy for upper extremities in people with stroke
Comparison: 3 Constraint versus control: secondary outcomes
Outcome: 2 Perceived Arm Motor Function (Quality of Use)
Study or subgroup Constraint Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 CIMT versus usual care
Boake 2007 9 1.59 (1.29) 13 1.05 (1.49) 2.2 % 0.54 [ -0.63, 1.71 ]
Brog rdh 2009 12 0.7 (1.8) 12 0.63 (0.65) 2.4 % 0.07 [ -1.01, 1.15 ]
Brunner 2012 13 1.23 (0.67) 15 1.4 (0.86) 4.6 % -0.17 [ -0.74, 0.40 ]
Dahl 2008 18 0.51 (0.95) 12 0.24 (1.41) 3.0 % 0.27 [ -0.64, 1.18 ]
Hammer 2009 13 0.6 (0.37) 15 0.22 (0.32) 6.4 % 0.38 [ 0.12, 0.64 ]
Huseyinsinoglu 2012 11 2.21 (0.81) 11 1.15 (1.27) 3.1 % 1.06 [ 0.17, 1.95 ]
Khan 2011 13 1.6 (1.94) 14 1.4 (7.12) 0.3 % 0.20 [ -3.68, 4.08 ]
Krawczyk 2012 24 0.78 (0.46) 23 0.84 (0.48) 6.4 % -0.06 [ -0.33, 0.21 ]
Lin 2007 17 1.55 (1.39) 15 0.21 (1.48) 2.7 % 1.34 [ 0.34, 2.34 ]
Lin 2009a 20 0.95 (0.48) 20 0.26 (0.87) 5.4 % 0.69 [ 0.25, 1.13 ]
Lin 2010 5 1.7 (2.22) 8 0.5 (2.14) 0.6 % 1.20 [ -1.25, 3.65 ]
Myint 2008 23 1.33 (0.56) 20 0.89 (0.84) 5.4 % 0.44 [ 0.01, 0.87 ]
Page 2005b 5 1.85 (0.41) 5 0.34 (0.14) 5.8 % 1.51 [ 1.13, 1.89 ]
Smania 2012 30 1.5 (1.16) 29 0.43 (0.56) 5.3 % 1.07 [ 0.61, 1.53 ]
Tariah 2010 10 1.24 (1.32) 8 0.54 (0.95) 2.5 % 0.70 [ -0.35, 1.75 ]
Van Delden 2013 21 1.3 (1) 16 1 (0.8) 4.6 % 0.30 [ -0.28, 0.88 ]
Wolf 2006 98 1.04 (0.6) 103 0.31 (0.52) 6.9 % 0.73 [ 0.57, 0.89 ]
Wu 2007a 15 1.11 (0.83) 15 0.3 (0.78) 4.6 % 0.81 [ 0.23, 1.39 ]
Wu 2007b 24 1.13 (0.72) 23 0.14 (0.52) 5.9 % 0.99 [ 0.63, 1.35 ]
Wu 2007c 13 1.2 (0.85) 13 0.14 (0.37) 5.0 % 1.06 [ 0.56, 1.56 ]
Wu 2011 22 1.24 (1.31) 22 0.67 (1.54) 3.2 % 0.57 [ -0.27, 1.41 ]
Wu 2012a 19 1 (1.14) 18 0.4 (1.1) 3.8 % 0.60 [ -0.12, 1.32 ]
Subtotal (95% CI) 435 430 89.8 % 0.65 [ 0.44, 0.86 ]
Heterogeneity: Tau2 = 0.14; Chi2 = 76.10, df = 21 (P<0.00001); I2 =72%
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Study or subgroup Constraint Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Test for overall effect: Z = 6.10 (P < 0.00001)
2 CIMT versus no treatment
Kim 2008 9 0.47 (0.27) 8 0.16 (0.55) 5.5 % 0.31 [ -0.11, 0.73 ]
Taub 1993 4 2 (0.42) 5 0.4 (0.44) 4.6 % 1.60 [ 1.04, 2.16 ]
Subtotal (95% CI) 13 13 10.2 % 0.94 [ -0.32, 2.20 ]
Heterogeneity: Tau2 = 0.77; Chi2 = 12.93, df = 1 (P = 0.00032); I2 =92%
Test for overall effect: Z = 1.46 (P = 0.14)
Total (95% CI) 448 443 100.0 % 0.68 [ 0.47, 0.88 ]
Heterogeneity: Tau2 = 0.15; Chi2 = 89.64, df = 23 (P<0.00001); I2 =74%
Test for overall effect: Z = 6.46 (P < 0.00001)
Test for subgroup differences: Chi2 = 0.20, df = 1 (P = 0.66), I2 =0.0%
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Analysis 3.3. Comparison 3 Constraint versus control: secondary outcomes, Outcome 3 Perceived Arm
Motor Function (Amount of Use).
Review: Constraint-induced movement therapy for upper extremities in people with stroke
Comparison: 3 Constraint versus control: secondary outcomes
Outcome: 3 Perceived Arm Motor Function (Amount of Use)
Study or subgroup Constraint Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 CIMT versus usual care
Boake 2007 9 1.73 (1.47) 13 1.25 (1.67) 2.7 % 0.48 [ -0.84, 1.80 ]
Brog rdh 2009 12 0.82 (0.98) 12 0.43 (0.96) 4.2 % 0.39 [ -0.39, 1.17 ]
Brunner 2012 13 1.3 (0.66) 15 1.5 (0.99) 4.8 % -0.20 [ -0.82, 0.42 ]
Dahl 2008 18 0.56 (1.68) 12 0.78 (1.66) 2.9 % -0.22 [ -1.44, 1.00 ]
Hammer 2009 13 0.6 (0.4) 15 0.37 (0.3) 5.8 % 0.23 [ -0.04, 0.50 ]
Huseyinsinoglu 2012 11 2.3 (0.83) 11 1.15 (1.91) 2.9 % 1.15 [ -0.08, 2.38 ]
Khan 2011 13 1.7 (2) 14 1.6 (1.57) 2.6 % 0.10 [ -1.26, 1.46 ]
Lin 2007 17 1.4 (1.25) 15 0.24 (1.37) 3.8 % 1.16 [ 0.25, 2.07 ]
Lin 2009a 20 0.73 (0.48) 20 0.14 (0.44) 5.7 % 0.59 [ 0.30, 0.88 ]
Lin 2010 5 1.5 (2.4) 8 0.6 (2.14) 1.0 % 0.90 [ -1.67, 3.47 ]
Myint 2008 23 1.53 (0.67) 20 0.54 (0.42) 5.6 % 0.99 [ 0.66, 1.32 ]
Page 2005b 5 2.42 (0.23) 5 0.07 (0.2) 5.8 % 2.35 [ 2.08, 2.62 ]
Smania 2012 30 1.4 (1.18) 29 0.28 (0.64) 5.2 % 1.12 [ 0.64, 1.60 ]
Tariah 2010 10 1.36 (1.48) 8 0.67 (1.11) 2.9 % 0.69 [ -0.51, 1.89 ]
Van Delden 2013 21 1.3 (1.3) 16 1 (0.8) 4.5 % 0.30 [ -0.38, 0.98 ]
Wolf 2006 98 1.15 (0.65) 103 0.29 (0.56) 6.0 % 0.86 [ 0.69, 1.03 ]
Wu 2007a 15 1.37 (0.85) 15 0.34 (0.57) 5.1 % 1.03 [ 0.51, 1.55 ]
Wu 2007b 24 1.21 (0.73) 23 0.17 (0.4) 5.6 % 1.04 [ 0.71, 1.37 ]
Wu 2007c 13 0.98 (0.77) 13 0.2 (0.36) 5.3 % 0.78 [ 0.32, 1.24 ]
Wu 2011 22 0.91 (1.33) 22 0.39 (1.18) 4.3 % 0.52 [ -0.22, 1.26 ]
Wu 2012a 19 0.9 (1) 18 0.4 (1) 4.7 % 0.50 [ -0.14, 1.14 ]
Subtotal (95% CI) 411 407 91.3 % 0.75 [ 0.44, 1.05 ]
Heterogeneity: Tau2 = 0.37; Chi2 = 169.59, df = 20 (P<0.00001); I2 =88%
Test for overall effect: Z = 4.77 (P < 0.00001)
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Study or subgroup Constraint Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
2 CIMT versus no treatment
Kim 2008 9 1.39 (0.57) 8 0.04 (1.38) 3.4 % 1.35 [ 0.32, 2.38 ]
Wittenberg 2003 9 1.1 (0.44) 7 -0.07 (0.48) 5.3 % 1.17 [ 0.71, 1.63 ]
Subtotal (95% CI) 18 15 8.7 % 1.20 [ 0.78, 1.62 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.10, df = 1 (P = 0.75); I2 =0.0%
Test for overall effect: Z = 5.63 (P < 0.00001)
Total (95% CI) 429 422 100.0 % 0.79 [ 0.50, 1.08 ]
Heterogeneity: Tau2 = 0.35; Chi2 = 171.50, df = 22 (P<0.00001); I2 =87%
Test for overall effect: Z = 5.41 (P < 0.00001)
Test for subgroup differences: Chi2 = 2.96, df = 1 (P = 0.09), I2 =66%
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Analysis 3.4. Comparison 3 Constraint versus control: secondary outcomes, Outcome 4 Arm Motor
Impairment.
Review: Constraint-induced movement therapy for upper extremities in people with stroke
Comparison: 3 Constraint versus control: secondary outcomes
Outcome: 4 Arm Motor Impairment
Study or subgroup Constraint Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Constraint therapy versus usual care
Atteya 2004 2 8.5 (2.12) 2 -0.5 (6.36) 0.6 % 1.08 [ -5.36, 7.53 ]
Boake 2007 10 18.2 (14.18) 12 14.1 (23.09) 7.5 % 0.20 [ -0.64, 1.04 ]
Hammer 2009 13 3.77 (3.03) 15 1.8 (2.91) 7.8 % 0.64 [ -0.12, 1.41 ]
Lin 2009a 20 6.25 (3.39) 20 1.5 (3.38) 8.1 % 1.38 [ 0.68, 2.07 ]
Lin 2010 5 5.6 (7.6) 8 3.5 (15.75) 6.5 % 0.15 [ -0.97, 1.27 ]
Page 2001 2 8 (1.41) 2 -0.5 (7.77) 0.9 % 0.87 [ -4.43, 6.17 ]
Page 2005b 5 18.4 (2.5) 5 4.2 (1.3) 1.5 % 6.44 [ 2.61, 10.27 ]
Page 2008 13 7.93 (10.88) 12 3.92 (16.31) 7.7 % 0.28 [ -0.51, 1.07 ]
Ploughman 2004 10 1.67 (2.25) 13 0.83 (1.12) 7.6 % 0.48 [ -0.36, 1.31 ]
Singh 2013 20 24.95 (3.74) 20 9.5 (2.7) 6.1 % 4.64 [ 3.40, 5.88 ]
Tariah 2010 10 9.1 (14.2) 8 1.87 (12.9) 7.2 % 0.50 [ -0.44, 1.45 ]
Van Delden 2013 21 7.8 (9.4) 16 9.8 (7.9) 8.2 % -0.22 [ -0.88, 0.43 ]
Wu 2007b 24 7.25 (6.63) 23 3.04 (5.88) 8.4 % 0.66 [ 0.07, 1.25 ]
Wu 2007c 13 7.69 (6.16) 13 2.31 (2.75) 7.6 % 1.09 [ 0.26, 1.93 ]
Yoon 2014 9 11.44 (11.71) 9 9.44 (11.29) 7.2 % 0.17 [ -0.76, 1.09 ]
Subtotal (95% CI) 177 178 92.9 % 0.88 [ 0.33, 1.42 ]
Heterogeneity: Tau2 = 0.78; Chi2 = 64.83, df = 14 (P<0.00001); I2 =78%
Test for overall effect: Z = 3.13 (P = 0.0018)
2 Constraint therapy versus no treatment
Kim 2008 9 1.34 (2.12) 8 0.37 (4.82) 7.1 % 0.25 [ -0.70, 1.21 ]
Subtotal (95% CI) 9 8 7.1 % 0.25 [ -0.70, 1.21 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.52 (P = 0.60)
Total (95% CI) 186 186 100.0 % 0.82 [ 0.31, 1.34 ]
Heterogeneity: Tau2 = 0.73; Chi2 = 65.55, df = 15 (P<0.00001); I2 =77%
Test for overall effect: Z = 3.14 (P = 0.0017)
Test for subgroup differences: Chi2 = 1.22, df = 1 (P = 0.27), I2 =18%
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Analysis 3.5. Comparison 3 Constraint versus control: secondary outcomes, Outcome 5 Quality of life.
Review: Constraint-induced movement therapy for upper extremities in people with stroke
Comparison: 3 Constraint versus control: secondary outcomes
Outcome: 5 Quality of life
Study or subgroup Constraint Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Constraint therapy versus usual care
Dahl 2008 18 9.72 (28.9) 12 7.5 (17.07) 22.0 % 2.22 [ -14.26, 18.70 ]
Lin 2009a 20 7.03 (14.73) 20 0.56 (16.07) 65.6 % 6.47 [ -3.08, 16.02 ]
Wu 2007c 13 11.16 (26.76) 13 -3.46 (30.35) 12.4 % 14.62 [ -7.38, 36.62 ]
Total (95% CI) 51 45 100.0 % 6.54 [ -1.20, 14.28 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.78, df = 2 (P = 0.68); I2 =0.0%
Test for overall effect: Z = 1.66 (P = 0.097)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
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Analysis 3.6. Comparison 3 Constraint versus control: secondary outcomes, Outcome 6 Dexterity.
Review: Constraint-induced movement therapy for upper extremities in people with stroke
Comparison: 3 Constraint versus control: secondary outcomes
Outcome: 6 Dexterity
Study or subgroup Constraint Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Constraint therapy versus usual care
Brunner 2012 14 0.12 (0.13) 16 0.1 (0.11) 27.4 % 0.16 [ -0.56, 0.88 ]
Hammer 2009 13 42 (52.8) 15 15.6 (36.4) 24.4 % 0.57 [ -0.19, 1.33 ]
Van Delden 2013 21 0.2 (0.2) 16 0.1 (0.1) 31.9 % 0.59 [ -0.07, 1.26 ]
Yoon 2014 9 14 (45.5) 9 0.89 (45.3) 16.3 % 0.28 [ -0.65, 1.20 ]
Total (95% CI) 57 56 100.0 % 0.42 [ 0.04, 0.79 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.00, df = 3 (P = 0.80); I2 =0.0%
Test for overall effect: Z = 2.18 (P = 0.029)
Test for subgroup differences: Not applicable
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Table 1. Criteria for subgroup analysis
Study ID Dosage of practice Anatomical restraint Constraint effect Time since stroke
1 = 3 hour or less; 2 =
more than 3 hours
1 = only hand; 2 = both
arm and hand
1 = restraint; 2 = restraint
plus exercise
1 =0 to3months; 2 = 3 to
9 months; 3 = more than
9 months; 4 = wide range
(from 0.5 to 37 months)
Alberts 2004 2 1 2 2
Atteya 2004 1 2 2 2
Azab 2009 1 1 2 1
Bergheim 2010 1 1 2 1
Boake 2007 2 1 2 1
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Table 1. Criteria for subgroup analysis (Continued)
Brogårdh 2009 1 1 2 1
Brunner 2012 1 1 2 1
Dahl 2008 2 1 2 4
Dromerick 2000 1 1 2 1
Dromerick 2009 1 1 2 1
Hammer 2009 1 2 1 1
Hayner 2010 2 1 2 3
Huseyinsinoglu 2012 1 1 2 2
Khan 2011 2 1 2 4
Kim 2008 1 1 1 3
Krawczyk 2012 2 2 2 3
Lin 2007 1 1 2 3
Lin 2009a 1 1 2 4
Lin 2010 1 1 2 4
Myint 2008 2 2 2 1
Page 2001 1 2 2 2
Page 2002b 1 2 2 2
Page 2004 1 2 2 3
Page 2005b 1 1 2 1
Page 2008 1 2 2 3
Ploughman 2004 1 1 2 1
Singh 2013 1 1 2 1
Smania 2012 1 1 2 2
Tariah 2010 1 1 2 2
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Table 1. Criteria for subgroup analysis (Continued)
Taub 1993 2 2 2 3
Treger 2012 1 1 2 1
Van Delden 2013 1 1 2 2
Wang 2011 1 1 2 1
Wittenberg 2003 2 2 2 3
Wolf 2006 2 1 2 2
Wu 2007a 1 1 2 4
Wu 2007b 1 1 2 4
Wu 2007c 1 1 2 4
Wu 2011 1 1 2 4
Wu 2012a 1 1 2 4
Yoon 2014 2 2 2 1
Table 2. Outcome measures used in the included studies
Study ID Arm mo-
tor func-
tion
Perceived
motor
function
Dexterity Arm
motor im-
pairment
Ac-
tivities of
daily liv-
ing
measures
Quality of
life
Kinemat-
ics
Neuro-
physio-
logics
Strength
Alberts
2004
Wolf Mo-
tor Func-
tion Test
Fugl
Meyer As-
sessment
Hand dy-
namome-
ter
Atteya
2004
Action Re-
search Arm
Test, Wolf
Mo-
tor Func-
tion Test
Motor Ac-
tivity Log
Fugl
Meyer As-
sessment
Azab 2009 Bartel In-
dex
Bergheim
2010
Wolf Mo-
tor Func-
tion Test,
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Table 2. Outcome measures used in the included studies (Continued)
Motor As-
sessment
Scale
Boake
2007
Motor Ac-
tivity Log
Grooved
Pegboard
Test
Fugl
Meyer As-
sessment
Transcra-
nial mag-
netic stim-
ulation
Brogårdh
2009
Motor As-
sessment
Scale,
Soller-
man Hand
Function
Scale
Motor Ac-
tivity Log
Brunner
2012
Action Re-
search Arm
Test
Nine-Hole
Peg Test
Dahl 2008 Wolf Mo-
tor Func-
tion Test
Motor Ac-
tivity Log
Functional
Indepen-
dence
Measure
Stroke Im-
pact Scale
Dromerick
2000
Action Re-
search Arm
Test
Dromerick
2009
Action Re-
search Arm
Test
Functional
Indepen-
dence
Measure
Stroke Im-
pact Scale
Hammer
2009
Action Re-
search Arm
Test,
Motor As-
sessment
Scale
Motor Ac-
tivity Log
Sixteen-
Hole Peg
Test
Fugl
Meyer As-
sessment
Grippit
Hayner
2010
Wolf Mo-
tor Func-
tion Test
Huseyinsinoglu
2012
Wolf Mo-
tor Func-
tion Test
Motor Ac-
tivity Log
Functional
Indepen-
dence
Measure
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Table 2. Outcome measures used in the included studies (Continued)
Khan2011 Wolf Mo-
tor Func-
tion Test
Motor Ac-
tivity Log
Kim 2008 Man-
ual Func-
tion Test
Motor Ac-
tivity Log
Perdue
Pegboard
Test
Krawczyk
2012
River-
mead mo-
tor assess-
ment arm
scale
Motor Ac-
tivity Log
Lin 2007 Motor Ac-
tivity Log
Functional
Indepen-
dence
Measure
Yes
Lin 2009a Motor Ac-
tivity Log
Fugl
Meyer As-
sessment
Functional
Indepen-
dence
Measure
Stroke Im-
pact Scale
Lin 2010 Motor Ac-
tivity Log
Fugl
Meyer As-
sessment
Functional
magnetic
resonance
Myint
2008
Action Re-
search Arm
Test
Motor Ac-
tivity Log
Nine-Hole
Peg Test
Bartel In-
dex
Page 2001 Action Re-
search Arm
Test, Wolf
Mo-
tor Func-
tion Test
Motor Ac-
tivity Log
Fugl
Meyer As-
sessment
Page
2002b
Action Re-
search Arm
Test
Motor Ac-
tivity Log
Fugl
Meyer As-
sessment
Page 2004 Action Re-
search Arm
Test
Motor Ac-
tivity Log
Fugl
Meyer As-
sessment
Page
2005b
Action Re-
search Arm
Test
Motor Ac-
tivity Log
Fugl
Meyer As-
sessment
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Table 2. Outcome measures used in the included studies (Continued)
Page 2008 Action Re-
search Arm
Test
Motor Ac-
tivity Log
Fugl
Meyer As-
sessment
Plough-
man
2004
Action Re-
search Arm
Test
Che-
doke Mc-
Master Im-
pairment
Inventory
Functional
Indepen-
dence
Measure
Jamar
Singh
2013
Wolf Mo-
tor Func-
tion Test
(only time)
Fugl
Meyer As-
sessment
Smania
2012
Wolf Mo-
tor Func-
tion Test
Motor Ac-
tivity Log
Tariah
2010
Wolf Mo-
tor Func-
tion Test
Motor Ac-
tivity Log
Fugl
Meyer As-
sessment
Taub 1993 Emory
Mo-
tor Func-
tion Test
Motor Ac-
tivity Log
Treger
2012
Man-
ual Func-
tion Test
Functional
Indepen-
dence
Measure
Van
Delden
2013
Action Re-
search Arm
Test
Motor Ac-
tivity Log
Nine-Hole
Peg Test
Fugl
Meyer As-
sessment,
Motricity
Index
Stroke Im-
pact Scale
Wang
2011
Wolf Mo-
tor Func-
tion Test
Witten-
berg
2003
Wolf Mo-
tor Func-
tion Test
Motor Ac-
tivity Log
Transcra-
nial mag-
netic stim-
ulation,
positron
emission
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Table 2. Outcome measures used in the included studies (Continued)
tomogra-
phy
Wolf 2006 Wolf Mo-
tor Func-
tion Test
Motor Ac-
tivity Log
Stroke Im-
pact Scale
Wu 2007a Motor Ac-
tivity Log
Functional
Indepen-
dence
Measure
Stroke Im-
pact Scale
Yes
Wu 2007b Motor Ac-
tivity Log
Fugl
Meyer As-
sessment
Yes
Wu 2007c Motor Ac-
tivity Log
Fugl
Meyer As-
sessment
Functional
Indepen-
dence
Measure
Stroke Im-
pact Scale
Wu 2011 Wolf Mo-
tor Func-
tion Test
Motor Ac-
tivity Log
Yes
Wu 2012a Action Re-
search Arm
Test
Motor Ac-
tivity Log
Stroke Im-
pact Scale
Yoon 2014 Wolf Mo-
tor Func-
tion Test
Nine-Hole
Peg Test,
Box and
Block Test
Fugl
Meyer As-
sessment
Bartel In-
dex
Hand Dy-
namome-
ter
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A P P E N D I C E S
Appendix 1. CENTRAL search strategy
The Cochrane Central Register of Controlled Trials (CENTRAL) (onlinelibrary.wiley.com)
#1 MeSH descriptor: [Cerebrovascular Disorders] explode all trees
#2 MeSH descriptor: [Brain Injuries] this term only
#3 MeSH descriptor: [Brain Injury, Chronic] this term only
#4 #1 or #2 or #3
#5 stroke* or cva or poststroke or post-stroke (Word variations have been searched)
#6 cerebrovasc* or “cerebral vascular” (Word variations have been searched)
#7 cerebral or cerebellar or brain* or vertebrobasilar (Word variations have been searched)
#8 infarct* or isch?emi* or thrombo* or emboli* or apoplexy (Word variations have been searched)
#9 #7 and #8
#10 cerebral or brain or subarachnoid (Word variations have been searched)
#11 hamorrhage or hemorrhage or haematoma or hematoma or bleed* (Word variations have been searched)
#12 #10 and #11
#13 MeSH descriptor: [Hemiplegia] this term only
#14 MeSH descriptor: [Paresis] explode all trees
#15 #13 or #14
#16 hempar* or hemipleg* or paresis or paretic or “brain injur*” (Word variations have been searched)
#17 #4 or #5 or #6 or #9 or #12 or #15 or #16
#18 MeSH descriptor: [Upper Extremity] explode all trees
#19 “upper limb*” or “upper extremit*” or “arm” or “shoulder” or “hand” or “axilla” or “elbow*” or “forearm*” or “finger*” or “wrist*”
(Word variations have been searched)
#20 #18 or 19
#21 MeSH descriptor: [Restraint, Physical] this term only
#22 MeSH descriptor: [Exercise Movement Techniques] this term only
#23 MeSH descriptor: [Exercise] this term only
#24 MeSH descriptor: [Exercise Therapy] this term only
#25 MeSH descriptor: [Immobilization] this term only
#26 MeSH descriptor: [Physical Therapy Modalities] this term only
#27 “constrain*” or “restrain*” or “immobili*” (Word variations have been searched)
#28 “mCIMT” or “CIT” or “CI therapy” or “forced use” (Word variations have been searched)
#29 MeSH descriptor: [Recovery of Function] this term only
#30 MeSH descriptor: [Splints] this term only
#31 MeSH descriptor: [Casts, Surgical] this term only
#32 #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28 or #29 or #30 or #31
#33 #17 and #20 and #32 in Trials
Appendix 2. MEDLINE (Ovid) search strategy
The following search strategy, which was developed by the Cochrane Stroke Group Trials Search Coordinator, was used for MEDLINE
(Ovid) and was adapted for the Cochrane Central Register of Controlled Trials (CENTRAL).
1. exp cerebrovascular disorders/ or brain injuries/ or brain injury, chronic/
2. (stroke$ or cva or poststroke or post-stroke).tw.
3. (cerebrovasc$ or cerebral vascular).tw.
4. (cerebral or cerebellar or brain$ or vertebrobasilar).tw.
5. (infarct$ or isch?emi$ or thrombo$ or emboli$ or apoplexy).tw.
6. 4 and 5
7. (cerebral or brain or subarachnoid).tw.
8. (haemorrhage or hemorrhage or haematoma or hematoma or bleed$).tw.
9. 7 and 8
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10. hemiplegia/ or exp paresis/
11. (hempar$ or hemipleg$ or paresis or paretic or brain injur$).tw.
12. 1 or 2 or 3 or 6 or 9 or 10 or 11
13. exp upper extremity/
14. (upper limb$ or upper extremit$ or arm or shoulder or hand or axilla or elbow$ or forearm$ or finger$ or wrist$).tw.
15. 13 or 14
16. restraint, physical/
17. exercise movement techniques/ or exercise/ or exercise therapy/
18. immobilization/
19. physical therapy techniques/
20. (constrain$ or restrain$ or immobili$).tw.
21. (mCIMT or CIT or “CI therapy” or “forced use”).tw.
22. recovery of function/
23. splints/ or casts, surgical/
24. 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23
25. 12 and 15 and 24
Appendix 3. EMBASE search strategy
EMBASE (Ovid)
1. cerebrovascular disease/ or exp basal ganglion hemorrhage/ or cerebral artery disease/ or exp cerebrovascular accident/ or stroke/ or
exp carotid artery disease/ or exp brain hematoma/ or exp brain hemorrhage/ or exp brain infarction/ or exp brain ischemia/ or exp
intracranial aneurysm/ or exp occlusive cerebrovascular disease/ or exp brain injury/ or stroke patient/ or stroke unit/
2. (stroke$ or cva or poststroke or post-stroke).tw.
3. (cerebrovasc$ or cerebral vasc$).tw.
4. (cerebral or cerebellar or brain$ or vertebrobasilar).tw.
5. (infarct$ or isch?emi$ or thrombo$ or emboli$ or apoplexy).tw.
6. 4 and 5
7. (cerebral or brain or subarachnoid).tw.
8. (haemorrhage or hemorrhage or haematoma or hematoma or bleed$).tw.
9. 7 and 8
10. hemiplegia/ or hemiparesis/ or paresis/
11. (hemipleg$ or hemipar$ or paresis or paretic or brain injur$).tw.
12. 1 or 2 or 3 or 6 or 9 or 10 or 11
13. exp arm/
14. (upper limb$ or upper extremit$ or arm or shoulder or hand or axilla or elbow$ or forearm$ or finger$ or wrist$).tw.
15. 13 or 14
16. constraint induced therapy/ or exp exercise/ or exp kinesiotherapy/ or physiotherapy/ or immobilization/
17. (restrain$ or constrain$ or immobili$).tw.
18. (mCIMT or CIT or CI therapy or “forced use”).tw.
19. dynamic splint/ or plaster cast/ or splint/
20. (splint$ or cast or casts).tw.
21. or/16-20
22. 12 and 15 and 21
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Appendix 4. CINAHL search strategy
CINAHL (Ebsco)
S1 .(MH “Cerebrovascular Disorders+”) or (MH “stroke patients”) or (MH “stroke units”)
S2 .TI ( stroke or poststroke or post-stroke or cerebrovasc* or brain vasc* or cerebral vasc or cva or apoplex or SAH ) or AB ( stroke or
poststroke or post-stroke or cerebrovasc* or brain vasc* or cerebral vasc or cva or apoplex or SAH )
S3 .TI ( brain* or cerebr* or cerebell* or intracran* or intracerebral ) or AB ( brain* or cerebr* or cerebell* or intracran* or intracerebral
)
S4 .TI ( ischemi* or ischaemi* or infarct* or thrombo* or emboli* or occlus* ) or AB ( ischemi* or ischaemi* or infarct* or thrombo*
or emboli* or occlus* )
S5 .S3 and S4
S6 .TI ( brain* or cerebr* or cerebell* or intracerebral or intracranial or subarachnoid ) or AB ( brain* or cerebr* or cerebell* or
intracerebral or intracranial or subarachnoid )
S7 .TI ( haemorrhage* or hemorrhage* or haematoma* or hematoma* or bleed* ) or AB ( haemorrhage* or hemorrhage* or haematoma*
or hematoma* or bleed* )
S8 .S6 and S7
S9 .(MH “Hemiplegia”)
S10 .TI ( hemipleg* or hemipar* or paresis or paretic ) or AB ( hemipleg* or hemipar* or paresis or paretic )
S11 .(MH “Left Hemisphere Injuries”) OR (MH “Right Hemisphere Injuries”) OR (MH “Brain Injuries”)
S12 .(MH “Upper Extremity+”)
S13 .TI ( upper limb* or upper extremit* or arm or shoulder or hand or axilla or elbow* or forearm* or finger* or wrist* ) or AB ( upper
limb* or upper extremit* or arm or shoulder or hand or axilla or elbow* or forearm* or finger* or wrist* )
S14 .(MH “Constraint-Induced Therapy”)
S15 .(MH “Restraint, Physical”)
S16 .(MH “Immobilization”)
S17 .(MH “Taping and Strapping”)
S18 .(MH “Exercise+”)
S19 .(MH “Therapeutic Exercise+”)
S20 .(MH “Physical Therapy/MT”)
S21 .(MH “Slings”) OR (MH “Splints”)
S22 .(MH “Casts”)
S23 .(MH “Task Performance and Analysis”)
S24 .TI ( constrain* or restrain* or immobil* ) or AB ( constrain* or restrain* or immobil* )
S25 .TI ( mCIT or CIT or “CI therapy” or “forced use” or splint* or cast or casts ) or AB ( mCIT or CIT or “CI therapy” or “forced
use” or splint* or cast or casts )
S26 .S1 or S2 or S5 or S8 or S9 or S10 or S11
S27 .S12 or S13
S28 .S14 or S15 or S16 or S17 or S18 or S19 or S20 or S21 or S22 or S23 or S24 or S25
S29 .S26 and S27 and S28
Appendix 5. AMED (Ovid) search strategy
AMED (Ovid)
1. cerebrovascular disorders/ or cerebral hemorrhage/ or cerebral infarction/ or cerebral ischemia/ or cerebrovascular accident/ or stroke/
2. brain injuries/ or hemiplegia/
3. (stroke$ or cva or poststroke or post-stroke).tw.
4. (cerebrovasc$ or cerebral vascular).tw.
5. (cerebral or cerebellar or brain$ or vertebrobasilar).tw.
6. (infarct$ or isch?emi$ or thrombo$ or emboli$ or apoplexy).tw.
7. 5 and 6
8. (cerebral or brain or subarachnoid).tw.
9. (haemorrhage or hemorrhage or haematoma or hematoma or bleed$).tw.
10. 8 and 9
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11. (hempar$ or hemipleg$ or brain injur$).tw.
12. 1 or 2 or 3 or 4 or 7 or 10 or 11
13. exp arm/
14. (upper limb$ or upper extremit$ or arm or shoulder or hand or axilla or elbow$ or forearm$ or finger$ or wrist$).tw.
15. 13 or 14
16. restraint physical/
17. exercise/ or exercise movement techniques/ or exercise therapy/
18. immobilization/ or casting/ or splinting/
19. physical therapy modalities/
20. splints/
21. “recovery of function”/
22. (constrain$ or restrain$ or immobili$).tw.
23. (mCIT or CIT or “CI therapy” or “forced use” or splint$ or cast or casts).tw.
24. 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23
25. 12 and 15 and 24
Appendix 6. PEDro search strategy
PEDro is a web-based database of randomised controlled trials and systematic reviews relevant to physiotherapy. The following search
strategy was used.
Abstract and Title: constraint, stroke, cva, poststroke, hemi, brain injur, *matoma, bleed, cerebrovasc, cerebral, brain, infarct, thrombo.
Body part: upper arm, shoulder or shoulder girdle / forearm or elbow / hand or wrist.
All search terms in the title or abstract were combined with body part descriptors using the AND operator.
WH A T ’ S N E W
Last assessed as up-to-date: 15 January 2015.
Date Event Description
31 May 2015 New search has been performed We updated the searches to January 2015 and have included
several new trials in the review; the previous review included
19 trials while the current version includes 42 trials involving
1453 participants
31 May 2015 New citation required and conclusions have changed New trials included in the review led to changes of the esti-
mated effects of treatment. Statistical significance and mean-
ingful differences were lost for clinically relevant outcomes,
changing our interpretation of results. Our conclusions are
now more conservative
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H I S T O R Y
Protocol first published: Issue 4, 2003
Review first published: Issue 4, 2009
Date Event Description
24 April 2008 Amended Converted to new review format.
C O N T R I B U T I O N S O F A U T H O R S
This systematic review has been written on the basis of the review authors’ clinical experience (VS, DC and RG). All review authors
contributed to all stages of the review. Three review authors (VS, DC and GC) independently assessed study selection, data extraction
and methodological quality. We resolved disagreements by consensus, and consulted a fourth review author (RG) if disagreement
persisted. LM provided insight into epidemiological and statistical methods. VS, DC, RG and LM drafted different parts of the
manuscript.
D E C L A R A T I O N S O F I N T E R E S T
Davide Corbetta: none known.
Valeria Sirtori: none known.
Greta Castellini: none known.
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• None, Other.
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This project was supported by the National Institute for Health Research, via Cochrane Incentive Award funding to the Cochrane
Stroke Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
In 2003, based on the-then existing evidence about CIMT, the protocol for this review was published in The Cochrane Library (Sirtori
2003); subsequently, the same authors found that the protocol did not reflect the increasing variability among potentially relevant
primary studies and the review was out of date in terms of systematic review methodology. The main shortcomings in the protocol
related to:
• the inclusion criteria in terms of participants, interventions and outcome measures, as they were too restrictive and narrowly
focused, being de facto a subgroup analysis (Higgins 2011). Outcome measures added during the systematic review process were not
present in the original protocol of this review. These items were perceived as being of importance for physiotherapists and people with
stroke, and offer a more complete picture about the efficacy of this technique;
• the Methods section, which did not provide enough detail to ensure replicability.
We have now revised these sections extensively, with the following main amendments.
• Background: to reflect what is known in 2015.
• Objectives: to include studies investigating not only CIMT but also modified CIMT (mCIMT) and Forced Use (FU) therapy,
which are closely related and belong to one specific class of intervention.
• Types of interventions: to include interventions that differ widely in duration and intensity.
• Types of outcome measures: new secondary outcomes were added in order to offer physiotherapists and people with stroke a
more complete picture of the efficacy of this technique.
• Methods of the review: to provide enough detail to allow repetition of the review by other researchers.
We considered these legitimate reasons to modify the original protocol.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Upper Extremity; Exercise Movement Techniques [∗methods]; Immobilization [∗methods]; Paresis [etiology; ∗rehabilitation]; Ran-
domized Controlled Trials as Topic; Stroke [complications; ∗rehabilitation]; Time Factors
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Humans
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